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ABSTRACT 
 
 
Bone is a tissue that continuously adapts to changes in mechanical load. This process 
can also result in maladaptive ectopic bone in response to injury and extreme 
mechanical insult, in a group of conditions known as heterotopic ossification.  
Despite recent advancements, pathological differences at the molecular and structural 
levels are poorly understood. A number of in vivo models exist but can often be 
unreliable or too complex to allow isolation of factors which may stimulate progression 
of ossification.  
This thesis presents the development of a biologically self-structuring model of mature 
bone formation using a fibrin gel which self-organises between two calcium phosphate 
ceramic anchors when seeded with cells. These bioinspired early wound analogues are 
seeded with primary femoral periosteal cells - key players in bone repair and a range of 
pathologies- and develop longitudinally over significant culture periods, allowing to 
study the temporal evolution of bone mineral and microstructure in excess of a year. 
This work demonstrates the production of a mature, bone-like morphology and 
chemistry, with differentiation of mature, mineral phase osteocytes. 
Raman spectroscopy and XRD revealed that the mineral was non-stoichiometric and 
poorly crystalline hydroxyapatite and associated with collagen. Second harmonic 
imaging demonstrated that collagen was organized similarly to mature mouse femora. 
The initial stem cell population differentiated to the terminal osteocytic phase, was 
integrated into longitudinal networks similar to the canaliculi in mature bone (as 
demonstrated with nanoCT) and remained viable over the full year of culture. Using this 
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model, this work demonstrated that pharmacological compounds can prevent the 
progress of ossification, displaying promise for applications in drug screening. Pilot 
work also showed that it is possible to initiate angiogenesis in these constructs, with 
endothelial tubes also aligned with the mechanical axis, a step closer to mimicking in 
vivo bone. 
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SIGNIFICANCE STATEMENT 
 
The work performed here is unique since it allows the growth of tissue that not only 
shares the biochemical composition of bone, but also exhibits a similar structure. The 
tissues that were produced contain populations of mature cells, osteocytes, which are 
linked by canalicular networks as encountered in vivo. The system developed here 
allows the maintenance of the osteocytic phenotype for one year in culture, a major 
advance on the current state of the art, which allows the culture of these cells for less 
than one month.  The biological relevance and utility of this system was demonstrated 
by blocking bone formation with a retinoic acid receptor (RAR) inhibitor that prevents 
ossification at the early chondrogenic stage.  This model will be an excellent tool for 
studying both aberrant and normal processes of bone formation. 
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spine, small hip size, weak knee joints and flat feet with expansive toes show that this primate is not normally bipedal but uses the 
arms for balance. b, Australopithecus sediba, hominin skeleton. This species of primate, originating from South Africa (1.95 million 
years old) shows an upright posture which indicates its hominin nature.  Compared to the specimen in a, this primate shows a 
smaller body and skull and longer lower limbs. c, Homo sapiens, female skeleton (France, 150 years old).  The only extant human 
species, which developed skeletal adaptations for upright walking, including several curvatures on the spine for balance and 
absorbing the mechanical shocks, arched feet, and similarly to the specimen in b, inward directed femurs used to transfer the weight 
of the trunk to the knees and lower bones. Note: image scales are not related, and have been enlarged to allow visualisation of skeletal 
parts. Original images. The author would like to thank the Natural History Museum, South Kensington, London. 
……………………………………………………………………………………………………………………………………………………………………………………………….4 
 
 
 
Figure 1.2 | Skeletal systems and limb bones from different orders and classes of animals have evolved to meet the mechanical 
demands of their environments. a, Fish; b, Monotremes; c, Primates; d, Amphibians; e, Birds. The common bones used to translate 
the mechanical forces from the trunk to the lower parts of the limbs for locomotion are shown in black boxes. Original images. 
Author would like to thank the Lapworth Museum of Geology, University of Birmingham. 
……………………………………………………………………………………………………………………………………………………………………………………………….6 
 
 
 
Figure 1.3 | The adaptation of bird skulls to different niches and environments, showing dramatic differences in the osseous 
structures of the beaks. a, Cross-section through the skull of a Rhinoceros Hornbill (Buceros rhinoceros), showing hollow air-filled 
pockets in its skeletal structure, a feature evolved to meet energetic costs during flying. b, Skull of a Silvery-Cheeked Hornbill, a bird 
related to the specimen in a but showing a distinct anatomical beak structure, a feature which is under tight genetic regulation. c-g, 
The adaptation of the osseous structures of the beaks according to different living environments and thus food sources.  c, 
Magellanic penguin – fish diet; d, Hyacinth macaw – diet of nuts from palm trees; e, Common toucan – fruit diet; f, Roseate spoonbill 
– diet of insects; g, Scarlet ibis -diet of shrimps and other crustaceans; This dietary specialisation was one of the observations which 
led to the development of Darwin’s theory of natural selection.  Original images. Author would like to thank the Lapworth Museum of 
Geology, University of Birmingham and the Natural History Museum, South Kensington, London. 
……………………………………………………………………………………………………………………………………………………………………………………………….10 
 
 
 
Figure 1.4 | The anatomical adaptation of the skeletons of flying vertebrates. a, Skeleton of a pigeon used by Charles Darwin as part 
of his research and development of the theory of evolutionary adaptation, later described in the Origin of Species. Specimens 
demonstrates a large wing bone size compared to the body size, a skeletal adaptation to powered flight. This feature can also be 
seen in other species which have evolved from a different lineage, such as the common pipistrelle bat skeleton (Pipistrellus 
pipistrellus) (b); and in the avian ancestors such as Pteranodon, a flying reptile from late Cretaceous (approx. 86-83 million years 
old) (c). Original images. Author would like to thank the Natural History Museum, South Kensington, London. 
……………………………………………………………………………………………………………………………………………………………………………………………….11 
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Figure 1.5 | Functions of bones. Bones perform numerous functions including supporting the body during movement, providing 
levers for moving the limbs (a); protecting the fragile internal organs (ribcage) (b) and the spine (b-c); as well as supporting the 
weight of the trunk during walking (c). Original images acquired from a skeletal specimen at the Natural History Museum, South 
Kensington, London.  
……………………………………………………………………………………………………………………………………………………………………………………………….14 
 
 
Figure 1.6 | Bone textures: spongy and compact bone in the femur. Long bones are composed of two texturally different types of 
tissue, compact bone and spongy bone, adapted for providing support during different types of mechanical load. The outer cortical 
layer is lined externally by the periosteum and internally by the endosteum. The internal cavities of bones contain the red and 
yellow marrow. Original image. Image of the femoral section acquired from a skeletal specimen at the Natural History Museum, South 
Kensington, London.  
……………………………………………………………………………………………………………………………………………………………………………………………….18 
 
 
Figure 1.7 | Structure of an osteon. Individual lamellae are arranged concentrically and are composed of mineralised collagenous 
fibres arranged in different directions in each lamellar unit to provide maximal resistance to stress. Centrally, osteons act as 
passageways for blood vessels (arteries and veins) and nerve fibres and are lined internally by the endosteum.  
……………………………………………………………………………………………………………………………………………………………………………………………….21 
 
 
Figure 1.8 | Horizontal section through an osteon. Osteocytes, the mature bone cells, are arranged concentrically at the junctions 
between lamellae. They are embedded in lacunae and linked by canaliculi, which allow cell-to-cell communication and connect to 
the endosteum.  
……………………………………………………………………………………………………………………………………………………………………………………………….22 
 
 
Figure 1.9 | Apatite mineral. Apatite is a calcium phosphate mineral that is produced and used by many biological environmental 
systems. Hydroxyapatite, one of principal types of apatite, is the main inorganic component of bone and dentin. Original image. 
Author would like to thank the Lapworth Museum of Geology, University of Birmingham. 
……………………………………………………………………………………………………………………………………………………………………………………………….26 
 
 
Figure 1.10 | Simplified schematic of the organic-inorganic hierarchical structure in bone tissue. This model was first proposed by 
(Petruska and Hodge 1964). Collagen molecules (normally triple-helical, simplified here) are arranged end-to-end and parallel to 
each other. These structures contain spaces of approximately 36 nm between them, which facilitate nucleation by apatitic crystals. 
The mineral develops in this space in the fibrils. Diagram inspired from (Fang and Holl 2013) and (Alexander, Daulton et al. 2012). 
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Figure 1.11 | Biomineralization is a process encountered in many orders and in the invertebrate forms of life, such as the 
exoskeletons of many arthropods, including extinct organisms such trilobites from the Palaeozoic Era (a-Ogyginus Cordensis trilobite 
and b- Ceratarges Armatus trilobite); shells of crustaceans including the Corystidae family (including crabs); the marine shells of 
gastropods (d-e) and coral skeletons (f). Original images. Author would like to thank the Lapworth Museum of Geology, University of 
Birmingham. 
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Figure 1.12 | Bending stress in femoral bones is distributed according to anatomical design. The weight of the upper body is 
transmitted to the femoral head, articulated to the hip. These compression (bending) forces act primarily along the dotted line, 
creating tensile (stretching) forces on one side (blue arrows) and compression on the other side (red arrows). These forces cancel 
each other internally, with very little stress being experienced in this region (white dot).  Schematic inspired from (Marieb and 
Hoehn 2010). Original image. Image of the femoral section acquired from a skeletal specimen at the Natural History Museum, South 
Kensington, London. 
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Figure 1.13 | Adaptation of dominant hand to increased loading forces. Cross-sectional differences in the arms of tennis players 
following prolonged periods of intense exercise. Bones of the racquet arm increase in strength and rigidity and the effect is more 
pronounced in players who started this type of exercise early in life. Diagram is based on CT/MRI cross-sectional appearance of arm 
bones and inspired by (Marieb and Hoehn 2010). 
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Figure 1.14 | Schematic of the tissue morphogenesis during fracture repair. a, The outside layer of long bones (periosteum) is a 
well-vascularised tissue. b, Trauma during fracture disrupts the blood supply at the site, which leads to the formation of a blood clot, 
also known as hematoma (c). Periosteal cells located inside the deeper, cambium layer, migrate to the site of injury (d) where they 
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is completely replaced (f). Following maturation, the cartilage template becomes progressively replaced with intramembranous 
bone (g-h), which is ultimately conversed under the action of osteoblasts and osteoclasts into lamellar bone and the initial geometric 
shape and function of the fractured bone is restored. 
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Figure 1.15 | Spinal fusion in Scoliosis. a, A spinal section from a patient with this condition, containing 2 cervical and 10 dorsal 
vertebrae. The bodies of the 3rd, 4th and 5th vertebra fused as a result of vertebral disk ossification and formed a bone mass, which 
created a typical S-shaped deformation in the upper dorsal region. At this stage of the disease, there appears to be no alteration in 
the vertebra located below and above. b, A more advanced case of scoliosis where the curvature and deformation caused a 
significant rotation of the vertebral bodies, which affected the thoracic greatly by reducing its size on the right side. The 4th-11th 
dorsal vertebra are ankylosed and fused together by a bony mass. c, An advanced case of scoliosis, showing multiple curvatures. The 
first one is caused by the fusion of the upper vertebra, causing a convex curvature to the right, and a fusion of the lower dorsal and 
lumbar vertebra, which causes a convex curvature to the left. These ectopic bone formations caused the vertebral bodies in the 
thoracic region to rotate significantly, causing a rib movement towards the back at the junction with vertebral bodies and got 
carried forward at the other end. As a result, the ribs became crowded together and their shafts became ossified and fused. Original 
images. Author would like to thank King’s College London.  
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Figure 1.16 | Ossification of the spine and the sacro-iliac joint in Ankylosing Spondylitis. a, A section of the spine of a patient with 
this condition, showing significant ankylosing of 6 cervical and the first dorsal vertebrae, which are firmly united on the anterior 
side due to ossification of the anterior common ligament; b, A specimen containing 4 dorsal vertebrae, which show an advanced 
degree ossification and ankylosis. The ligaments surrounding the vertebrae have become converted into compact bone, causing the 
joint cavities to become narrow and fixing them in place, causing immobility. The inter-spinous ligaments are also ossified, and 
fused to the transverse processes of the vertebra; c, This specimen from the lower part of the spine shows osteo-arthritis of the 
lumbar spine by spondylitis. The 3 lumbar vertebra show prominent osteophytic outgrowths emerging from the margins of the cell 
bodies, restricting movement, but they do not show signs of ankylosis. The intervertebral space has become narrower due to a 
partial collapse of the vertebral bodies; d, In contrast, this specimen, containing the last 3 lumbar vertebra as well as portions of the 
sacrum and ilia shows ankylosis caused by ossification of the ligaments connecting the vertebra of the lumbar and sacrum regions. 
In addition, the sacro-iliac joints are also partially ossified and ankylosed, showing a high degree of osteophytosis and disk space 
damage; e, A spine from a patient with advanced ankylosis. The specimen has been cut longitudinally, showing a striking, complete 
replacement of all intervertebral disks by trabecular bone, making it very difficult to distinguish between the original bone structure 
and the newly formed bone, which appear to be continuous with each other. Laterally, the vertebra and disk spaces are surrounded 
by compact bone, which has formed in the outer part surrounding the trabecular bone and highlights the complexity of the 
pathological bone formation. Original images. 
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Figure 1.17 | Ectopic bone formation following spinal fractures and osteosarcoma. a, Portion of a spine that underwent trauma 
causing dislocation of the dorso-lumbar region. A mass of new bone emerges from and connects the last 2 dorsal and first 3 lumbar 
vertebra. b-c, A similar bone formation takes place in secondary sarcoma, in this specimen from the lumbar region showing a mass 
of imperfectly ossified growth which has been deposited on the surface of the vertebral body under the periosteum. Original images. 
……………………………………………………………………………………………………………………………………………………………………………………………….68 
 
 
 
Figure 1.18 | Ectopic ossification of the hip joints in osteoarthritis. Femoral bone heads and hip joints show ossification as a result 
of osteoarthritis. The femoral heads show thick, osteophytic collars and further ossification can be seen at the point of attachment, 
where the ligamentum teres is located. The acetabulum appeared re-modelled by osteophytic bony outgrowths, causing abnormal 
grooves in which the abnormal femoral heads fit. Original images. 
……………………………………………………………………………………………………………………………………………………………………………………………….69 
 
 
 
Figure 1.19 | Osteosarcomas of the upper and lower limbs. a-b, Osteomas of the humeral bones. a, Presents a lobulated growth of 
very dense, cortical bone attached to a large part of the upper shaft. b, Longitudinal section through the upper part of a humerus, 
which has been invaded by a large tumour, composed of dense connective tissue. The original structure of the shaft is completely 
lost in the newly forming bone; c, Parosteal osteosarcoma of the tibia, situated between the metaphysis and upper diaphysis. The 
underlying tibial shaft is preserved. This type of osteosarcoma produces large quantities of mature bone without affecting the 
medullary cavity; d, Osteosarcoma of the lower part of the femur, extending from the articular surface upwards, causing significant 
destruction of the bone tissue. The cavity left behind shows a growth of spongy bone. Original images. 
……………………………………………………………………………………………………………………………………………………………………………………………….70 
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Figure 1.20 | Osteomyelitis of the upper and lower limbs. a, Chronic osteomyelitis of the humerus where the whole shaft has 
undergone necrosis as a result of acute osteomyelitis and has been replaced by a hollow cylinder of new bone, which is significantly 
deformed and communicates with the exterior using several openings, or grooves; b, Acute osteomyelitis of the right humerus, 
showing necrosis of a significant part of its shaft, and forms a sequestrum which lies within an involucrum composed of dense bone 
growing from the periosteum. c, Chronic osteomyelitis of the femur, showing great amounts of new bone (involucrum), perforated 
by 3 large openings. At the top end, a sequestrum can be observed; d, Chronic osteomyelitis of the femur which has been divided 
sagitally. The shaft is greatly thickened, and the marrow cavity has been replaced with dense white bone. Original images. 
……………………………………………………………………………………………………………………………………………………………………………………………….71 
 
 
Figure 1.21 | Fracture non-union and ectopic bone deposition in fracture malunion. a, Example of a transversal fracture of the 
humerus, just above the condyle, resulting in non-union; b, An oblique fracture which damaged the upper shaft of a femoral bone, 
leading to a significant and firm bony mal-union between the two parts, which causes significant deformity. The lower part rotated 
inwards and at the same time moved upwards, resulting in a disarrangement where the broken end is located at a higher level than 
the femoral head; c, Fracture of the middle third of a femur, where the upper fragment lies in front of the lower one.  Despite this 
arrangement, a firm bony mal-union took place, formed of dense, mature bone; d, Coronal section of an oblique fracture through the 
shafts of both the tibia and fibula. Because of the outward displacement of fractured ends, the upper fragment of the fibula has come 
into contact with the lower part of the tibia and has become fused to it through a firm, dense mass of bone. Original images. 
……………………………………………………………………………………………………………………………………………………………………………………………….73 
 
 
Figure 1.22 | Other conditions of abnormal bone deposition. a, Rickets. Longitudinal section through a tibia of an individual with the 
condition showing a significant deformation and a thickening of the cortical bone on the concave surface. b, Paget’s disease (Osteitis 
deformans). Longitudinal sections through the tibia and femoral bone. The femoral bone (right) shows a marked convexity and 
enlargement and is composed of porous bone, which has been deposited in patches. Compact bone is increased in thickness. Both 
tibia (left) and fibula show a similar appearance externally and internally to the femur. Original images. 
……………………………………………………………………………………………………………………………………………………………………………………………….74 
 
 
Figure 2.1 | Schematic representation of the development of a construct over time. Contraction and alignment of the matrix occur 
maximally within the first 7 days. Within the following 2-3 days, the mineralization process becomes apparent, through the creation 
of nucleation points which aid in the formation of mineralized nodules, most prominently around the two anchors. These nodules 
increase in size over the first month in culture and ultimately fuse into a fully mineralized matrix. Following 1 month in culture, 
significant amounts of collagen can be detected around the anchor areas. The mineralized matrix advances from the anchor regions 
towards the centre of the construct until the previous template is completely substituted with the new, bone-like matrix containing 
hydroxyapatite-like mineral. Cells differentiate into osteocyte-like cells after 2 months of full osteogenic supplementation and 
maintain their phenotype over the extended months in culture.  
……………………………………………………………………………………………………………………………………………………………………………………………….94 
 
 
Figure 2.2 | Cell morphologies observed in 2D prior to embedding in fibrin hydrogels.  a, Femoral periosteal cells cultured in 2D for 
ten days displayed typical osteoblastic morphology (a-b), with some developing long projections (c). A few cells appeared 
hypertrophic, with typical senescent morphology (d). 
……………………………………………………………………………………………………………………………………………………………………………………………….97 
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Figure 3.1 | Early construct development. a, Fibrin scaffold is reorganized around the retention points over the first week in culture. 
Control constructs, developed without cells showed a small degree of contraction over 7 days, but remained as flat gels and did not 
assemble into 3D structures. b, Tensile forces between the two anchor points cause cell alignment before day 6 (left). Mineralization 
nodules are observed throughout the structure after 10 days (middle). c, Mineral deposits are not noticeable following 7 days but 
individual mineralization points can be observed 4 days later in the close proximity of the calcium phosphate source. Scale bars b = 
50 µm (Day 6, 10), 200 µm (Day 11). d, Changes in the fibrin template are visually noticeable at 14 days, with a distinct matrix 
forming from the anchor regions towards the centre, until the constructs appear to be fully covered with the new matrix at 3 
months. 
……………………………………………………………………………………………………………………………………………………………………………………………….109 
 
 
Figure 3.2 | The effect of CaP anchors on matrix contraction and alignment. Previous work has demonstrated that in the 
absence of anchors (illustrated in the diagram series in the top row), cells contract the fibrin scaffolds over three weeks into 
spherical structures (a), whereas the provision of the 2 retention points (bottom row) allows the formation of a cylindrical structure 
in-between the two calcium phosphate structures (b). Scale bars = 10 mm.  
……………………………………………………………………………………………………………………………………………………………………………………………….110 
 
 
Figure 3.3 | Anchors are required for cellular alignment in constructs. Previous work has demonstrated using 
immunofluorescence staining that the formation of tensile forces during contraction causes alignment at a cellular level, with the 
cytoskeleton and nuclei arranged along the direction of force. Confocal microscopy images of (a) disordered cells in unanchored 
constructs at day 0 and (b) elongated, highly aligned cells in anchored constructs at day 18.  
……………………………………………………………………………………………………………………………………………………………………………………………….111 
 
 
Figure 4.1 | Inelastic scattering in Raman spectroscopy. This technique uses monochromatic light (laser) to excite photons to virtual 
energy states. When photos are scattered from a molecule most of them are elastically scattered (Rayleigh scattering), having the 
same energy (frequency and wavelength) as the incident photons. A very small proportion of these photons (1 in 10 million) are 
scattered inelastically (Raman scattering), which involves the loss (Stokes) or gain (anti-Stokes) of energy due to the interaction of 
light with vibrations associated with bonds within the sample.  
……………………………………………………………………………………………………………………………………………………………………………………………….115 
 
 
Figure 4.2 | The optical effect of Second Harmonic Generation. Collagen has a molecular structure (triple helix) which is non-centro-
symmetrical. The incident monochromatic light emitted by a laser interacts with collagen and creates an oscillating field at twice the 
frequency and half the wavelength. 
……………………………………………………………………………………………………………………………………………………………………………………………….117 
 
 
Figure 4.3 | Applications of non-destructive XRF. a, XRF follows a series of processes including a photoelectron ejection from the 
atomic shell exposed to high-energy primary X-Ray radiation and the subsequent ‘jump’ of an outer electron from the near shells in 
order to fill this vacancy. The process is associated with the emission of X-Ray Fluorescence, with different characteristics for each 
chemical element. When the jump takes place from the L to the K layer, it is known as the Kα emission line. When an electron from 
the M layer jumps to fill the place, the emission line is known as Kβ.  b-e, Due to its non-destructive properties and highly accurate 
detection levels, this technique has been recently applied to some of the most valuable historical artefacts and paintings, including 
Mona Lisa (b), St. John the Baptist (c), Bacchus (d) and the Gayer-Anderson cat (e).  Original images. Author would like to thank the 
Louvre Museum, Paris and the British Museum, London. 
……………………………………………………………………………………………………………………………………………………………………………………………….120 
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Figure 4.4 | Development of mineralization and matrix over time. a-n, Reconstructed µCT images of early constructs (days 12-15, a-
c/h-j) and mature constructs (3 months – 1 year, d-g/k-n), illustrating the development of ossification over time. a-e, Mineralization 
starts at the anchors (a) and progresses over time throughout the entire length of the constructs (b-c) until the mineral covers the 
entire structure of constructs (d-e). Bottom panel presents colour-coded versions of the constructs above, illustrating the 
development of the new matrix over time. The fibrin template (green), which predominates after 15 days (j), is progressively 
replaced over time with new matrix (blue) (h-j) until it becomes completely substituted after 3 months with the new, denser matrix, 
which also contains discrete deposits of high-density mineral (red) (k-l). Following a year in culture, the constructs contain 
considerable amounts of the high-density mineral (m-n). Cropped section illustrates the high-density material comprising the outer 
layer of constructs after a year in culture. Scale bars = 2.5 mm. 
……………………………………………………………………………………………………………………………………………………………………………………………….128 
 
 
Figure 4.5 | Chemical characteristics of the newly forming matrix. a, Comparison of a microCT reconstruction and a high-resolution 
Raman map, developed based on the CH2 peak (1447 cm-1) showing a similar distribution of the denser, newly forming matrix in 
constructs which are 2 weeks old. b, As early as day 7 (yellow), peaks corresponding to collagen can be detected, including amide I, 
III, CH2, but also hydroxyproline (Hp) and phenylalanine (Pa). 5 days later (day 12, brown), small phosphate peaks corresponding to 
OCP start to emerge in the central and interface regions. Spectra from mature (3-month constructs, pink) are provided for 
comparison. c, Spectra from spatially distinct regions from a mature construct (3 months) showing in all cases a strong 
hydroxyapatite content co-localised with all the components associated with collagen. Spectra contain all peaks detectable in bone 
using this technique. 
……………………………………………………………………………………………………………………………………………………………………………………………….132 
 
 
Figure 4.6 | Raman Spectra of the anchors of early constructs. Raman spectra acquired from distinct points on the anchor surface at 
3 time points within the first two weeks of development revealed spectral characteristic for the brushite-TCP component, and 
different in all cases from the new mineral phases forming within the soft tissues. 
……………………………………………………………………………………………………………………………………………………………………………………………….133 
 
 
Figure 4.7 | Development of the collagenous matrix in constructs. a, Images of 7-day constructs stained with Sirius Red for collagen. 
Left image illustrates high amounts of collagen in the marginal region adjacent to the brushite anchor; right image demonstrates 
collagen emerging from cell-like structures next to the anchor. Scale bars = 200 μm. b, Micro-XRF mapping of live constructs over 21 
days, based on Ca and P, the inorganic components of bone and S, as an indicator of the organic matrix. Maps show the progression 
and co-localisation of Ca and P from the anchor towards the centre during this period of development up to one month. Scale bar = 
4mm.  c, Two-photon microscopy 3D reconstruction of cells (TPEF) and collagen (SHG), simultaneously visualised in live constructs. 
Collagen is present in ‘pocket’-like deposits. Scale bars = 100 µm. d, SHG visualisation of collagen in distinct regions at different time 
points. e, Collagen is abundant around the anchor areas in early stages, but not detected in the central region at 1 month. Over the 
subsequent 2 months, the collagenous matrix extends into the tissue at the mm level, displaying a level of organisation similar to 
murine femora.  
……………………………………………………………………………………………………………………………………………………………………………………………….136 
 
 
Figure 4.8 | Collagen and cells, observed using SHG/TPEF. Emission spectra of early and mature constructs in different regions, 
illustrating the second harmonic linear effect generated by collagen at half the wavelength of the incoming laser (860 nm), 
generated in the purple-blue area of the spectrum; and with Calcein AM green-stained cells appearing in the 481-577 nm region of 
the spectrum, corresponding to light blue-green region. 
……………………………………………………………………………………………………………………………………………………………………………………………….137 
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Figure 4.9 | Evolution of the inorganic component over a year in culture, as detected through micro-XRF. Calcium and Phosphorus, 
main components of the inorganic component of bone, increase with extended culture times until they reach a level similar to that of 
murine femurs. 
……………………………………………………………………………………………………………………………………………………………………………………………….138 
 
 
Figure 5.1 | Excitation-Emission Spectra of fluorophores chosen for Immuno-Histochemistry. The Alexa Fluor 488 fluorophore was 
conjugated to antibodies raised against the molecular markers of interest, Alexa Fluor 555 was conjugated to Phalloidin for 
detection of cytoskeletal actin and DAPI was applied to detect the presence of DNA/nuclei. Spectra were produced using the 
Fluorescence SpectraViewer online resource (Thermo Fisher Scientific, MA, USA). 
……………………………………………………………………………………………………………………………………………………………………………………………….146 
 
 
Figure 5.2 | Equipment design for sample scanning using synchrotron-radiation computed tomography. a, Stage containing sample 
is fixed in place. b, 5 mm samples were cut from dried constructs and were placed in the centre of the stage used for high-resolution 
scanning. 
……………………………………………………………………………………………………………………………………………………………………………………………….148 
 
 
Figure 5.3 | Cellular morphological changes over a year in culture and final differentiation to osteocytes. a, Following a month in 
culture, morphology of cells in constructs is mainly elongated and resembling osteoblastic cells (left). With additional osteogenic 
supplementation and over the following 2 months, cells develop typical osteocytic characteristics, including numerous 
interconnected osteocytic networks (middle) and canaliculi-like structures containing long cell projections (right). b, The most 
mature cells (1 year) show a marked re-structuration of the cytoskeleton, displaying osteocytic phenotypes strikingly similar to 
those encountered in vivo (left).  The long projections are very well preserved (right top and bottom). 
……………………………………………………………………………………………………………………………………………………………………………………………….154 
 
 
Figure 5.4 | Detection and localisation of bone markers in mature constructs. a, Immunohistochemistry of constructs, showing 
expression of osteocytic marker sclerostin on the surface of cells and in neighbouring network-like structures at 5 months (middle). 
The matrix of 1-year-old constructs contains long networks, where podoplanin could be detected (right). Scale bars = 100 µm. b, 
mRNA for sclerostin and podoplanin was detected at these time points as well. Results are presented compared to a rat 
osteosarcoma cell line as positive control. UMR-106 produces sclerostin and podoplanin continuously. Please note cycle threshold 
(Ct) is inversely proportional to the amount of target nucleic acid in the sample. npdpn= 4 (umr,5 m), 2 (1 yr). nsost= 4 (umr), 2 (5m,1 
yr). ngapdh= 4 (umr,5 m), 2 (1 yr). c, The inorganic component of constructs following a year in culture equals approximately 70% of 
the total content. 
……………………………………………………………………………………………………………………………………………………………………………………………….155 
 
Figure 5.5 | Secondary antibodies are highly specific and do not bind at random locations on constructs during 
immunohistochemistry. Goat anti-rabbit IgG conjugated to Alexa Fluor 488 (green) were applied to all samples in the same 
conditions, without the addition of a primary antibody in order to detect non-specific binding. These results that these antibodies 
were highly specific, showing minimal or non-existent binding to the construct slices, thus reducing the possibility of false positive 
results.   
……………………………………………………………………………………………………………………………………………………………………………………………….156 
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Figure 5.6 | Typical X-Ray Diffraction pattern obtained from mature constructs. The pattern confirms the presence of 
hydroxyapatite, the mature bone mineral in 1-year samples. Traces of whitlockite, a second type of mineral abundant in bone (Jang, 
Jin et al. 2014, Jang, Lee et al. 2015), can also be detected.  
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Figure 5.7 | Development of bone cells in constructs. a, SEM images of cells in constructs after 12 months of culture, showing cells 
embedded in the significantly mineralized matrix. The main cellular structure in a has been false-coloured to allow a better 
visualization. There are many podocytes embedded in the heavily mineralized matrix. Cells communicate through extensive 
projections. b, Synchrotron radiation computed tomography illustrating a typical osteocyte lacuna (L) with emerging canaliculi (C) 
that branch into the tissue. c, XRF maps based on S, Ca, P showing network-like structures throughout the matrix and connecting 
adjacent lacunar-like structures (arrows). Scale bars = 200 μm. 
……………………………………………………………………………………………………………………………………………………………………………………………….160 
 
Figure 5.8 | Development of osteocytic features, H&E stain of tissue sections. Canalicular-like structures emerging from lacunar 
spaces were observed as early as 3 months (a, arrows), with some branching into the tissue (b, arrows) and connecting adjacent 
similar structures, which contained cell DNA and remnants of the cytoplasm (a, b). Networks of DNA containing lacunae (c, arrows), 
could be observed arranged along the length of constructs. Scale bars a, b = 10 μm; c = 100 μm. 
……………………………………………………………………………………………………………………………………………………………………………………………….162 
 
 
Figure 5.9 | Formation of a ‘periosteal’ structure in constructs. a, Micro-CT tomographies indicated a density difference between the 
outer layer of constructs and the central portion in the oldest constructs. b, Raman maps of the central area revealed that the outer 
structure contained collagen type I associated with hydroxyapatite, whereas the central region contained a combination of HA and 
OCP. c, Immunohistochemistry on tissue sections indicated that this region was rich in sclerostin (green) and cellular DNA (blue). 
The latter was also observed using H&E staining, where DNA was localised to the outer region (blue). 
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Figure 5.10 | Mechanical characterisation of 3D constructs. Several cellular features can be observed, particularly projections 
characteristic to osteocytes (Area 1). Pods appear more adhesive compared to the surrounding matrix, suggesting the presence of 
biological material entrapped within a less adhesive, inorganic component. Areas 2 and 3 appear noisier due to sample movement. 
These maps appear to show a mixture of structures with different mechanical properties, including round, adhesive structures with 
a low slope, indicating biological material, and structures which are harder (higher slope) and have less adhesion, indicating 
inorganic material. 
……………………………………………………………………………………………………………………………………………………………………………………………….167 
 
 
Figure 5.11 | Nano-characterisation of osteocytic features. The cellular projections observed using AFM were also detected using 
synchrotron radiation tomography, where they appeared as canaliculi (C), connecting lacunar structures (L). 
……………………………………………………………………………………………………………………………………………………………………………………………….168 
 
 
Figure 5.12 | Mechanical characterisation of individual osteocytes in tissue sections. Tissue sectioning allows the detection of 
clearer osteocytic structures, including cell body and projections. These cells and surrounding matrix showed mixed mechanical 
properties. The adhesion channel (right) shows a pattern of alternative soft and hard structures.  
……………………………………………………………………………………………………………………………………………………………………………………………….169 
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Figure 6.1 | Development of the Immuno-isolation method. Monoclonal IgG antibodies (a) were incubated with the magnetic beads 
for 15 minutes at room temperature with gentle rotation (b). During this incubation period, the antibodies bound via their Fc region 
to protein G, which is covalently coupled to the surface of the beads (c). The resulting bead contained multiple antibodies attached 
to it, which were capable of binding the antigen of interest (TNAP) via their Fab regions.  
……………………………………………………………………………………………………………………………………………………………………………………………….180 
 
 
Figure 6.2 | Immuno-isolation of matrix vesicles. a, As mineralisation progresses in constructs with maturation, culture medium is 
collected from culture dishes (b) and subjected to nanoparticle analysis. c, Dynamic Light Scattering analysis of samples from 
control (serum supplemented, cell-free), 14 days and 1 year-old medium samples. Compared to controls, media from both young 
and mature constructs contained nanoparticles in the size range of 50-300 nm. d, Immuno-isolation of matrix vesicles from this 
population was performed by incubating 1000 μl of culture medium with the Ab-MB complex for 15 minutes at room temperature, 
in PBS-Tween 20. Monoclonal antibodies bound to the vesicles via their Fab regions by binding to TNAP on the outer membrane of 
matrix vesicles (e). Purification of the Ab-MB-MV complex was performed via magnetic separation (f).  
……………………………………………………………………………………………………………………………………………………………………………………………….181 
 
 
Figure 6.3 | Characterisation of immuno-selected vesicles. a, Nanoparticles, visualised in real-time exclusively using NTA. Controls 
(sterile PBS) do not contain any nano-particles. The growth medium of constructs contains an abundance of nano-particles, whereas 
the buffer containing the isolated vesicles contains a very small population of particles. Positive controls (200 nm polystyrene 
beads) are provided for comparison. b, The small population of purified vesicles contains particles of sizes in a much more narrow 
range than total exosomes in construct medium. Vesicles ranging between 100-200 nm are particularly abundant. c, When 
denatured using SDS-PAGE, the Ab-MV complexes separate into several fractions, which include the TNAP protein dimer (80-110 
kDa), the IgG antibody (170 kDa) and several unidentified protein fractions belonging to matrix vesicles (110-160 kDa).  
……………………………………………………………………………………………………………………………………………………………………………………………….183 
 
 
Figure 6.4 | Isolated MVs contain ATP. a, Mineralisation is an ATP-mediated process. ATP is transformed by membrane-bound 
TNAP on the surface of vesicles into Pi. ATP on vesicles was labelled using quinacrine dihydrochloride and visualised indirectly 
using confocal microscopy, where it was detected as blue fluorescence from the beads. b, Purified MVs and controls were stained 
directly on the magnetic beads using quinacrine dihydrochloride. Controls contained the bound antibody but were treated with 
dH2O as opposed to culture medium. All images were acquired under the same conditions and settings. Some degree of background 
staining can be observed in control beads. The vesicle-bound beads show a higher amount of fluorescence, indicating the presence 
of ATP associated with the MVs. 
……………………………………………………………………………………………………………………………………………………………………………………………….185 
 
 
Figure 6.5 | Isolated matrix vesicles show a high degree of osteocompetency. The TNAP-bound vesicles have the ability to bind 
collagen type I (top row), whereas TNAP antibodies alone (post-elution, centre) show a small degree of non-specific binding. The 
binding of vesicles and controls to collagen I was detected using secondary antibodies conjugated to Alexa Fluor 488. These 
secondary antibodies showed a small amount of non-specific binding to the collagen I matrix in the absence of sample/control. 
Images were acquired using the same settings and conditions. Scale bar = 100 μm. 
……………………………………………………………………………………………………………………………………………………………………………………………….186 
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Figure 7.1 | Application of two ossification-inhibiting compounds to constructs. Two novel drugs were selected based on recent 
advancements. The first compound, CD1530 is a retinoic-acid-γ receptor agonist that has been recently tested with multiple types of 
heterotopic ossification; while LDN 193189 is an inhibitor of the BMP mineralisation pathway, acting as a selective inhibitor of the 
BMP type I activin receptor like kinase ALK2 and ALK3.  
……………………………………………………………………………………………………………………………………………………………………………………………….188 
 
 
Figure 7.2 | Tomographic analysis of the progression of ossification in constructs. Administration of two inhibiting compounds in a 
pilot study lasting 21 days appeared to reduce the progression of ossification in treated constructs compared to controls. CD1530 (1 
μM) significantly reduced mineralized matrix formation following 21 days of culture compared to equivalent controls. LDN193189 
(25 nM) also appeared to be effective.   
……………………………………………………………………………………………………………………………………………………………………………………………….193 
 
 
Figure 7.3 | Ossification – inhibiting compounds decrease matrix and mineral formation in constructs. Comparison of the 
mineral volume located in the central portion of constructs following 21 days of culture, quantified by morphometric CT analysis. 
Constructs treated with CD1530 showed an average of 99% less mineral in this region compared to controls, which was statistically 
significant, whereas the group treated with LDN193189 showed 70% less mineral, although not significant. Data is presented as 
means ± SD. *p < 0.05, n=3. 
……………………………………………………………………………………………………………………………………………………………………………………………….194 
 
 
Figure 8.1 | Development of other connective tissues. a, 6-months old construct developed using chick tendon fibroblasts, showing 
a tendon-like 3D structure. b, Example of a construct developed with human chondrocytes and human-derived matrix components, 
and which has been fixed with Bouin’s fluid (yellow, not visible) and stained with Alcian Blue for cartilage detection. c, Examples of 
constructs which have undergone pro-chondrogenic treatment (left) vs. control (right). Constructs supplemented with ITS and TGF-
β3 develop more matrix (blue) compared to control (green-blue), are more still and more resilient to histochemical processing 
compared to controls, which undergo shrinking. 
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Figure 8.2 | Endothelial tubes resembling microvasculature align with the mechanical axis in constructs. Large image (left) has been 
reconstructed from multiple brightfield images and shows endothelial tubes branching along the axis of constructs. When observed 
in a 2D plane (middle right), these cells established complex networks which connect to larger tubes, with diameters ranging 
between 50-200 μm, as seen through a cross section using TPEF (bottom right). Scale bar = 200 μm. 
……………………………………………………………………………………………………………………………………………………………………………………………….208 
 
 
Figure 8.3 | Osteoblastic and vascular cell morphology in individual and mixed-cell constructs. 2T3 cells (left) attached to the matrix 
and showed a typical osteoblastic morphology, while HUVECS (centre) were able to assemble into tubular structures of 50-200 μm 
in dimeter. Constructs containing co-cultures of these cell populations showed both types of cell morphology, with endothelial tubes 
forming adjacent to osteoblastic cells. 
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Figure 8.4 | A tissue-engineered model of pathological bone formation in spinal soft tissue where calcium phosphate “vertebrae” 
are connected with fibrin gels encapsulating a population of stem cells. a, Fibrin gels encapsulating stem cells are formed around 
phosphate vertebra. Over time, these gels attach strongly to the anchoring material and contract, giving rise to a disk-like structure 
after approximately 14 days. b, The individual ‘vertebra’ with soft tissue attached to them are assembled together into the spinal 
structure and gels are allowed to connect to the adjacent vetrebra over the subsequent 3-4 weeks until the structure can support its 
own weight.  Over time, the fibrin is replaced with mineralised collagen and the resulting structures mimic the complex cellular 
organisation of real bone. These culture systems can be used to study pathological bone formation or to trial new therapies. 
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Figure 10.1 | An account of cell types compatible with the present model. Several types of cells, including primary, expanded from 
tissue and cell lines were encapsulated in constructs. Their characteristics in terms of ability to fully contract the initial fibrin 
scaffold and their ability to mineralise the tissue were amongst the criteria used for evaluation in developing the final system. 
Periosteal cells of rat origin were selected due to their enhanced ability to contract the matrix and mineralise it. Cell lines tend to 
over-contract and detach the constructs from the anchors. 
……………………………………………………………………………………………………………………………………………………………………………………………….223 
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CHAPTER I 
INTRODUCTION TO BONE FORMATION 
 
 
 
1.1 BIOMECHANICAL EVOLUTION OF THE SKELETON 
Bones have evolved in an environment where gravity represented a factor of physical 
restriction, which led to the generation of skeletal adaptations in all aquatic, 
amphibious, terrestrial and volant organisms. The continuously changing mechanical 
conditions experienced by the ancestors of all living creatures led to molecular and 
structural adaptations designed to manage this force of gravity. In humans, the skeletal 
system evolved to counteract the gravitational force during walking and standing on 
two legs, with the line of gravity passing through the base of the spine so that the body 
is well balanced when upright, whilst the centre of gravity is located front of the ankles 
to prevent falling (Buckey 2006, Le Huec, Saddiki et al. 2011). The development of such 
superior biomechanics was allowed by a continuously changing anatomical design, seen 
in modifications of long-bones, the verticalization and broadening of the pelvis and the 
lordotic curvature of the spine in the lumbar and cervical regions and the kyphosis in 
the thoracic and sacral regions, features that did not develop in primates (Figure 1.1), 
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which use their upper limbs to reduce the anterior imbalance caused by propulsive 
forces from the lower limbs (Berge 1998, Le Huec, Saddiki et al. 2011).   
Secondly, these traits were allowed by the concomitant evolution of a well-orchestrated 
biochemical signalling system, which could constantly feedback on the quality and 
functionality of bones. These events include the processes of bone tissue formation and 
remodelling and will be discussed in detail in the following sections.  
It is therefore not surprising that when alterations in environmental forces take place, 
such as decreased loading experienced in microgravity during space exploration 
(Barratt and Pool 2008), extended buoyancy (Gray, Kainec et al. 2007) or 
immobilisation due to injury (Houde, Schulz et al. 1995, del Puente, Pappone et al. 1996, 
Demirbag, Ozdemir et al. 2005), dramatic losses in bone content and macrostructure 
can be observed immediately. These alterations increase the susceptibility of bone to 
breakage and compromise the ability to perform intense physical tasks.  
At the opposite end of the spectrum, increased mechanical forces due to limb exposure 
to overpressure, CNS or SC injury, or mechanical trauma due to surgical procedures of 
the knee, hips or spine lead to enhanced bone formation in the tissues surrounding the 
affected areas (Ahrengart 1991, Pape, Lehmann et al. 2001, Board, Karva et al. 2007, 
Potter, Burns et al. 2007, Potter, Forsberg et al. 2010, Alfieri, Forsberg et al. 2012, 
Sullivan, Torres et al. 2013). These ectopic bone formations are very debilitating, 
especially when forming adjacent to major arteries, veins or nerves (Spencer and 
Missen 1989, Board, Karva et al. 2007, Baird and Kang 2009, Cullen and Perera 2009, 
Isaacson, Stinstra et al. 2010). 
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At the molecular level, bone formation and breakdown are finely controlled by the 
muscular, endocrine and nervous systems.  Dysregulations in these systems or their 
interactions also have a profound effect on bone composition and architecture.   
The following sections of this chapter will expand on these aspects. This review, which 
continues with the results chapters, is not written as an exhaustive account of 
information on bone, but as a selection of our current understanding of the 
biomechanical, physiological and pathological processes which trigger bone tissue 
formation, that allowed the production of the focused conclusions presented at the end 
of this thesis.  The following sections will focus on the effectors of the skeletal system, 
the bone cells and the physiological and pathological events underlying normal and 
abnormal bone formation which lead to the translation of the biomechanical forces into 
organised, structured bone. Finally, this chapter will discuss the gaps in our 
understanding of the bone formation process, the current models available in research 
to study ossification in normal and abnormal states and also the advantages and flaws 
of these models.  
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1.1.1 EARLY BONES 
The evolution of a skeleton containing a vertebral spine was one of the major 
transformations which separated the animal kingdom.  The skeletal system was one of 
the most dramatically changing physiological systems across the millions of years of 
evolution. Life is thought to have originated in water around 3.5 billion years ago and so 
the abundance of features that evolved over this substantial period, in bacteria, 
invertebrates and ultimately vertebrates was for a significant time specialised to the 
aquatic environment. Therefore, the skeletal systems of marine vertebrates became 
compositionally and structurally adapted to life under buoyancy conditions (Gray, 
Kainec et al. 2007), something that will be discussed in detail in the next section.  
As the transition from water to land started to take place around 380 million years ago 
in mid-Devonian, and continued for millions of years, the first terrestrial-suited bones 
appeared in elpistostegalians, which were tetrapods evolved from fish predecessors 
(Shubin, Daeschler et al. 2014) that developed physiological features adapted to both 
life on water and at the surface.  The dramatic change in the mechanics of the 
environment required the development of bone structures with anatomical features 
suitable for terrestrial walking, a transition which was poorly understood until recently. 
This aspect was clarified recently (2004) with the extraordinary discovery of the fossil 
of Tiktaalik roseae, a late Devonian tetrapod, in Ellesmere Island in the Canadian Arctic, 
which provided the missing link in the evolutionary history of modern land vertebrates 
(Daeschler, Shubin et al. 2006). Tiktaalik contained many musculo-skeletal structures 
providing support for posture and locomotion on land, including endochondral bones, 
pelvic girdle and appendices and an articulated skeleton from head to toe similarly to 
modern tetrapods (Daeschler, Shubin et al. 2006, Shubin, Daeschler et al. 2006).  
 
 
 
 
 6 
1.1.2 ADAPTATION OF BONES TO DIFFERENT ENVIRONMENTS   
The diversification of the skeletons within the vertebrate subphylum over millions of 
years of evolution was achieved by changes in cartilaginous and osseous tissue, which 
developed to provide locomotion based on the environmental constraints present. 
Figure 1.2 illustrates a selection of skeletons of species from mechanically-distinct 
ecosystems, highlighting the differences in bones used in locomotion.  
 
 
 
 
Figure 1.2 | Skeletal systems and limb bones from different orders and classes of animals have evolved to meet the 
mechanical demands of their environments. a, Fish; b, Monotremes; c, Primates; d, Amphibians; e, Birds. The common bones 
used to translate the mechanical forces from the trunk to the lower parts of the limbs for locomotion are shown in black boxes. 
Original images. Author would like to thank the Lapworth Museum of Geology, University of Birmingham. 
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As expected, there are evolutionarily-driven skeletal differences across different 
species. Some of the most striking adaptations include the skeletal pneumatisation of 
bones in birds (hollow air-filled bones), which have a high density and stiffness but a 
low mass and volume, an adaptation intended to reduce the metabolic costs of powered 
flight (see Figure 1.3a) (Dumont 2010, Gutzwiller, Su et al. 2013). Additionally, other 
adaptations in anatomical design have evolved, which include fusions of many skeletal 
structures and a relatively small body skeleton compared to wing size (Figure 1.4a), a 
common feature of flying vertebrates, including bats (Figure 1.4b), which has been 
preserved since their avian pterosaurian predecessors (c) (Swartz, Bennett et al. 1992, 
Maina 2000, Dumont 2010).  
In fish and other aquatic and semi-aquatic animals, the weight is mainly supported by 
buoyancy and as such, skeletal micro-structure and bone density has adapted to 
support alternations between powered locomotion and gliding motion to minimise the 
energetic costs (Sato, Aoki et al. 2013), a feature also present in gliding animals during 
horizontal flight (Rayner, Viscardi et al. 2001).  
At the other end of the spectrum, in land tetrapods which have secondarily invaded 
aquatic niches, such as sloths, several osteological modifications took place as a result of 
the increased mechanical constraints caused by locomotion in water, including 
densification of bones and an increase in volume (Gray, Kainec et al. 2007, Amson, de 
Muizon et al. 2014). Interestingly, this complex adaptive plasticity of the skeletal bones 
in response to their environment was also demonstrated by the historical transition of 
many other species such as archaeocetes (ancient aquatic mammals, ancestors of 
modern whales and dolphins, 55-20 million years ago) from terrestrial animals. The 
skeletal microstructure of these animals initially adapted to shallow or semi-aquatic 
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environments by increasing in density to provide static buoyancy control and stability 
and was then followed by a process of osteoporosis, meant to provide a dynamic 
buoyancy control as the animals adapted to a fully oceanic and deep-water life (Taylor 
2000, Gray, Kainec et al. 2007).   
The processes of increased cortical bone density and volume are known as 
osteopetrosis and pachyosteosclerosis and in the context of mechanical adaptation, they 
are recognised as a variable strategy for adapting to buoyancy (Taylor 2000).  However, 
the process of osteopetrosis is also encountered in pathological conditions in humans, 
where excessive bone mass is caused by genetic mutations in genes responsible for 
osteoclast formation and function (bone cells involved in resorption) and will be 
discussed later in this chapter (see Section 1.6.3 Formation of Osteoclasts) (Sobacchi, 
Schulz et al. 2013).   
The evolution of other mineralised tissues such as teeth and beaks allowed the 
development of defence mechanisms, hunting and eating. Indeed, the remarkable 
diversity in bird beak morphology, specifically adapted to very narrow niches (and 
illustrated in Figure 1.3), was one of the most significant biological evidences on the 
basis of which Charles Darwin postulated the theory of evolution of natural selection 
following his voyage to the Galapagos (Figure 1.4 a-b), the work which was later 
published as ‘On the Origin of Species by Means of Natural Selection’. These skeletal 
adaptations, based on the nature and accessibility of the food sources (Figure 1.3c-g) 
allowed to demonstrate important aspects of the evolutionary theory, such as the 
concepts of speciation, natural selection and niche partitioning (Abzhanov 2010). This 
diversification process is under the direct control of several bone signalling pathways, 
some which will be discussed in further detail in section 1.4 Cellular Composition of 
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Bone. Specifically, the formation of the pre-nasal cartilage forms under the control of 
BMP-4 and Calmodulin signalling pathways, whereas the premaxillary bone forms 
under the action of TGF-βIIr, β-catenin and Dkk3 signalling pathways, as well as the 
Indian Hedgehog (Ihh) pathway (Mallarino, Campàs et al. 2012). These distinct 
signalling pathways can exclusively or in combination, generate beak shapes of similar 
or different morphology in various species of birds (Figure 1.3b) (Grant and Grant 1997, 
Mallarino, Campàs et al. 2012).  
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Figure 1.3 | The adaptation of bird skulls to different niches and environments, showing dramatic differences in the 
osseous structures of the beaks. a, Cross-section through the skull of a Rhinoceros Hornbill (Buceros rhinoceros), showing hollow 
air-filled pockets in its skeletal structure, a feature evolved to meet energetic costs during flying. b, Skull of a Silvery-Cheeked 
Hornbill, a bird related to the specimen in a but showing a distinct anatomical beak structure, a feature which is under tight genetic 
regulation. c-g, The adaptation of the osseous structures of the beaks according to different living environments and thus food 
sources. c, Magellanic penguin – fish diet; d, Hyacinth macaw – diet of nuts from palm trees; e, Common toucan – fruit diet; f, 
Roseate spoonbill – diet of insects; g, Scarlet ibis -diet of shrimps and other crustaceans; This dietary specialisation was one of the 
observations which led to the development of Darwin’s theory of natural selection.  Original images. Author would like to thank the 
Lapworth Museum of Geology, University of Birmingham and the Natural History Museum, South Kensington, London. 
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Figure 1.4 | The anatomical adaptation of the skeletons of flying vertebrates. a, Skeleton of a pigeon used by Charles Darwin as 
part of his research and development of the theory of evolutionary adaptation, later described in the Origin of Species. Specimens 
demonstrates a large wing bone size compared to the body size, a skeletal adaptation to powered flight. This feature can also be 
seen in other species which have evolved from a different lineage, such as the common pipistrelle bat skeleton (Pipistrellus 
pipistrellus) (b); and in the avian ancestors such as Pteranodon, a flying reptile from late Cretaceous (approx. 86-83 million years 
old) (c). Original images. Author would like to thank the Natural History Museum, South Kensington, London. 
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In humans, identical physiological and pathological adaptations take place in bone mass 
and density as a result of age, immobilisation, unloading, vigorous exercise and trauma 
and these will be discussed in detail in the following sections.  
From an evolutionary perspective, the development of longer leg bones in humans, 
starting with more recent hominin species such as in Homo heidelbergensis compared to 
the first bipedal humans such as Homo erectus was due to an adaptation to tropical 
conditions, as they could provide a larger surface for cooling the body. This skeletal 
adaptation did not take place in  other species such as Homo neanderthalensis, which 
lived in colder climates, and as such had shorter limb legs and a lower body size (Elton 
2008). CT analysis of trabecular bone density from these different hominid species 
revealed that high trabecular bone density was a feature of earlier hominin species 
compared to more recent ones including Homo sapiens (Chirchir, Kivell et al. 2015), 
which was probably due to the intense physical activity undertaken by these species 
during hunting of large animals, which placed considerable stress on the bones and 
hence resulted in a higher bone density. 
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1.2 FUNCTIONS OF BONE 
Despite their inert appearance, bones are responsible for more than shaping the human 
skeleton, and fulfil a whole range of vital functions (Figure 1.5).  
 
1.2.1 MECHANICAL SUPPORT 
As discussed in the previous sections of this chapter, bones provide a framework for 
mechanical support. The lower limbs provide support to the trunk during standing and 
walking, while other structures, such as the rib cage, support the thorax. In addition, 
bones provide suspension of the soft, internal organs of the abdomen and cavities for 
sensory organs of the head (Marieb and Hoehn 2010) (Figure 1.5a-c). 
 
1.2.2 PROTECTIVE FUNCTION 
Several bones offer protection to the vital organs, including the fused cranio-facial 
bones, which enclose and protect the brain, the ribcage which protects the heart and 
lungs; and the vertebra of the spine which protect the spinal cord (Marieb and Hoehn 
2010) (Figure 1.5a-c). 
 
1.2.3 LOCOMOTION 
Bones provide a source of attachment to all muscles, tendons and ligaments, acting as 
levers during body movement. This has implications for many vital functions, especially 
breathing. Moreover, the biomechanical design of bone joints directly influences 
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different types of movement, including flexion, extension, gliding, retraction and 
protraction, elevation and depression (Marieb and Hoehn 2010) (Figure 1.5a,c).   
 
 
 
 
Figure 1.5 | Functions of bones. Bones perform numerous functions including supporting the body during movement, providing 
levers for moving the limbs (a); protecting the fragile internal organs (ribcage) (b) and the spine (b-c); as well as supporting the 
weight of the trunk during walking (c). Original images acquired from a skeletal specimen at the Natural History Museum, South 
Kensington, London.  
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1.2.4 STORAGE OF MINERALS 
In addition to their mechanical functions, bones provide a source of calcium and 
phosphate to the rest of the body (Boden and Kaplan 1990). The maintenance of 
constant levels of these minerals in the bloodstream is essential not only for the skeletal 
system, but also for the function of other body systems, including the nervous system 
(Braet, Cabooter et al. 2004), where Ca2+ signalling is essential for the operation and 
integration of chemical and electrical signals by neurons and glial cells at the synapse;  
and muscular system (Szent-Györgyi 1975) where the same element directly regulates 
muscle contraction through binding to regulatory proteins such as troponin. As such, 
Calcium and Phosphorus are continuously deposited and released into the bloodstream 
under the action of regulatory hormones including PTH, which also aid in maintaining 
Ca and P homeostasis by acting on other organs as well, including the kidneys and the 
intestines.  
The simultaneous physiological processes undertaken by bones make it very difficult to 
maintain their health and restore their normal composition. This is because both 
mechanical loading and the hormone-controlled release of ions to the body 
continuously require these elements. Therefore, the ionic balance can be quickly 
disrupted, as seen in numerous pathological states (Boden and Kaplan 1990, del Puente, 
Pappone et al. 1996, Lau and Guo 2011). The chemical properties of the calcium and 
phosphate content of bone will be discussed in detail in section 1.4 Chemical 
Composition of Bone.    
Bone matrix also provides a supply of growth factors, including insulin-like growth 
factors (Kawai and Rosen 2012, Mohan and Kesavan 2012), transforming growth 
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factors (Baylink, Finkelman et al. 1993)and bone morphogenic proteins (BMPs) (Shore, 
Xu et al. 2006, Katagiri, Osawa et al. 2015) essential for cellular communication.   
 
1.2.5 SOURCE OF BLOOD CELLS 
The inner cavities of bones contain the red bone marrow, which is the body’s source of 
hematopoietic and stem cells (Taichman 2005), essential for differentiating into all the 
different types of blood cells, including erythrocytes and lymphocytes. Hematopoietic 
tissue (red marrow) is found between the trabeculae of spongy bone, whereas in flat 
bones such as the sternum or skull is found in the spongy tissue known as diploë.  The 
red marrow of flat bones and in some irregular bones (such as the hip) have a higher 
level of haematopoiesis and for this reason, are regularly used clinically for sampling 
marrow tissue. Despite a high hematopoietic activity at birth, red marrow in the 
medullary cavities of long bones become gradually converted with age into a less 
metabolically-active, yellow (fatty) bone marrow, a process which concludes in 
adulthood (25-30 years). However, yellow bone marrow can dynamically revert to red 
marrow in certain pathologic conditions (e.g. anaemia, obesity) that require an 
enhanced red blood cell supply and a higher tissue oxygenation (Bigelow and Tavassoli 
1984, Guillerman 2013). 
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1.2.6 STORAGE OF TRIGLYCERIDES 
Bones also contain triglycerides as a source of stored energy (Mularchuk and Boskey 
1990). Although lipids only constitute less than 2% of the dry weight of bone tissue, 
they appear to have an influential role in the development of mechanical functionality of 
bones (Goldberg and Boskey 1996), as phospholipase D is involved in the initial stages 
of ossification during embryogenesis, and it has been found to be expressed in the 
extracellular matrix of the developing mouse skeleton (Gregory, Kraemer et al. 2005). 
 
1.2.7 STORAGE OF TOXIC COMPOUNDS 
In addition to storing essential minerals ions, bone tissue can temporarily house 
dangerous compounds in the systemic circulation, including radioactive compounds, 
lead (Pounds, Long et al. 1991), aluminium (Ballanti, Wedard et al. 1996) and 
tetracyclines from diet, including oxytetracycline (OTC) and chlortetracycline (CTC) 
(Honikel, Schmidt et al. 1978).  
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1.3 STRUCTURE OF BONE 
Bones are composed of two structurally distinct textures, compact bone on the exterior 
and spongy bone, also known as trabecular or cancellous bone, internally (Figure 1.6). 
 
 
 
 
Figure 1.6 | Bone textures: spongy and compact bone in the femur. Long bones are composed of two texturally different types of 
tissue, compact bone and spongy bone, adapted for providing support during different types of mechanical load. The outer cortical 
layer is lined externally by the periosteum and internally by the endosteum. The internal cavities of bones contain the red and 
yellow marrow. Original image. Image of the femoral section acquired from a skeletal specimen at the Natural History Museum, South 
Kensington, London.  
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1.3.1 COMPACT BONE 
Compact bone is composed of highly organised units named osteons, which are long, 
cylindrical structures arranged parallel to the long axis of the bone. These structures 
provide canals through which blood and lymphatic vessels and nerves can supply the 
surrounding bone tissue. Each osteon is composed of concentric, hollow tubes 
(lamellae), which are made of mineralised collagenous matrix. Each lamella contains 
collagen fibres running in the same direction but in a different direction from fibres in 
other lamellae, a reinforced design meant to withstand torsion forces (Figure 1.7).  This 
arrangement of lamellar collagen directly affects the mechanical properties of individual 
lamella. Mechanical studies by Pidaparti and colleagues (Pidaparti and Burr 1992) and 
later by Ascenzi and colleagues (Ascenzi, Baschieri et al. 1994) showed that in combined 
loading situations (torsion and bending), collagen fibres with a geometrical orientation 
ranging between 15°-30° of the long axis are the best suited for maximizing the overall 
mechanical properties of bone tissue.  
The central portion of osteons contains the Haversian canals, which contain the small 
blood vessels and nerves that supply the cells inside osteons. These central canals 
communicate with the blood supply and innervation of the periosteum using 
Volkmann’s canals, which run perpendicular to the long axis of the bones. The interior 
lining of these canals consists of the endosteum.  
There are additional lamellae in compact bone which are not part of osteons. These are 
interstitial lamellae which fill the spaces between osteons. Additionally, there are 
circumferential lamellae just underneath the periosteum and above the endosteum 
which play a  role in mechanical resistance against stress. A study by Liu and colleagues 
(2000) comparing the mechanical properties of circumferential and osteonal lamellar 
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bone in a primate model showed that the mechanical behaviour of the two types of 
lamellar bone under bending tests were similar for the same orientations relative to the 
bone axis, suggesting that the complex arrangement of mineralised collagen fibrils itself 
is reposible for stress resiliance. However, the authors found that osteonal and 
circumferential lamellar bones exhibit different behaviours during induced fractures, 
with osteonal lamellar bones tending to remain connected after the main fracture event, 
whereas circumferential lamellar bones separated following fracture. This implied that 
osteonal fractures have higher chances of repair and the chances of fracture non-unions 
are lower compared to circumferential fractures (Liu, Wagner et al. 2000). 
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Figure 1.7 | Structure of an osteon. Individual lamellae are arranged concentrically and are composed of mineralised collagenous 
fibres arranged in different directions in each lamellar unit to provide maximal resistance to stress. Centrally, osteons act as 
passageways for blood vessels (arteries and veins) and nerve fibres and are lined internally by the endosteum.  
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The mature bone cells, osteocytes, are located concentrically at the lamellar junctions 
(Figure 1.8). These cells are embedded in lacunar spaces and contain numerous 
projections which are contained within canalicular structures. These canaliculi allow 
inter-cellular communication, the flux of waste and nutrients, as well as connecting 
osteocytes to the endosteum (Dallas and Bonewald 2010, Bonewald 2011). The 
formation of osteocytes  and their complex function is described in further detail in 
section 1.5 Cellular Composition of bone. 
 
 
 
Figure 1.8 | Horizontal section through an osteon. Osteocytes, the mature bone cells, are arranged concentrically at the junctions 
between lamellae. They are embedded in lacunae and linked by canaliculi, which allow cell-to-cell communication and connect to 
the endosteum.  
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1.3.2 TRABECULAR BONE  
Unlike compact bone, spongy bone appears to consist of disorganised bone tissue. 
However, the trabeculae are actually aligned in a fashion which allows the bones to 
withstand maximal amounts of stress, and are located at anatomical points where 
significant amounts of stress are transmitted to the rest of the skeleton (e.g. femoral 
head – Figure 1.6)(Ryan and Ketcham 2005). The trabeculae contain irregularly 
arranged lamellae and osteocytes, which communicate with each other through 
canaliculi, and receive nutrients from capillaries passing these canaliculi emerging from 
the endosteum surrounding the trabeculae (Lafage-Proust, Roche et al. 2015, Prideaux, 
Schutz et al. 2016).  
 
1.3.3 THE PERIOSTEAL MEMBRANE 
As discussed above, bones also contain an external membrane, the periosteum, which 
covers the entire surface with the exception of the joint. The periosteum is composed of 
two thin layers – externally by an outer fibrous layer, composed of dense irregular 
connective tissue, whereas the internal layer, the cambium, is highly osteogenic, 
consisting of bone-forming osteoblasts and bone-resorbing osteoclasts as well as a large 
population of stem cells which can differentiate into osteoblasts (Zhang, Naik A Fau - Xie 
et al. 2005, Marsell and Einhorn 2011, Chang and Knothe Tate 2012). The periosteum 
contains a rich supply of nerve fibres, blood vessels and lymphatic vessels, which enter 
the bone through the nutrient foramina openings. This layer is firmly anchored to the 
underlying bone tissue through collagen fibres (Sharpey’s) fibres. The periosteum 
serves an additional purpose, which is to provide anchorage to the ligaments and 
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tendons. These regions are very rich in Sharpey’s fibres (Marieb and Hoehn 2010, Chang 
and Knothe Tate 2012).  
 
1.3.4 THE ENDOSTEUM 
Internally, bone is covered by the endosteum, a fragile connective tissue structure 
which covers the trabeculae of spongy bone and lines the canals in lamellar bone. This 
layer is similar to the periosteum in terms of cellular composition, containing both 
osteoblasts and osteoclasts. 
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1.4 CHEMICAL COMPOSITION OF BONE  
 
1.4.1 THE INORGANIC COMPONENT 
The nature of the inorganic component of bone was elucidated many decades ago using 
X-Ray diffraction. Studies by de Jong in 1926 (de Jong 1926) and later by Roseberry 
(1931) (Roseberry, Hastings et al. 1931) were the first to show using X-Ray Diffraction 
that bone samples contained small particles with diffractograms very similar to the 
crystals of naturally-occurring hydroxyapatite (HA) Ca5(PO4)3(OH) (Figure 1.9), a 
calcium phosphate mineral with a Ca:P ratio of 1.67. This composition, which was 
mainly deducted from cortical bone samples due to the ease of preparation for 
examination, was initially generalised to a variety of calcified tissues. However, over 
time, it became clear that there were differences in the mineral phases in different 
tissues, and in the same mineral phase across different phyla and species. The molar 
ratios of Ca and P can vary considerably in osseous tissues due to variations in 
vacancies and substitutions (Palmer, Newcomb et al. 2008), which take place due to the 
ongoing process of homeostasis, where calcium, magnesium and phosphorus ions are 
continuously removed from the bone reserves in order to supply the rest of the tissues 
(Boden and Kaplan 1990, Favus and Goltzman 2013).  
In both the bones and teeth of mammalian vertebrates, the mineral is mainly 
carbonated apatite, Ca10(PO4,CO3)(OH)2 (Favus and Goltzman 2013), although other 
minerals have been identified in small proportions, such as whitlockite (Jang, Jin et al. 
2014, Jang, Lee et al. 2015) and more recently, intermediate phases such as octacalcium 
phosphate (OCP) (Ban, Jinde et al. 1992, Crane, Popescu et al. 2006). 
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Figure 1.9 | Apatite mineral. Apatite is a calcium phosphate mineral that is produced and used by many biological environmental 
systems. Hydroxyapatite, one of principal types of apatite, is the main inorganic component of bone and dentin. Original image. 
Author would like to thank the Lapworth Museum of Geology, University of Birmingham. 
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1.4.2 THE ORGANIC COMPONENT 
The organic component of bone is composed of cells (osteogenic cells, osteoblasts, 
osteoclasts and osteocytes) and osteoid. Osteoid comprises approximately 35% of the 
weight of the matrix and is composed of the ground substance (which includes 
proteoglycans and glycoproteins) and collagenous tissue, both which are the product of 
osteoblasts.   As discussed in the previous sections, collagen contributes not only to the 
structure of the matrix, but also to the resistance of bone to tensile and bending forces.  
The organic component of bone matrix is composed in a proportion of 90% of collagen 
type I, with the remaining 10% composed of non-fibrous proteins.  Type I collagen is 
found in both osseous tissue and non-calcifying mesenchymal tissues and is composed 
of fibrils of approximately 78 nm diameter, showing a very characteristic periodic 
banding appearance when viewed under the electron microscope (Olsen 1964).  Two 
bands can be identified, which have different densities, of 0.4 D and 0.6 D (Bonucci 
2007). Their appearance of these periodic bands depends on the arrangement of the 
molecules and their amino acid sequence (von der Mark, Wendt et al. 1970). Collagen 
molecules are 280-300 nm long and are composed of three polypeptide chains which 
assemble into a left-handed triple helical configuration (Ramachandran 1956, Hulmes 
2002, Orgel, Irving et al. 2006). The polypeptide chains are composed of approximately 
33% glycine, found in every third position in the conformation gly-x-y, and 
approximately 22% is composed of proline and hydroxyproline (Martin, Piez et al. 1963, 
Bonucci 2007). Molecules of collagen type I consist of three chains, out of which two are 
identical and termed αI(I) and a different, third chain, αI(II) (Bonucci 2007). 
The inorganic component, hydroxyapatite, which accounts for approximately 65% of 
the weight of the bone is associated with collagenous fibres, which offers the bone 
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tissue great strength and resistance to compression. Although the role of collagen in 
nucleation of hydroxyapatite crystals has been a subject of great debate, fundamental 
studies performed since the 1950s on the mineral distribution in avian calcifying 
tendons suggested that two types of collagen mineralisation take place in vertebrates: 
intrafibrillar (Jackson 1957, Weiner and Traub 1986, Landis, Moradian-Oldak et al. 
1991, McEwen, Song et al. 1991) and interfibrillar (Landis, Hodgens et al. 1996).  In the 
intrafibrillar model of mineralisation, it was proposed that crystals penetrate through 
the fibrils, suggesting this as a mechanism through which apatitic crystals become 
orientated parallel to the collagen fibre axis (Jackson 1957). Later studies by Weiner 
and colleagues (1986) reported that crystals are located within the fibrils at the level of 
‘grooves’ created by adjacent gaps (Weiner and Traub 1986) (Figure 1.10).  
Work by McEwen and colleagues showed that 64% of the crystals were located in the 
collagen gap areas and only 36% in the collagen overlap areas (McEwen, Song et al. 
1991). Later work (Landis, Hodgens et al. 1996) demonstrated the presence of mineral 
crystals on the surface of collagen fibrils (inter-fibrillar mineralisation) along intra-
fibrillar mineralisation.  
Recent evidence from Wang and colleagues (2012) revealed that collagen type I itself 
can initiate and orientate the growth of apatite crystals in vitro in the absence of any 
other biochemical components involved in vertebrate skeletal development (Wang, 
Azaïs et al. 2012). Moreover, the authors showed that collagen type I can control the 3D 
distribution of the inorganic component from the atomic to the macroscopic scales. 
Recently (2017), the work of Niu and colleagues demonstrated using a polyanion and 
polycation-directed mineralisation that that the process of interfibrillar mineralisation 
is mediated by a balance between osmotic equilibrium and electroneutrality, as the 
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outward movement of ions and intrafibrillar water through the collagen surface 
occurred irrespective of the charges of the electrolytes  (Niu, Jee et al. 2017). 
 
 
 
 
 
 
Figure 1.10 | Simplified schematic of the organic-inorganic hierarchical structure in bone tissue. This model was first 
proposed by (Petruska and Hodge 1964). Collagen molecules (normally triple-helical, simplified here) are arranged end-to-end and 
parallel to each other. These structures contain spaces of approximately 36 nm between them, which facilitate nucleation by apatitic 
crystals. The mineral develops in this space in the fibrils. Diagram inspired from (Fang and Holl 2013) and (Alexander, Daulton et al. 
2012). 
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The organic component of bone is sometimes referred to as being completely separate 
from the inorganic component, a definition that not necessarily correct, as the two 
components are highly inter-related and defects in cell processes can lead to abnormal 
matrix production, which in turn gives rise to abnormal mineral deposition (e.g. 
osteogenesis imperfecta, a number of dysplasias and tumours) (Marie 2015). These will 
be reviewed in detail in Section 1.11 Pathological Bone Formation.  
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1.5 TYPES OF BIOMINERALISATION 
The process of deposition of mineral salts in the organic matrix of biological tissues has 
been referred to using multiple terms such as calcification, biomineralization and 
ossification. Whilst sometimes they are considered to be synonymous, in many contexts 
their meanings change. In this thesis, the process of calcification is referred to as the 
precipitation of calcium phosphate salts on the surface of tissues, whereas the term 
‘ossification’ is used to describe a hierarchical and organised deposition of mineral on 
collagen and other proteins belonging to the organic matrix of bone. However, it has to 
be stressed that it is not always possible to distinguish between the two processes, and 
therefore, in this thesis, the term ‘biomineralization’ is sometimes used to refer to the 
process of cell-mediated formation of a stable, crystalline phase of inorganic material. 
Irrespective of the pathway of mineralisation, this process is indispensable to many 
organisms, from prokaryotic forms of life to invertebrates and vertebrates.   
 
1.5.1 BIOMINERALISATION IN INVERTEBRATES  
Biomineralization in animals of the invertebrate subphylum is a process that is found in 
many morphologically-distinct structures. These can range from intracellular mineral 
particles, calcifying bacteria, calcified exoskeletons of arthropods (Figure 1.11a-c), 
which include extinct marine arachnomorphs as far as the Cambrian period (approx. 
500 million years ago) such as trilobites (a) and (b) and the exoskeletons of crustaceans 
(c); shells of molluscs and gastropods (d-e) and coral skeletons (e). These structures 
have a very high mineral component composed of calcium phosphates and carbonates, 
and a very low organic component (e.g. in molluscs, the organic matrix constitutes less 
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than 5% of the total weight). The mineral in these species can range from calcium 
carbonate (CaCO3) in mollusc shells (Weiner and Hood 1975) to crystalline fluorapatite 
in most crustacean mandibular teeth (Bentov, Aflalo et al. 2016). 
 
 
 
 
 
 
Figure 1.11 | Biomineralization is a process encountered in many orders and in the invertebrate forms of life, such as the 
exoskeletons of many arthropods, including extinct organisms such trilobites from the Palaeozoic Era (a- Ogyginus Cordensis 
trilobite and b- Ceratarges Armatus trilobite); shells of crustaceans including the Corystidae family (including crabs); the marine 
shells of gastropods (d-e) and coral skeletons (f). Original images. Author would like to thank the Lapworth Museum of Geology, 
University of Birmingham. 
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1.5.2 BIOMINERALISATION IN VERTEBRATES 
In terrestrial vertebrates, different parts of the skeletal system form through complex 
ossification pathways, known as endochondral and intramembranous ossification.  
 
1.5.2.1 INTRAMENBRANOUS OSSIFFICATION 
In the first type of ossification, known as intramembranous ossification, 
osteoprogenitor cells directly differentiate into osteoblasts, the bone building cells, to 
form mature bone. This is the major pathway of ossification in the bones of the skull and 
one of the main repair pathways during callus-mediated fracture repair, which takes 
place at the broken ends of a bone, compared to the central portion, which forms 
through a cartilage intermediate (Gerstenfeld, Cullinane et al. 2003, Claes, Recknagel et 
al. 2012). 
 
1.5.2.2 ENDCHONDRAL OSSIFFICATION 
The second type, known as endochondral ossification, represents the formation of bone 
through a cartilage intermediate or template. In this type of ossification, osteochondral 
progenitors differentiate into separate lineages of chondrocytes and osteoblasts to give 
rise to a cartilage template on top of which the future mature bone will eventually form.  
This is the major process by which long bones of the limbs form and, as mentioned 
above, is also involved in bone repair (Einhorn and Gerstenfeld 2015). 
The processes of intramembranous and endochondral ossification will be described in 
more detail in Section 1.8 – Bone Fracture Repair. An introduction to the essential 
cellular events in bone formation is presented in the next section. 
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1.6 CELLULAR AND CYTOPATHOLOGICAL EVENTS IN BONE FORMATION  
The skeletal system in vertebrates is composed of cartilaginous and osseous tissue, 
which forms during embryogenesis through the action of mesenchymal osteochondral 
progenitor cells, which differentiate into either chondrocytes or osteoblasts.   
 
1.6.1 FORMATION OF CHONDROCYTES 
Chondrocytes form during endochondral ossification, the first step which is the 
formation of a cartilage template. Chondrocytic cells differentiate from osteochondral 
precursors and undertake a series of tightly controlled events of proliferation, which 
take place along the longitudinal axis of the cartilage template (interstitial growth) and 
continue with appositional growth, where the structure becomes thicker with 
subsequent matrix deposition. A peripheral cartilage formation takes place as the 
structure grows in thickness (the perichondrium). This template is subsequently 
invaded by a mixed population of cells which give rise to a primary ossification centre 
(located centrally in the diaphysis). The perichondrium becomes the periosteum, 
containing osteoprogenitor cells which will give rise to osteoblasts and produce bone 
appositionally (Mackie, Ahmed et al. 2008). Chondrocytes which are located furthest 
from the ossification centre are actively proliferating and become flattened as they pack 
into column-like structures. Chondrocytes which are closest or inside the ossification 
centre become hypertrophic, secreting collagenous matrix (type II and X) which 
becomes mineralised (Rosen, Bouillon et al. 2013).  Secondary ossification centres 
develop in the epiphyses, in a similar manner, and continue to grow until the cartilage 
remaining between the two ossification centres forms an epiphyseal plate. 
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Chondrocytes in this structure continue to produce cartilage which is replaced by bone, 
which is essential for the longitudinal growth of bones. The bone-resorbing cells, 
osteoclasts, aid in removing excess cartilage matrix. The transition of chondrocytes is a 
process controlled by multiple signalling and genetic mechanisms and different stages 
of endochondral ossification show different gene expression patterns. Chondrocytes in 
immature stages express the transcription factors Sox 5, Sox 6, Sox 9 (Hardingham, 
Oldershaw et al. 2006, Leung, Gao et al. 2011). The pre-hypertrophic stage is 
characterised by parathyroid hormone I receptor (PTH1r) and Indian hedgehog 
expression, which form a negative feedback loop that controls the chondrocyte’s 
decision to carry on proliferating or become hypertrophic (Yang 2013). Ihh-/- rodents 
show a lack of endochondral bone due to a 50% reduction in proliferation and increase 
in hypertrophic progression (St-Jacques, Hammerschmidt et al. 1999, Long, Zhang et al. 
2001). Early hypertrophic chondrocytes decrease the expression of Sox 5,6 and 9 and 
collagen type II and increase the production of collagen type X (Kielty, Kwan et al. 
1985). Hypertrophic chondrocytes develop with the expression of vascular endothelial 
growth factor A (VEGFA)(Zelzer, Mamluk et al. 2004), matrix metalloproteinase 13 
(MMP-13) and osteopontin (Gerstenfeld and Shapiro 1996, Pullig, Weseloh et al. 2000), 
indicating the subsequent invasion of osteoblasts, osteoclasts and endothelial cells 
which are going to replace the cartilage template with bone (Li and Dong 2016).  
It is important to note that cartilage is an avascular tissue which develops under 
hypoxic conditions, as some of the centrally-located chondrocytes do not have access to 
vasculature-provided oxygen. As a result, the transcription factor hypoxia-inducible 
factor 1α (HIF- 1α) is essential, as seen in other hypoxic conditions, in mediating the 
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hypoxic response in cartilage. Removal of HIF- 1α results in the death of chondrocytes 
inside the growth plate (Schipani, Ryan et al. 2001).  
 
1.6.2 FORMATION OF OSTEOBLASTS  
The osteoblastic differentiation can be classified according to four stages, including 
division, extracellular matrix deposition, matrix maturation and mineralisation (Stein 
and Lian 1993).  There are several key enzymes and proteins essential in these 
processes, including alkaline phosphatase (ALP), type I collagen (Col I), bone 
sialoprotein (BSP), osteopontin (OPN) and osteocalcin (OC). These are also used as 
differentiation markers which can be detected at different stages in osteogenesis, for  
which ALP is known to be an early osteoblastic marker, whereas OC is used as a late 
marker for osteoblast differentiation (de Gorter and ten Dijke 2013).  Several signalling 
pathways control these processes, including RUNX2, BMP, TGF-β, WNT, HEDGEHOG, 
PTH, IGF-1, FGF and NOTCH (de Gorter and ten Dijke 2013). The pathways which are 
important for understanding some of the results in this thesis are described in detail 
below. 
 
1.6.2.1 RUNX2 PATHWAY 
This pathway is a critical event in osteoblastic differentiation. The activation of 
transcription factor RUNX2 is indispensable for the mineralisation step and formation 
of a skeleton. Homozygous mutants for RUNX2 (also known as Cbfa1) are not able to 
survive at birth due to respiratory failure and show a lack of osteoblasts and of both 
intramembranous and endochondral bone (Otto, Thornell et al. 1997). Heterozygous 
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mutants develop skeletal abnormalities which appear to be similar to pathological 
conditions such as cleidocranial dysplasia (CCD), a condition characterised by abnormal 
development of the cranial bones and marked absences in parts of the collar bone 
(Mundlos 1999). RUNX2 is able to interact with gene promoters to increase or 
downregulate the expression of Col I, ALP, OPN, OC and ON and osterix (Osx)(Harada, 
Tagashira et al. 1999, Kern, Shen et al. 2001).   
 
1.6.2.2 BMP PATHWAY 
Experiments conducted by Urist in 1965 originally identified bone morphogenic 
proteins (BMPs) as active components in bone extracts which are able to promote 
ossification when implanted subcutaneously, giving rise to ectopic bone (Urist 1965). 
Since then, the role of BMPs in bone formation has become well known. They are 
present in skeletal tissue and are involved in bone homeostasis and fracture repair 
(Gazzerro and Canalis 2006) and as such, several types such as BMP-2 and 7 have 
recently been applied in clinical practice to accelerate bone healing and treat fracture 
non-unions  (Gautschi, Frey et al. 2007, Schmidmaier and Wildemann 2009). Their 
abnormal activity caused by genetic mutations which trigger overactivation in 
conditions such as Fibrodysplasia ossificans progressiva leads to large amounts of 
ectopic bone formation and will be discussed later in this chapter.  
BMPs are part of the TGF-β superfamily of proteins and bind to type I and II 
serine/threonine receptor kinases, forming an oligomeric complex (de Gorter and ten 
Dijke 2013), which leads to the phosphorylation and hence activation of type I receptors 
by the constitutively active type II receptors. This in turn, activates intracellular 
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signalling mediators Smad 1, 5 and 8, which then associate with co-Smad 4, and 
together they translocate to the nucleus, where they act as transcription factors, 
stimulating alkaline phosphatase activity and ultimately bone formation (Feng and 
Derynck 2005, Massague, Seoane et al. 2005, de Gorter and ten Dijke 2013). 
 
1.6.2.3 TGF-β PATHWAY 
TGF-β signalling is involved in the proliferation and differentiation of numerous cell 
types, including chondrocytes and osteoblasts. The signalling mechanism is similar to 
BMPs, but is mediated by Smad 2 and 3 factors (Feng and Derynck 2005, Massague, 
Seoane et al. 2005). Smad3 is able to greatly increase ALP activity in osteoblastic cells 
(MC3T3) in vitro, as well as type I procollagen and OPN (Sowa, Kaji et al. 2002).  
 
1.6.2.4 WNT PATHWAY 
The WNT pathway regulates bone mass and influences osteoblast differentiation (Wang, 
Li et al. 2014).  WNTs are glycoproteins which signal via membrane receptors to β-
catenin. In normal conditions, β-catenin forms a complex with adenomatous polyposis 
coli (APC), axin, glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1). The 
presence of WNT causes dissociation of this complex, which releases β-catenin into the 
cytoplasm and translocates to the nucleus, where it affects expression of proteins such 
as ALP. This pathway is essential for the transition of mesenchymal cells to an 
osteoblastic phenotype and thus, bone formation (de Gorter and ten Dijke 2013). 
Disruption of WNT signalling is linked to osteoporosis (Canalis 2013) and deletion of β-
catenin causes osteochondral progenitors to differentiate into a chondrocytic lineage as 
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opposed to osteoblastic (Day, Guo et al. 2005). Moreover, ectopic WNT signalling 
enhances osteoblastic differentiation and suppresses chondrocyte formation (Day, Guo 
et al. 2005). Importantly, the WNT signalling pathway plays an essential role in 
osteocytes (Bonewald and Johnson 2008), where it is believed to allow osteocytes to 
signal information on mechanical loading to the cells on the bone surface. Osteocyte-
deficient β-catenin deficient mice show progressive bone loss in the appendicular and 
axial skeleton (Kramer, Halleux et al. 2010) and mutations in SOST, the gene encoding 
sclerostin, which is produced by osteocytes and acts as an antagonist of WNT, lead to 
the rare Van Buchem disease and sclerosteosis (Semenov, Tamai et al. 2005, ten Dijke, 
Krause et al. 2008), which are characterised by abnormally high bone mass.  
 
1.6.2.5 PTH PATHWAY 
The parathyroid hormone (PTH) can have both anabolic and catabolic effects on bone 
formation and appear to vary with the mode of administration. For example, 
intermittent parathyroid hormone therapy leads to increased bone mass by conversion 
of the quiescent lining cells to active osteoblasts (Kim, Pajevic et al. 2012), and by 
reducing sclerostin levels, thereby allowing WNT-driven bone formation (Keller and 
Kneissel 2005); whereas continuous PTH administration leads to greater bone 
resorption (Tam, Heersche et al. 1982, Neer, Arnaud et al. 2001). Homozygous 
inactivating mutations in the PTH or PTH related peptide receptor lead to the lethal 
genetic disorder known as Blomstrand chondrodysplasia (Zhang, Jobert et al. 1998). 
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1.7 FORMATION OF OSTEOCLASTS 
Osteoclasts are exclusively bone-resorptive cells, which derive from bone macrophage 
lineages (Suda, Takahashi et al. 1999). Osteoclastogenesis take place under the action of 
two important cytokines, the receptor activator of nuclear factor kB ligand (RANKL), a 
member of the tumour necrosis factor (TNF) superfamily, which is crucial for osteoclast 
formation (Boyle, Simonet et al. 2003); and the macrophage-colony stimulating factor 
(M-CSF/CSF-1), which influences proliferation and differentiation (Pixley and Stanley 
2004). These cytokines exist as membrane bound, secreted by T cells, and soluble 
forms, secreted by bone marrow stromal cells and osteoblasts and therefore, the 
initiation of osteoclastogenesis requires the presence and activity of bone residing cells 
(Ross 2013). However, it has been recently shown that the mature bone cells, 
osteocytes are the major producers of RANKL in vivo, as mice with osteocytes deficient 
for RANKL show an osteopetrotic phenotype (Nakashima, Hayashi et al. 2011) (see 1.1.2 
Adaptation of Bones to Different Environments and 1.65 Osteocyte control of bone 
remodelling). 
Mutations in the genes responsible for proper osteoclast formation (genes TNFSF11 and 
TNFRSF11A) and proper resorptive function of these cells (defects in the chloride 
channels that modulate osteoclast acid secretion) (TCIRG1, CLCN7, OSTM1, SNX10, 
PLEKHM1) (Sobacchi, Schulz et al. 2013) have also been linked to osteopetrosis.  At the 
opposite end of the spectrum, RANKL overactivation leads to osteolytic bone disease 
(Wittrant, Théoleyre et al. 2004) and RANKL production by osteocytes and B 
lymphocytes is required for bone loss caused by estrogen decline at menopause 
(Fujiwara, Piemontese et al. 2016). 
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1.7.1 OSTEOCYTES 
Aside from the osteoblasts which constitute around 4-6% of the cells in bone, and the 
osteoclasts, which represent 1-2% of the total cell population, 90-95% of the cells in 
bone are actually osteocytes, the mature bone cells, which are terminally differentiated 
osteoblasts that play an essential role in mechano-sensing and orchestrating the bone 
remodelling process.  They are also the longest-living bone cells, with a life span of 
around 25 years (Franz-Odendaal, Hall et al. 2006), where they live entrapped within 
15-20 μm lacunae, in a highly mineralised matrix. For a long time, due to their 
localisation and the inability to isolate them, they were considered passive cells and 
their functions were poorly defined. Over the recent years, we have become more aware 
of the essential role they play in many physiological processes (Bonewald 2011).  
As mentioned above, evidence has recently emerged which shows that osteocytes are 
essential in regulating phosphate homeostasis, by secreting into the circulation the 
fibroblast growth factor 23 (FGF23), acting as mini ‘endocrine glands’ (Dallas, Prideaux 
et al. 2013).  Therefore, abnormalities in these cells may contribute towards several 
bone diseases, including bone fragility induced by corticoids and osteoporosis 
(Bonewald 2011, Bonewald 2013).  
They also perform a mechanical sensing function, which is permitted by their strategic, 
regular arrangement in the lacuno-canalicular system (see Figure 8), containing 
dendritic processes which extend to the bone surface and to the marrow. These events 
are still not fully characterised, and this section will summarise the current state of 
knowledge.  
Osteocytes form from the terminal differentiation of osteoblastic cells derived from a 
bone marrow lineage. Following ossification, osteoblasts can become embedded in their 
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own osteoid, becoming osteocytes, they can become quiescent bone lining cells or can 
undergo apoptosis (Jilka, Weinstein et al. 1998). The genetic mechanisms controlling 
the fate of these cells is still unknown. Several recent studies in osteocyte-like cell lines 
(IDG-SW3 and MLO-Y4) indicated changes in gene expression involving the hedgehog 
signalling pathway and a desensitisation to the vitamin D3 hormone (St John, Bishop et 
al. 2014) and a role in vitamin K in promoting differentiation (Atkins, Welldon et al. 
2009). 
The mechanism by which osteocytes become entrapped in the matrix is also unknown, 
although several authors (Franz-Odendaal, Hall et al. 2006) suggested a progressive 
embedding mechanism in which a population of osteoblasts on the surface of bone slow 
down the production of matrix relative to adjacent cells, which become buried in the 
matrix (Dallas and Bonewald 2010).  Although some authors consider this event a 
passive matrix embedding process (Nefussi, Sautier et al. 1991), other researchers 
believe this is an active and invasive process that requires matrix degradation and 
cleavage of collagen under the action of MT1-MMP for the formation of lacunar and 
canalicular structures and maintenance of an osteocytic phenotype, as mice deficient for 
this metalloproteinase develop osteocytes without processes and which are unable to 
degrade collagen (Holmbeck, Bianco et al. 2005). Moreover, mice resistant to collagen I 
degradation show osteocytic and osteoblastic death and an increase in bone mass in a 
similar way caused by PTH in wild type mice (Zhao, Byrne et al. 2000).  
Osteoid osteocytes actively produce and calcify their matrix (Bonewald 2013) and 
shrink in size by 30% from the osteoblastic phase during the formation of projections 
and by 70% when they have become fully mature (Bonewald 2013).  
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Their characteristic genetic markers have been identified rather recently, with low 
alkaline phosphatase (ALP) expression, high CD44 linked to E11 (Hughes, Salter et al. 
1994), E11/GP38/Podoplanin involved in early embedding and dendrite formation and 
increases with mechanical load (Zhang, Barragan-Adjemian et al. 2006); dentin matrix 
protein 1 (DMP 1) (Toyosawa, Shintani et al. 2001) and phosphate-regulating neutral 
endopeptidase on chromosome X (PHEX) (Westbroek, De Rooij et al. 2002, Plotkin and 
Bellido 2016), expressed in both early and late osteocytes, and support phosphate 
metabolism and mineralisation; elevated FGF23 in early and mature osteocytes induces 
hypophosphatemia (Bonewald and Wacker 2013); and sclerostin (SOST) and ORP150, 
expressed in mature osteocytes inhibit bone formation and protect from hypoxia, 
respectively (Poole, van Bezooijen et al. 2005, Guo, Keightley et al. 2010). 
 
1.7.2 OSTEOCYTE CONTROL OF BONE REMODELLING  
The mature skeleton of mammals, although appearing mechanically inert, is 
continuously maintained through the well-synchronised activity of osteoblasts and 
osteoclasts, termed remodelling units and with the input of the mature bone cells, 
osteocytes. These processes are temporally and spatially coupled and so when 
dysregulation in these functions take place, abnormal changes in bone mass take place. 
In the adult skeleton, bone remodelling takes place at the surface of both the periosteum 
and endosteum (the thin connective tissue lining of the internal part of bones). The 
mass of forming bone is maintained constant, an indication that the rates of bone 
production and removal are approximately equal. However, there are regional 
differences, for example in the femur, where the distal part is remodelled every 5-6 
months, whereas the shaft is processed much less frequently (Marieb and Hoehn 2010). 
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Evidence has accumulated over the past years which indicated that osteocytes play a 
major role in bone deposition and resorption. Growth medium from the osteocytic line 
MLO-Y4 can promote proliferation of MSCs and increase the expression of ALP and OC 
(Heino, Hentunen et al. 2004) as well as inhibiting resorption by osteoclasts (Heino, 
Hentunen et al. 2002). Moreover, these cells are able to support osteoclast formation in 
the absence of any exogenous osteotropic factors and express RANKL on their surface 
(Zhao, Zhang et al. 2002). The viability of osteocytes is necessary to prevent the loss of 
bone mass, as shown in a study in mice where osteocyte necrosis was induced by 
DMP1-directed diphtheria infection, causing osteoclast activation, osteoporosis-like 
effects and a decrease in mechanotransduction, indicating that the osteocyte control of 
osteoblasts and osteoclasts is mechanically-induced (Tatsumi, Ishii et al. 2007), 
something that will be discussed in section 1.7.3 - Mechanotransduction.   
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1.8 TRANSLATION OF MECHANICAL FORCES 
 
1.8.1 THE LOWER LIMBS: THE FEMURS 
The lower limbs of most species, highlighted in Figure 1.2, are subjected to exceptional 
forces during locomotion. In humans, they support the weight of the erect body and as 
such, are much thicker and stronger compared to upper limb bones.  
Femoral bones are the single bones comprising the upper parts of the leg in most 
species of vertebrates. In humans, femurs are the largest, strongest and longest bones in 
the skeletal system. They are able to resist significant loading stress during intense 
exercise, reaching up to 280 kg/cm2. Lengthwise, they average approximately 25% of a 
person’s height (Marieb and Hoehn 2010). 
From an anatomical perspective, femurs articulate with the hip bones proximally and 
continue medially towards the knee. As mentioned at the start of this chapter, this 
design allows the knee joints to be closer to the body’s centre of gravity and as such, the 
body is better balanced during upright positions. Gender differences exist in the medial 
course of the femoral bones, this geometry being more pronounced in females due to 
their wider pelvic area (arch is approximately 30 degrees broader), and this is believed 
to contribute to a greater incidence in knee problems, particularly in female athletes 
(Boling, Padua et al. 2010). 
As discussed in previous chapters, the force of gravity and muscle pull on the bones 
represent two stressors which influence bone formation. According to Wolff’s law, 
which was developed by German anatomist and surgeon Julius Wolff in the 19th century,  
 the response of bones to mechanical stress is proportional to the load placed on them 
and as such, the anatomy of bones directly influences local changes (Wolff, Maquet et al. 
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1986). This is particularly obvious with the femoral bones, as body weight transmitted 
to the femoral head bends the bone on one side, causing great compression. The 
internal trabecular structure functions as an arch, which transfers the compressive load 
to the femoral shaft (Rudman, Aspden et al. 2006). For this reason, bones are thickest 
centrally (mid-diaphysis), where compression and tension stresses are the greatest.  
Compression and tensile forces cancel each other out towards the centre of the bone 
(Figure 1.12) and hence the stress is minimal internally. Because less bone material is 
needed, the central portion of bones is hollow and filled with spongy bone to minimise 
mass (Marieb and Hoehn 2010).  
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Figure 1.12 | Bending stress in femoral bones is distributed according to anatomical design. The weight of the upper body is 
transmitted to the femoral head, articulated to the hip. These compression (bending) forces act primarily along the dotted line, 
creating tensile (stretching) forces on one side (blue arrows) and compression on the other side (red arrows). These forces cancel 
each other internally, with very little stress being experienced in this region (white dot).  Schematic inspired from (Marieb and 
Hoehn 2010). Original image. Image of the femoral section acquired from a skeletal specimen at the Natural History Museum, South 
Kensington, London. 
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1.8.2 THE UPPER LIMBS 
The set of observations described by Wolff centuries ago are particularly noticeable in 
handedness (strong right or left-handed individuals) and in sport players who 
undertake vigorous exercise (Ireland, Degens et al. 2015), who show differences in bone 
thickness in the dominant arm. For example, in tennis players, the serving arm bones 
become thicker and show a higher bone mineral content (BMC) (Figure 1.13) (Bass, 
Saxon et al. 2002, Ireland, Maden-Wilkinson et al. 2013, Ireland, Maden-Wilkinson et al. 
2014). Humeral bone cross sectional areas (CSA) have been reported to expand up to 23 
± 12 % (Ireland, Maden-Wilkinson et al. 2014) and this enlargement appears to be a 
cortical one as opposed to a medullary one (Kontulainen, Sievänen et al. 2003), with 
cortical areas reported to expand as much as 7-11% (Bass, Saxon et al. 2002) 
particularly in the distal portions compered to central areas. Multiple tomographic and 
MRI studies indicated that these differences persist in long-term and take place in a 
similar fashion  irrespective of gender (Bass, Saxon et al. 2002), age (Ireland, Maden-
Wilkinson et al. 2014) or starting age (Ireland, Maden-Wilkinson et al. 2014). 
As described in sections 1.1.2 and 1.6.3, this type of increase in bone density and 
volume takes place in other species as well during re-adaptation to a higher-loading 
regime, but can also happen pathologically, in autosomal dominant and recessive 
conditions known as osteosclerosis and osteopetrosis, also known as ‘marble bone 
disease’ (Huang and Ogawa 2010). 
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Figure 1.13 | Adaptation of dominant hand to increased loading forces. Cross-sectional differences in the arms of tennis players 
following prolonged periods of intense exercise. Bones of the racquet arm increase in strength and rigidity and the effect is more 
pronounced in players who started this type of exercise early in life. Diagram is based on CT/MRI cross-sectional appearance of arm 
bones and inspired by (Marieb and Hoehn 2010). 
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1.8.3 MECHANOTRANSDUCTION 
Mechanical strain is required for the formation of post-natal bone, but not the pre-natal 
skeleton. Bone mass depends on peak applied strain (Rubin 1984) and studies in rats 
showed that the rate of new bone formation is related to the frequency of loading 
(Robling, Hinant et al. 2002). However, a loading regime containing rest intervals is 
more beneficial for increasing bone formation and strength is maximised if the applied 
loading forces are shorter and more frequent (Robling, Hinant et al. 2002).  
The mechanism by which these mechanical signals are received and interpreted by cells 
are still a subject of great debate, although it is widely accepted that a process of 
sensory transduction is involved, which converts mechanical signals into electro-
chemical information and directs remodelling. Moreover, the amplitude of electrical 
potentials as a result of stress is related to the frequency and scale of bony deformation, 
while polarity is determined by the direction of bending (Bassett and Becker 1962). In 
the 1960s, Bassett and colleagues performed a series of experiments on excised and in 
vivo bones and determined that the areas which underwent compression developed 
negative potentials with respect to other regions. As a result of different charges 
observed in tensed areas, it is believed that these electrical impulses control the process 
of remodelling (Marieb and Hoehn 2010) and this is the basis for many electromagnetic 
therapies designed to accelerate bone repair and fracture healing, representing a 500 
million $ market in the US (Mollon, da Silva et al. 2008). 
The same group proposed that collagenous matrix-inorganic crystal piezoelectricity was 
a mechanism through which osteocytic and osteoblastic cells perceive loading forces 
and areas of greater stress (Bassett and Becker 1962, Ahn and Grodzinsky 2009) and 
was based on the principle that applied mechanical deformation on femoral bones (and 
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the apatite-collagen junctions) creates local gradients in electric potential. They 
proposed that these electrical signals propagate along the collagen fibres and thus 
provide an osteogenic stimulus locally by affecting differential cellular responses and 
changing the orientation of the newly forming collagen, ultimately allowing the bone to 
withstand the greater forces experienced. Interestingly, these effects were absent when 
the inorganic component of bones was removed (Bassett and Becker 1962, Bassett, 
Pawluk et al. 1964).  
This theory was later substituted by other theories, such as streaming potential and 
fluid-generated shear stress (Bonewald 2006, Wittkowske, Reilly et al. 2016).  
Theoretical and in vitro models show that the flow of bone fluid is dependent upon 
extravascular pressure and applied cyclic loading of osteocytes (Weinbaum, Cowin et al. 
1994). The forces that bones are subjected to during walking or standing cause fluid 
flow via canaliculi connecting osteocytes, which create waves of shear stress and 
deform the cell membranes and cilia (flagellar-like structures extending from the body 
to the ECM) (Malone, Anderson et al. 2007, Temiyasathit and Jacobs 2010). These 
stresses on in vivo membranes have been estimated to be range from 8-30 dynes/cm3 
(Weinbaum, Cowin et al. 1994) and in vitro they have been estimated to be around 5 Pa  
(Price, Zhou et al. 2011, Bonewald 2013). Indeed, more recent evidence has confirmed 
the link between osteocyte response to compressive mechanical forces and control of 
both osteoclasts and bone surface cells (osteoblasts and bone lining cells), to which they 
are connected through processes containing gap junctions, most importantly Cx43. They 
are able to communicate with these cells either directly, through these channels, or by 
releasing short-distance metabolites such as prostaglandin PGE2, ATP and nitric oxide 
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into the extracellular fluid (Palazzini, Palumbo et al. 1998, Kamioka, Ishihara et al. 2007, 
Schaffler, Cheung et al. 2014, Takano-Yamamoto 2014).  
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1.9 BONE FRACTURE REPAIR 
The process of skeletal regeneration is essential to maintain the quality and 
functionality of bones. There has been a great amount of research involved in 
understanding bone repair following injury, in both human subjects and animal models, 
in order to develop more efficient measures to accelerate healing, prevent fracture non-
union and many other bone complications.  
The final purpose of all developmental events is the formation of a tissue which can 
provide an adequate morphological structure that can allow it to carry out the 
physiological function it is designed for. In the case of fracture healing, the regeneration 
process initiated following injury requires a complex set of processes meant to re-
establish not only the initial geometry but also the biomechanical capabilities of the 
damaged structure (Gerstenfeld, Cullinane et al. 2003). 
 
1.9.1 CELLULAR EVENTS 
The bone healing process involves different cell types, including inflammatory cells, 
osteoprogenitor, chondrocytes and pre-chondrocytes, osteoblasts and osteoclasts. 
The healing process is common across different vertebrate groups, but takes place more 
rapidly in small rodents such as mice and rats (Zuscik 2013). In all cases, the process 
involves a combination of intramembranous and endochondral ossification (Figure 
1.14) (Gerstenfeld, Cullinane et al. 2003, Marsell and Einhorn 2011, Einhorn and 
Gerstenfeld 2015). 
The initial mechanical trauma results in bleeding and the formation of a haematoma, 
which surrounds the fracture site. Several cytokines are involved in the process, 
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including tumour necrosis factor-α (TNF-α) and interleukins (IL) IL1, IL6, IL11 and IL18 
which control the initiation and modulation of the immune response (Gerstenfeld, 
Cullinane et al. 2003). 
These cytokines are believed to be involved in the generation of secondary responses 
involving recruitment of mesenchymal stromal cells, which may derive from the 
marrow space adjacent to the damaged cortical bone (Matsumoto, Mifune et al. 2008, 
Ueno, Uchida et al. 2011), the surrounding muscular tissue (Glass, Chan et al. 2011, 
Henrotin 2011), the periosteum (Zhang, Naik A Fau - Xie et al. 2005, Ushiku, Adams et 
al. 2010) and the systemic circulation (Granero-Moltó, Weis et al. 2009).  
 
1.9.2 THE ROLE OF PERIOSTEAL CELLS IN FRACTURE REPAIR 
The primary source of cells that enters the callus is the periosteal population of cells 
from the cambium layer, which has the ability to differentiate into both chondrocytes 
and osteoblasts (Fang and Hall 1996, Li, Amizuka et al. 2004). Intramembranous bone 
formation always takes place close to the bone fracture ends (Figure 1.14d), where 
vasculature is preserved, whereas the site furthest away from the fracture, where 
oxygen tension is the lowest due to disrupted blood supply, takes place via an 
endochondral route, consistent with what is seen during bone formation (Mackie, 
Ahmed et al. 2008, Zuscik 2013). Cells closest to the fracture site differentiate into 
osteoblasts, which secrete collagenous matrix and lay down mineral without a cartilage 
intermediate. The most central cells give rise to cartilage and recapitulate several stages 
of chondrocyte maturation in the growth plate (Claes, Recknagel et al. 2012).  The 
forming calcified cartilage turns into a template for the new bone formation and 
terminally differentiated chondrocytes contribute to the mineralisation of the tissue 
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(Gerstenfeld, Cullinane et al. 2003). Ultimately, they undergo apoptosis and a process of 
osteoclast-mediated resorption takes place under the action of M-CSF, RANKL and 
osteoprotegerin (OPG) (Kon, Cho et al. 2001). 
The mechanical properties of the forming bone depend on the stability of the fracture, 
with stabilised fractures showing little evidence for cartilage, whereas non-stabilised 
fractures produce high amounts of cartilage (Thompson, Miclau et al. 2002).  
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Figure 1.14 | Schematic of the tissue morphogenesis during fracture repair. a, The outside layer of long bones (periosteum) is a 
well-vascularised tissue. b, Trauma during fracture disrupts the blood supply at the site, which leads to the formation of a blood clot, 
also known as hematoma (c). Periosteal cells located inside the deeper, cambium layer, migrate to the site of injury (d) where they 
differentiate into osteoblasts and give rise to intramembranous bone close to the bony ends, where blood supply is still active. The 
central portion of the hematoma is replaced with endochondral bone, which allows central cells, furthest to the blood supply, to 
survive the hypoxic conditions. Cartilage formation continues (e) and blood vessels invade this structure until the initial hematoma 
is completely replaced (f). Following maturation, the cartilage template becomes progressively replaced with intramembranous 
bone (g-h), which is ultimately conversed under the action of osteoblasts and osteoclasts into lamellar bone and the initial 
geometric shape and function of the fractured bone is restored.  
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1.10 THE EFFECT OF UNLOADING ON BONES  
The microgravity environment in Space is an excellent model to study the effect of the 
absence of gravitational forces and muscle pull on the bones. Space exploration during 
the past 50 years has provided valuable clues into the pathological effects of prolonged 
periods of unloading on the skeletal system. These consequences are profound and are 
characterised by a marked bone loss and increased bone resorption, similar to clinical 
conditions such as osteoporosis, and are accompanied by hypercalcemia and 
hypercalciuria (Lau and Guo 2011).  
These physiological changes, aimed to adapt the skeletal system to the new loading 
regime, constitute a major barrier for potential interplanetary travel. This is because the 
major motivation behind sending human crews in planetary explorations compared to 
robotic probes is their potential to perform complex physical tasks and choose research 
spots, as well as to handle complex research tools. However, the environment on 
planets such as Mars is far more challenging than on Earth, requiring a good skeletal 
health. Whilst the gravity of Mars is approximately one third of that of Earth’s, thus 
providing some degree of loading, the landscape contains geographical structures such 
as canyons and mountains which are far wider and higher. This would require a 
potential crew to be of superior physical fitness in order to perform such strenuous 
exercise (Buckey 2006, Barratt and Pool 2008).   
Whilst the technology to return to the Moon and for a journey to Mars has been 
available for some time, the level of bone loss during such long, strategic missions is still 
being investigated, as it is directly proportional to the time spent in microgravity. 
Although the journey to Mars would only last approximately 6 months, to allow for the 
return journey, astronauts would have to wait for another period of planetary 
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alignment that would allow for a low-energy transfer between the two planets. This 
would imply a further 1-1.5 years spent on the planetary surface, and therefore a total 
journey time of approximately 3 years (Buckey 2006, Clément 2007). The severe bone 
loss during that period could lead to increased susceptibility to contraction damage and 
therefore potentially compromise the success of the mission. It could also make the 
bones too weak to withstand the intense re-entry forces and re-exposure to the Earth 
gravity, which could potentially have fatal consequences.  
 
1.10.1 THE ‘ACCELERATED AGING’ EFFECT OF BONE UNLOADING  
In space, very little muscular force is required to initiate movement, which is 
accomplished mainly with the help of the upper part of the body and limbs and for this 
reason, the muscles and bones of the upper part are less affected than the ones in the 
hip and legs, which do not receive the powerful muscle contractions that are usually 
required on Earth during walking or standing and these are mainly used for stability 
(Clément 2007). Similar effects can be observed on Earth in the elderly and in 
conditions such as primary and secondary osteoporosis (Lau and Guo 2011), as well as 
in paraplegic patients following injury of the CNS or peripheral nerves, in disuse 
osteoporosis (Houde, Schulz et al. 1995, del Puente, Pappone et al. 1996, Demirbag, 
Ozdemir et al. 2005). 
Studies have reported that on average, astronauts lose between 1-1.6% of bone mass 
per month (Surhone, Timpledon et al. 2010). The most affected bones are those of the 
vertebra, pelvis and the femoral neck and trochanter, which are essential in 
counteracting and distributing the force of gravity. 
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The monthly losses in proximal femur per month are very similar to the yearly bone 
loss in post-menopausal osteoporotic women (Cavanagh, Licata et al. 2005, Lane 2006).  
Initial studies on the MIR space station showed that the rate of bone loss following 6 
month missions can reach 4.5% in trabecular bone and 2.94% in cortical bone in the 
tibia, whereas slight increases in the bones of the arm (radius) were recorded, with a 
0.2% increase in trabecular bone and 0.51% increase in cancellous bone (Collet, 
Uebelhart et al. 1997). Studies by Lang and colleagues (Lang, LeBlanc et al. 2004) 
showed that the spinal volumetric bone mineral density (vBMD) was reduced at an 
average rate of 0.9% and 0.7% in trabecular and cortical bone, respectively, during 4-6 
months of spaceflight, whereas the hip integral, cortical and trabecular bone density 
was lost at a rate of 1.2-1.5%/month, 0.4-0.5%/month and 2.2-2.7%/month 
respectively.  
In all studies, bigger losses appear to happen in cancellous bone as opposed to cortical 
bone, which is a feature also seen in type I (postmenopausal) osteoporosis (Iwamoto, 
Takeda et al. 2005, Finkelstein, Brockwell et al. 2008).  
Calcium supplementation does not affect bone homeostasis, but decreases the 
abnormally high serum levels (Iwamoto, Takeda et al. 2005). As such, a regime of 
exercise and frequent loading is performed in microgravity in order to slow down the 
rate of bone loss (Cavanagh, Licata et al. 2005).  
When prolonged bed-rest studies (33 weeks) were performed on healthy individuals, a 
decrease in bone mineral content ranging between 25% and 44.5% were reported 
(Donaldson, Hulley et al. 1970). 
In simulated microgravity using ground-based rodent models, where hind-limb 
unloading using tail suspension was used, a preferential decrease in periosteal bone 
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mineral mass following 90 days of unloading was reported (LeBlanc, Marsh et al. 1985, 
Sessions, Halloran et al. 1989).  
 
1.10.2 THE EFFECT OF UNLOADING ON BONE CELLS 
The weightlessness experienced by bones in space leads to structural and molecular 
changes meant to stabilise the body to the reduced loading introduced by the micro-G 
environment. Observations from both spaceflight studies and ground-based analogues 
have provided significant amounts of evidence on the cellular processes underlying the 
significant bone loss.  
In C5BL/6J mice which were flown for 15 days on the International Space Station, 
dramatic losses in pelvic bone mass were observed. These changes have been found to 
occur due to an increase in osteoclast-mediated bone resorption, but also due to a 
process of osteocytic osteolysis, as well as a cell cycle arrest in osteoblasts. (Vico, 
Hinsenkamp et al. 2001, Tamma, Colaianni et al. 2009, Blaber, Dvorochkin et al. 2013). 
The decrease in bone forming capacity as well as the increased bone breakdown and 
decrease in osteocytic ability to modulate these processes, resulted in major imbalances 
in bone tissue formation during unloading.  
Recent work from Nabavi and colleagues (Nabavi, Khandani et al. 2011) showed a 
decrease in cellular integrity in space flown osteoblasts, with fragmented or condensed 
nuclei, shorter and wavier microtubules, fewer focal adhesions, thinner cortical actin 
and a high number of stress fibres. These effects on the nucleus and cytoskeleton had 
been previously observed in space-flown MC3T3-E1 osteoblasts, but a reduced growth 
activation and glucose consumption were also observed (Hughes-Fulford and Lewis 
1996). 
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1.11 PATHOLOGICAL BONE FORMATION 
As described in the sections above, bone is a tissue that has evolved to counteract the 
changing mechanical and environmental conditions. Different pathways controlled by 
an accurately synchronised control system allow the deposition and resorption of 
mineralised tissue to meet the physiological demands. However, maladaptive ectopic 
ossification can occur in bone and other types of tissues in response to altered genetic 
expression, injury or extreme mechanical insult. This process is known as heterotopic 
ossification (HO) and is best defined as an ectopic bone formation in bone and extra-
skeletal soft tissues that would not calcify under normal physiological circumstances 
(Isaacson, Brown et al. , Isaacson, Stinstra et al. 2010). The underlying manifestations 
vary greatly in every condition and as such the underlying causes are still a subject of 
debate. Section 1.6 Cellular and Cytopathological events in bone formation provided an 
introduction to the cellular mechanisms underlying the major pathways in bone 
formation and the clinical consequences that take place following dysregulation of these 
mechanisms. This section aims to demonstrate the complexity of heterotopic bone 
formation by providing representative examples of the clinical appearance of these 
ossifications.  
 
 
 
 
 
 
 
 
 
 
 
 
 62 
1.11.1 ABNORMAL BONE CONDITIONS 
Pathological ossification is a rather frequently encountered condition, which can occur 
at specific and/or multiple sites in the body, including the subcutaneous tissue, tendons 
and ligaments, skeletal muscle and the periarticular regions or can extend from bones 
into the surrounding tissues (Isaacson, Stinstra et al. 2010).  
Heterotopic bone can develop in various clinical contexts, most noticeably in genetic, 
post-traumatic and post-surgical circumstances. Interestingly, it is frequently 
encountered in individuals who have experienced traumatic brain injury (TBI) or spinal 
cord injury (SCI) (Cipriano, Pill et al. 2009, Sullivan, Torres et al. 2013). These forms of 
neurologic injury are typically followed by bone formation in multiple sites, highlighting 
a strong neurogenic component of the disease (McCarthy and Sundaram 2005, Vanden 
Bossche and Vanderstraeten 2005). When heterotopic ossification is triggered by 
neurogenic causes, the most common sites for bone formation are the periarticular 
sites, mostly affecting the joints of the hip, shoulder and elbow. It appears that 
ankylosing of the knee area rarely occurs following head injury, but it is the second 
most common place for HO formation following trauma to the spinal cord (Pape, 
Lehmann et al. 2001). 
The most common site for post-surgical HO formation is the pelvic bone following open-
reduction internal fixation surgery for fractures of the acetabulum. The hip is the second 
most affected area following total hip arthroplasty (THA) (Ahrengart 1991). Figure 1.18 
provides a similar example of ectopic bone formation in the acetabulum and 
surrounding area, as a result of osteoarthritis.  
Orthopaedic procedures of the knee, shoulders and elbows can also sometimes result in 
ectopic bone formation in the surrounding areas (Baird and Kang 2009).  
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The incidence of HO following surgical interventions like hip arthroplasty ranges 
between 16-53%, although it is reported that only a rather small number of patients (3-
7%) develop clinically significant manifestations. In contrast, the incidence of HO 
following neurologic trauma has been reported to be as high as 10-30% (Baird and 
Kang 2009).  
The ossification of soft tissues can also be encountered in degenerative conditions such 
as atherosclerosis, forming along vascular smooth muscle cells, as a secondary effect to 
other conditions such as diabetes and chronic kidney disease (CKD) (Hayden, Tyagi et 
al. 2005).  It also occurs in other conditions known as chondrocalcinosis (Caswell, 
Guilland-Cumming et al. 1983) forming in hyaline and/or fibrocartilage; in scoliosis 
(Mullaji, Upadhyay et al. 1994, Murphy and Mooney 2016) (Figure 1.15), and ankylosing 
spondylitis (McVeigh and Cairns 2006) (Figure 1.16) where it forms in intervertebral 
disks and in the sacroiliac joint, in diffuse idiopathic skeletal hyperostosis, (Atzeni, Sarzi-
Puttini et al. , Nascimento, Gatto et al. 2014) forming along the anterior longitudinal 
ligament of the spine; in as well as in osteogenic osteosarcomas of the femurs and tibias 
(Kumar, Barwar et al. 2014, Pan, Chan et al. 2014) (Figure 1.19).  
The ossification of soft tissues is a severely debilitating process. The damage associated 
with its formation in regions such as joints, major arteries and muscles can cause 
considerable loss of function, with additional manifestations including pain, stiffness 
and immobility and in some cases premature death (Balboni, Gobezie et al. 2006).  
The following sections will provide examples of the clinical manifestations in some of 
the most severe conditions.  
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1.11.2 OSSIFICATION OF THE SPINE 
Ossification of the spine can occur in various conditions, including scoliosis, ankylosing 
spondylitis and due to trauma associated with vertebral fracture; and the underlying 
causes are still poorly understood. Figures 1.15-1.17 present examples of clinical 
manifestations of these conditions.   
Both scoliosis and ankylosing spondylitis (AS) are characterised by a significant 
transformation of the vertebral disks and in the case of AS, the surrounding ligaments as 
well into mature bone (Figures 1.15 and 1.16, respectively). In both cases these ectopic 
ossifications cause severe disability due to deformations of the spine and the attached 
structures, such as ribs, diminishing the thoracic capacity and causing immobilisation 
(Figure 1.15 a-c). Interestingly, longitudinal sections through an ankylosed spine 
(presented in Figure 1.16e) reveal that the new formation of bone connecting the 
vertebral bodies is mainly composed of trabecular bone, with compact bone 
surrounding the outer edges of the vertebral discs, as encountered in long bones.  
The underlying causes of both AS and scoliosis are still unknown. It is believed that a 
combination of genetic and environmental factors are involved. Exome sequencing has 
recently identified a missense variant in the HSPG2 gene in scoliosis, coding for the 
heparan sulphate proteoglycan 2 (perlecan), a ubiquitous multifunctional ECM protein 
(Baschal, Wethey et al. 2014). Buchan and colleagues have recently demonstrated using 
the same technique that variations in the fibrillin-1 and 2 genes (FBN1 and FBN2) are 
most commonly associated with adolescent scoliosis (Buchan, Alvarado et al. 2014). In 
ankylosing spondylitis, several abnormal gene variants have been recently found, 
including ERAP1, HLA-B27, RUNX3 and ILI213 (Evans, Spencer et al. 2011).  
 
 
 
 
 65 
Figure 1.17 presents an example of heterotopic bone forming as a result of fracture and 
vertebral dislocation in the lumbar area (a), with a major bone growth extending across 
the vertebra. Similarly, in secondary osteosarcoma of the spine (b-c), a mass of 
imperfectly ossified bone can be observed on the surface of the vertebral bodies and 
under the periosteum, again supporting the role of this structure in heterotopic bone 
formations.  The mechanisms of ectopic bone formation following trauma will be 
discussed later in this chapter. 
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1.11.3 CONDITIONS WITH ABNORMAL BONE MASS DEPOSITION 
Several metabolic and cancerous disorders lead to abnormal ossification, characterised 
by a diminished or enhanced bone deposition. These include conditions such as Rickets, 
Paget’s disease, osteoarthritis, osteosarcomas, osteomyelitis and malunions of fractures. 
Figures 1.18-1.22 demonstrate the clinical manifestations of these conditions. 
Figure 1.18 presents an example of the hip and proximal femurs where ectopic bone has 
arisen around the femoral heads and inside the acetabulum as a result of osteoarthritis, 
massively impairing the hip joints. The underlying causes of this condition are still 
unknown (Koczy, Stoltny et al. 2009). As that junction is biomechanically essential for 
transferring the upper body weight to the lower limbs, movement is significantly 
impaired.  
 
 
 
 
Figure 1.18 | Ectopic ossification of the hip joints in osteoarthritis. Femoral bone heads and hip joints show ossification as a 
result of osteoarthritis. The femoral heads show thick, osteophytic collars and further ossification can be seen at the point of 
attachment, where the ligamentum teres is located. The acetabulum appeared re-modelled by osteophytic bony outgrowths, causing 
abnormal grooves in which the abnormal femoral heads fit. Original images. 
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Osteosarcomas of the upper and lower limb bones are the most common primary 
osseous malignancies (Kundu 2014) characterised by a significant deposition of mature 
bone, which emerges from the bone shafts and extends into the surrounding tissues 
(Figure 1.19). These bone masses can manifest as compact, dense bone (a), a mixture of 
trabecular and compact (b-c) or trabecular bone (d).  
Although the causes of these malignancies are still unknown, it is thought that point 
mutations affecting tumour suppressor genes such as p53 or retinoblastoma 
susceptibility gene (Rb) play a major role in the formation of the osteosarcomas (Miller, 
Aslo et al. 1996, Kong and Hansen 2009, Martin, Squire et al. 2012). 
 
 
 
 
Figure 1.19 | Osteosarcomas of the upper and lower limbs. a-b, Osteomas of the humeral bones. a, Presents a lobulated growth 
of very dense, cortical bone attached to a large part of the upper shaft. b, Longitudinal section through the upper part of a humerus, 
which has been invaded by a large tumour, composed of dense connective tissue. The original structure of the shaft is completely 
lost in the newly forming bone. c, Parosteal osteosarcoma of the tibia, situated between the metaphysis and upper diaphysis. The 
underlying tibial shaft is preserved. This type of osteosarcoma produces large quantities of mature bone without affecting the 
medullary cavity. d, Osteosarcoma of the lower part of the femur, extending from the articular surface upwards, causing significant 
destruction of the bone tissue. The cavity left behind shows a growth of spongy bone. Original images. 
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In conditions such as osteomyelitis, considerable bone infections are caused most 
frequently by Staphylococcus aureus (Calhoun, Manring et al. 2009). They affect mainly 
the long bones of the upper and lower limbs, where significant bone ‘collars’ grow from 
the periosteum of the original shaft, causing necrosis or entrapping the original bone 
(Figure 1.20). Interestingly, these structures always show cavities that are used to 
communicate with other tissues on the exterior. The condition is thought to arise 
following the significant bone necrosis and the formation of new bone from surviving 
fragments of the periosteum (Calhoun, Manring et al. 2009). Some researchers believe 
that this formation mimics the process of bone tumour formation (Huang, Wu et al. 
2013, Anagnostakos, Schmitt et al. 2014). 
 
 
Figure 1.20 | Osteomyelitis of the upper and lower limbs. a, Chronic osteomyelitis of the humerus where the whole shaft has undergone necrosis as 
a result of acute osteomyelitis and has been replaced by a hollow cylinder of new bone, which is significantly deformed and communicates with the 
exterior using several openings, or grooves. b, Acute osteomyelitis of the right humerus, showing necrosis of a significant part of its shaft, and forms a 
sequestrum which lies within an involucrum composed of dense bone growing from the periosteum. c, Chronic osteomyelitis of the femur, showing 
great amounts of new bone (involucrum), perforated by 3 large openings. At the top end, a sequestrum can be observed. d, Chronic osteomyelitis of the 
femur which has been divided sagitally. The shaft is greatly thickened, and the marrow cavity has been replaced with dense white bone. Original 
images. 
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Whilst in many long bone fractures the repair process is slow and may result in non-
union based on the severity and location of the injury as well as the degree of 
immobilisation (De Buren 1962)(Figure 1.21a presents an example of a fracture non-
union), in some cases mal-unions form around the broken bone ends to try and 
reconnect the original bone parts, irrespective of their spatial arrangement following 
injury. This can occur when considerable rotation or movement of these parts has taken 
place and no surgical intervention has been performed (Hillen and Eygendaal 2007). 
These bone masses can be considerable and are composed of both trabecular and 
cortical bone (Figure 1.21 b-d).  
Other conditions in which significant bone deformation takes place due to abnormal 
ossification are Rickets (Figure 1.22a) and Paget’s disease (Osteitis deformans) (b), 
where bones of the femur and tibia and fibula become significantly bent. Both 
conditions are characterised by abnormal mineralisation, which although triggered by 
different factors (impairment of Ca, P and Vitamin D metabolism in Rickets compared to 
excessive bone formation and breakdown and disorganised bone remodelling in Paget’s 
disease)(Roodman and Windle 2005, Holick 2006), the cortical bone tissue at the site of 
maximal bending becomes thicker in size in both conditions, highlighting the amazing 
plasticity of this tissue. 
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Figure 1.22 | Other conditions of abnormal bone deposition. a, Rickets. Longitudinal section through a tibia of an individual with 
the condition showing a significant deformation and a thickening of the cortical bone on the concave surface. b, Paget’s disease 
(Osteitis deformans). Longitudinal sections through the tibia and femoral bone. The femoral bone (right) shows a marked convexity 
and enlargement and is composed of porous bone, which has been deposited in patches. Compact bone is increased in thickness. 
Both tibia (left) and fibula show a similar appearance externally and internally to the femur. Original images. 
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1.11.4 CONGENITAL HETEROTOPIC OSSIFICATION  
Some of the most severe manifestations of HO are those caused by hereditary disorders 
such as Fibrodysplasia ossificans progressiva (FOP) and Progressive osseous heteroplasia 
(POH), where impaired regulation of bone morphogenic proteins (BMPs) leads to a 
severely debilitating and progressive post-natal ossification of muscles, tendons, 
ligaments, cutaneous and sub-cutaneous tissues (Kaplan, Craver et al. 1994, Glaser, 
Rocke et al. 1998, Vanden Bossche and Vanderstraeten 2005, Kaplan, Le Merrer et al. 
2008). Unlike FOP, which has been identified for more than a century ago, POH has only 
been recognized since 1994, when a new pattern of ossification was observed in a group 
of patients, which was characterized by ossification of primarily the cutaneous and 
subcutaneous tissue (Kaplan, Craver et al. 1994).  In genetic types of HO, bone formation 
can occur spontaneously but it is exacerbated by environmental factors such as minor 
traumas of the soft tissues (Cohen, Hahn et al. 1993).  
 
1.11.5 HO FOLLOWING MILITARY OPERATIONS 
Heterotopic ossification is also a condition which has recently emerged as a 
consequence of exposure to modern wartime combat devices, such as improvised 
explosive devices (IEDs). Over the recent years, extremity injuries caused by exposure 
to IEDs have led to very complex and challenging bone formations in the soft tissues 
surrounding the affected areas (Isaacson, Stinstra et al. 2010).  The complications 
associated with these ectopic bone formations have led towards considerable patient 
morbidity and loss of function, as well as significantly obstructing the use of prostheses 
following amputation (Potter, Burns et al. 2007, Potter, Forsberg et al. 2010, Alfieri, 
Forsberg et al. 2012). Unlike other acquired forms of HO or the rare genetic forms, the 
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prevalence of HO in combat-related injuries has been reported to be as high as 64%, 
thus making it one of the most devastating medical complications in the war-wounded 
population (Potter, Burns et al. 2007, Brown, Dharm-Datta et al. 2010, Potter, Forsberg 
et al. 2010, Alfieri, Forsberg et al. 2012). 
Whilst significant progress has been made recently in understanding the genetic 
mechanisms underlying the inherited forms of the disease, the aetiology of trauma and 
blast-induced heterotopic ossification remains largely unknown. These mechanisms will 
be described later in this chapter.  
 
1.11.6 MANAGEMENT AND PROPHYLAXIS OF HO 
Considerable effort has been directed towards understanding the fundamental 
mechanisms leading to heterotopic bone formation and the most effective ways of 
managing and preventing the recurrence of the condition. However, the lack of 
knowledge regarding early events in particular makes treatment and the development 
of effective compounds very difficult.  
Following the development of ectopic bone structures, surgical excision is the most 
effective intervention that allows the removal of the unwanted formations. However, 
surgical intervention is not possible in the prophylaxis of the hereditary forms, as the 
tissue trauma associated with surgery can cause further ossification at the site of 
operation (Connor and Evans 1982). 
Additional systemic therapy with pharmacological compounds such as NSAIDS 
(naproxen, indomethacin) is used to attenuate the inflammatory response that is 
thought to play a role in ossification and thus indirectly prevent further tissue 
mineralization in a wide range of pathologies including ankylosing spondylitis. 
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Localized radiation (Gy XRT) is used to prevent recurrence following surgery and it 
believed to interfere with the differentiation of pluripotent mesenchymal stem cells into 
bone precursor cells (Vanden Bossche and Vanderstraeten 2005, Cullen and Perera 
2009, Shore and Kaplan 2010). There are, however, major drawbacks with both drug 
and radiation therapies. Whilst continuous NSAID therapy causes side effects in the 
form of gastrointestinal bleeding, XRT radiation cannot be applied effectively in early 
stages as it requires the physician to predict the area which will undergo ossification 
(Popovic, Agarwal et al. 2014, Mourad, Packianathan et al. 2015). Radiation 
administration is also impeded by the open-wound nature of injuries, delaying wound 
healing and also presenting the risk of post-radiation cancer. These effects limit the 
group of treatable patients to either those individuals who do not exhibit visible 
traumatic wounds or an apparent soft tissue compromise, and those who have easily 
detectable ectopic bone zones.   
 
1.11.7 PHARMACOLOGICAL TARGETING OF HO  
Several pharmacological agents are used to manage HO, including bisphosphonates. 
These are enzyme-resistant analogues of pyrophosphates which are given orally and 
intravenously in a range of malignancies. Bisphosphonates are however poorly 
absorbed and they also chemically interact with compounds present in some types of 
foods, such as dairy products, having a reduced potential. It is thought that 
approximately 50% of the drugs accumulate at the site of interest, with the remaining 
free compounds being excreted unchanged by the kidneys. Etidronate is an example of a 
first-generation bisphosphonate which has been used in the prevention and 
management of HO (Banovac, Gonzalez et al. 1993, Banovac, Gonzalez et al. 1997, 
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Banovac 2000). Etidronate has been reported to act by inhibiting calcium phosphate 
precipitation, thus delaying hydroxyapatite crystal aggregation. It is still debated 
whether the inhibitory effects of bisphosphonates on HO are limited to the 
crystallization process or if they have an effect on the matrix formation as well (Vanden 
Bossche and Vanderstraeten 2005). Other bisphosphonates including pamidronate, 
neridronate and zoledronate are used to treat conditions such as Paget’s disease, 
osteogenesis imperfecta and ankylosing spondylitis (Filipponi, Cristallini et al. 1998, 
Merlotti, Gennari et al. 2007, Toussirot and Wendling 2007, Viapiana, Gatti et al. 2014). 
Novel compounds have recently emerged and have successfully been used to stop the 
progression of genetic and acquired HO in animal models by interacting with the 
cartilage formation pathway that precedes bone deposition, thus removing the template 
base on which mineral can be deposited and built on. These compounds are known as 
retinoic acid receptor gamma agonists (RAR-γ) (Kaplan and Shore 2011, Shimono, Tung 
et al. 2011) and will be discussed further at a later stage in this thesis, in Chapter IX, 
Administration of ossification-inhibiting compounds. 
In conclusion, the choices of treatment of HO are of limited efficacy and this is a result of 
the gap in understanding the fundamental processes occurring in the initial stages of the 
disease. The development of advanced prophylactic treatments for HO will require a 
more complete understanding of the cellular mechanisms that contribute to this 
disease. 
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1.11.8 MICRO-STRUCTURAL FEATURES OF ECTOPIC BONE 
The morphology of HO appears to be rather heterogeneous, as the amount of bone 
forming in soft tissues has been described to vary from small osteophytes to 
widespread osseous attachment to the skeleton; and that HO manifests as cancellous 
bone, cortical bone or woven bone (Isaacson, Stinstra et al. 2010).  
Unlike dystrophic calcification, associated with conditions such as renal failure and 
hyperparathyroidism, heterotopic ossification can be differentiated morphologically 
and histologically, due to the presence of trabecular features, typically encountered in 
bone (Balboni, Gobezie et al. 2006, Tannous, Stall et al. 2013). 
This is an aspect which was noticed as early as 1980s, when Spencer and Missen noticed 
areas of progressive maturation in excised ectopic tissue from the femoral area from a 
patient with myositis ossificans, which included a cortical bone shell and an inner core of 
young, cancellous or woven bone (Spencer and Missen 1989). Isaacson and colleagues 
(Isaacson, Brown et al.) also found that heterotopic bone forming in wounds from burns 
and trauma due to accidents, showed only signs of endochondral ossification, with a 
high proportion of adipose tissue and bone marrow present in the tissue samples 
obtained from these patients.  
It is important to note that the sample size was very limited in many of these studies, 
which makes it extremely difficult to answer some of the basic questions regarding the 
processes taking place or any of the further implications. However, in vivo models 
where rabbits and other rodents were used confirmed an endochondral bone formation 
pathway (Tannous, Stall et al. 2013). Intramembranous ossification was reported to 
occur in one of the hereditary forms of HO, POH, where both intramembranous and 
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endochondral ossification were thought to occur when examining samples from 
children with this condition (Kaplan, Craver et al. 1994). 
 
1.11.9 CELLULAR PATHOPHYSIOLOGY OF HO 
Some of the current views suggest that ectopic bone originates from distant, migrating 
or local mesenchymal stem cells residing in soft tissues such as muscle in a dormant 
state (van Kuijk, Geurts et al. 2002, Anthonissen, Ossendorf et al. 2016). Mesenchymal 
stem cells are pluripotent progenitor cells with the ability to divide as uncommitted 
cells and to then differentiate to lineages of different tissues, including cartilage, fat, 
tendon, ligament, bone and muscle (Caplan 1991).  It is thought that during the process 
of ectopic bone formation, these cells can differentiate to osteogenic cells under the 
right micro-environmental stimuli (Williams, Southerland et al. 1999, van Kuijk, Geurts 
et al. 2002). This is a generally accepted view, which has been hypothesised as early as 
the 1970s, which states that that the induction of bone formation following trauma or 
injury requires three major components (Chalmers, Gray et al. 1975):  
1. An inducing biomechanical agent (trauma applied to the tissue);  
2. A population of progenitor or mesenchymal cells that are able to undergo 
osteogenic differentiation in response to this event;  
3. A microenvironment that is favourable for osteogenesis.  
However, this model is likely to be more complex, as newly emerging data supports the 
idea of a multi-systemic involvement in this disorder. For instance, in subjects who have 
experienced TBI and SCI, neurogenic factors could create the favourable conditions for 
the release of systemic factors which subsequently interact with local factors to 
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stimulate MSCs to differentiate into osteoblasts and thus give rise to heterotopic 
ossification (Williams, Southerland et al. 1999, Pape, Lehmann et al. 2001, Sullivan, 
Torres et al. 2013). 
Tissue hypoxia is thought to play a major role in the formation of endochondral bone. A 
study by Agarwal and colleagues has recently shown that inhibition of HIF- 1α in mice 
can prevent both the acquired and congenital forms of HO (Agarwal, Loder et al. 2016). 
In addition, Wang and colleagues have recently demonstrated that early human FOP and 
murine model lesions are highly hypoxic, and that HIF- 1α increases BMP signalling via 
the ACVR1 receptor (Wang, Lindborg et al. 2016).  
Other authors have demonstrated that tissue hypoxia is also driven by the accumulation 
of adipocytes in the lesioned areas, which lower the oxygen tension in the tissue, thus 
favouring the formation of cartilage (Olmsted-Davis, Gannon et al. 2007). Recently, it 
has been demonstrated using a murine model that excised ectopic tissues, but not 
normal tissues, express a high level of uncoupling protein 1 (UCP1), a marker for brown 
adipocytes, which, as thought previously, play a critical role in regulating heterotopic 
ossification (Salisbury, Dickerson et al. 2017). 
In addition, circulating osteoprogenitor cells of hematopoietic origin are thought to 
migrate from close bone marrow sources. A study by Suda and colleagues (Suda, Billings 
et al. 2009) showed that a population of type I collagen+/CD45+, mononuclear adherent 
cells are present in the early, pre-osseous, fibroproliferative lesions of FOP patients and 
have been shown to nucleate HO in a murine implantation assay. In addition, these 
authors demonstrated that patients with an active form of FOP have a higher number of 
these cells in their bloodstream compared to patients with a stable stage of FOP or 
unaffected individuals. 
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A separate, underlying mechanism was demonstrated by Medici and colleagues (Medici, 
Shore et al. 2010, Medici and Olsen 2012), who showed that in both human FOP and 
mouse lesions, endothelial cells transdifferentiate into mesenchymal stem cells through 
a mechanism known as endothelial-to-mesenchymal transition (EndMT). This process 
was shown to be mediated in an ALK2 signalling manner and ultimately contributed to 
HO formation. Interestingly, the process was inhibited by application of short 
interfering RNA (siRNA). 
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1.12 IN-VIVO MODELS OF ECTOPIC OSSIFFICATION 
As described in the previous sections, bone tissue forms in various physiological 
circumstances, ranging from normal bone development and callus-mediated fracture 
repair (Einhorn and Gerstenfeld 2015), to pathological heterotopic bone formation in 
extra-skeletal tissues, as seen following muscle trauma (Potter, Burns et al. 2007, Potter, 
Forsberg et al. 2010, Shore and Kaplan 2010, Edwards and Clasper 2014), traumatic 
brain and spinal cord injury (Wittenberg, Peschke et al. 1992, Sullivan, Torres et al. 
2013), surgical procedures of the hip and knee (Thilak, Panakkal et al. , Board, Karva et 
al. 2007); and in genetic conditions such as Fibrodysplasia ossificans progressiva (FOP) 
(Thilak, Panakkal et al. , Shore and Kaplan 2010). These contexts, normal or otherwise, 
share fundamental characteristics at many levels, including molecular (overexpression 
of bone morphogenic proteins, BMPs) (Ramirez, Ramirez et al. 2014, Katagiri, Osawa et 
al. 2015), cellular (a set of progenitor cells that commits to an osteoblastic lineage) 
(Kan, Liu et al. 2009, Shore and Kaplan 2010, Ramirez, Ramirez et al. 2014) and 
biomechanical (translation of the mechanical forces into structured and organized 
bone) (Isaacson, Brown et al. , McCarthy and Sundaram 2005, Lin, Shen et al. 2010). 
However, there are still significant gaps in our understanding of these events.  
There are several modalities to recreate pathological ossifications in animal models, 
including the overexpression or inhibition of molecular osteoinductive factors (Liu, 
Kang et al. 2014), trauma induction (Liu, Kang et al. 2014) and heterotopic implantation 
(Ueno, Kagawa et al. 2003, Lounev, Ramachandran et al. 2009).  
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1.12.1 ANIMAL MODELS OF INHERITED HO AND GENETIC MANIPULATION 
Currently, there are representative animal models for the inherited form of HO, such as 
FOP, since the genetic mutations underlying this disease have been identified. The 
genetic fault lies in a mutation consisting of a heterozygous single nucleotide 
substitution in the gene encoding ACVR1/ALK2, a BMP type I receptor, which causes a 
dysregulation in the BMP pathway and leads to an over-activation of the signalling 
process even in the absence of a BMP ligand (Shore, Xu et al. 2006). This process is 
further enhanced when BMP ligands are present (Shore, Xu et al. 2006).  As a result, 
there are some successful, genetic knock-in murine models which are able to recreate 
the hereditary form of HO (Chakkalakal, Zhang et al. 2012). Gene targeting in these 
animals allowed the development of models showing progressive endochondral bone 
formation. Moreover, it was shown that both wild-type and mutated osteoprogenitor 
cells exist within the ectopic bone formations, suggesting that whilst the mutations 
were necessary to induce bone formation, it was not required for the contribution of 
progenitor cells to cartilage and bone formation (Chakkalakal, Zhang et al. 2012). 
In general terms, the effects of abnormal BMP function can be studied in several ways 
(Kaplan, Shore et al. 2005, Kan and Kessler 2011, Liu, Kang et al. 2014) specifically by:  
1. Introducing a hyperactive BMP receptor (Le and Wharton 2012);  
2. Knocking-out BMP inhibitors (Zhao 2003);  
3. Implanting BMP-releasing Matrigels (Glaser, Economides et al. 2003);  
4. Overexpressing specific BMP target genes (Wang, Green et al. 2014);  
5. Modifying BMP signalling indirectly by interfering with other molecular factors 
that play a role in the BMP pathway (e.g. TGF-β, Smads)(Yamazaki, Fukushima et 
al. 2009). 
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Genetic manipulation, whilst straightforward and inexpensive, presents numerous 
disadvantages (Tong, Huang et al. 2011). In the case of target gene overexpression 
models, constitutive overexpression often leads to non-relevant levels of protein 
expression, being misleading with regards to the role of the gene and as such, animals 
with dominant negative variants have to be simultaneously produced. Secondly, 
overexpression of genes which play a major role in bone formation can lead to lethality, 
making it hard to establish consistent transgenic lines for investigation (M. Lyons 2013).  
With respect to gene targeting, loss of function is very useful in understanding the role 
of the ablated gene product. There are several issues with this technique, however, 
which is that knock-outs are not necessarily limited to a particular tissue or system and 
the deletion of these genes may prevent an adequate analysis of their role in skeletal 
processes. In addition, many knockout strains do not exhibit obvious phenotypes and as 
such, multiple-knockouts have to be performed (M. Lyons 2013).  
Finally, there are major environmentally-driven differences in phenotype between 
different populations of rats despite being genetically-identical, making results less 
reproducible (Nagy, Krzywanski et al. 2002, Champy, Selloum et al. 2004). 
In conclusion, care must be taken when extrapolating the results from animal studies to 
humans, especially as they have different mechanical loading and metabolic activity. 
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1.12.2 ANIMAL MODELS OF ACQUIRED HO 
There are also several models available for simulating the acquired form of HO (for a 
review see (Kan and Kessler 2011)) and they include: 
1.  The hip arthroplasty model  
(Tannous, Stall et al. 2013, Amar, Sharfman et al. 2015); 
2. Immobilisation-manipulation of knee joints (Michelsson model)  
(Michelsson, Granroth et al. 1980);  
3. Achilles tenotomy  
(Lin, Shen et al. 2010, Zimmermann, Schwitter et al. 2016);  
4. Trauma-induction (limbs and brain) 
(Elder, Dorr et al. 2012, Liu, Kang et al. 2014, Liu, Zhang et al. 2015);  
5. Injection of osteogenic agents (BMP-2) into the muscles  
(Olmsted-Davis, Gannon et al. 2007, Liu, Kang et al. 2014);  
However, some of these models are not fully representative of the pathological states, 
requiring the use of a large number of animals (Kan and Kessler 2011). Some results 
cannot be generalised to other tissues or are too complex to allow the isolation of 
individual molecular components in early-phase bone formation, which makes it 
difficult to answer some essential questions on biological ossification objectively. As so, 
it is hard to develop a single hypothesis that can unify all the clinical and experimental 
findings into one model.  
This lack of knowledge of early pathogenesis has, for a long time, hindered the 
validation of these animal models or their improvement. The inconsistencies generally 
noticed with these models and the fairly low reproducibility mean that a high number of 
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animals is required for consistent results. In addition, some of these models require the 
application of significant amounts of trauma to animals, which means that some of these 
animals have to endure suffering during their lifespan.  
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1.13 IN-VITRO MODELS OF BONE FORMATION 
For many years, in vitro cell cultures have been used for first-stage analysis of the 
behaviour of bone cells. These cells can originate either from primary bone sources, 
being isolated through matrix digestion, or expanded from ex-vivo bone fragments, or 
used from highly-proliferative engineered populations (e.g. MC3T3-E1, 2T3). They are 
then cultured and sub-cultured in monolayer (2D) on rigid, flat surfaces, where they can 
produce osteoid and mineralisation nodules (Bellows, Aubin et al. 1986, Buttery, 
Bourne et al. 2001, Wang, Liu et al. 2006). 
2D cell culture is a valuable tool which is excellent for reproducibility and 
standardisation. However, it cannot simulate the tissue architecture and cellular 
interactions found in vivo in bone as these cells are organised within the extracellular 
matrix in a 3D fashion. 
Therefore, it is necessary to engineer new biological models that can shed light on both 
the processes of bone formation and of heterotopic ossification. Intermediate models, 
more complex than monolayer 2D populations but less complex than in vivo rodent 
models could provide further information regarding the cellular pathophysiology of the 
condition and the involvement of different molecular factors.  
Many biomaterials and methods have been developed over the past years for producing 
mineralised bone-like cultures in 3D, with closer structural similarities to in vivo bone 
tissue (Edmondson, Broglie et al. 2014, Bouet, Cruel et al. 2015), which will be discussed 
in the next section. 
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1.14 3D MINERALISED CULTURES USING BIOMATERIALS 
This method for producing bone-like tissue involves applying cells to a variety of 
biomaterials to create artificial tissues in vitro. The materials used for scaffolds are 
natural or synthetic polymers such as hydrogels or elastomers (Liu, Zeng et al. 2017). 
Other materials include bioactive ceramics such as calcium phosphates (Wang, Zhao et 
al. 2014) and bioactive glasses (Rahaman, Day et al. 2011).  
Composite systems containing both ceramics and polymers have been used to increase 
the mechanical properties of the scaffolds and to simulate the biochemical composition 
of bone (Wahl and Czernuszka 2006, Chesnutt, Viano et al. 2009, Moreau, Weir et al. 
2009, Šupová 2009, Maas, Guo et al. 2011, Thein-Han, Liu et al. 2012, Wang, Bongio et al. 
2014). 
Since the 1990s, a variety of hydrogels have become available for bone and cartilage 
tissue engineering, due to their structural similarity to the extracellular matrix and their 
porosity, which enables cell proliferation and exchange of nutrients. Hydrogels are 
three-dimensional cross-linked networks formed by homopolymers, copolymers and 
macromeres (Liu, Zeng et al. 2017) which provide cells with an environment similar to 
the ECM, thus facilitating cell adhesion, proliferation and differentiation of 
osteoprogenitor cells towards an osteoblastic lineage. 
These biomaterials include gelatin, chitosan, alginate, hyaluronic acid, polyethylene 
glycol, collagen I and fibrin, each with significant advantages and disadvantages (Lee 
and Mooney 2001, Perka, Stern et al. 2003, Chesnutt, Viano et al. 2009, Wang, Bongio et 
al. 2014). 
For bone tissue engineering, collagen type I gels are the most popular choice due to its 
chemical and structural similarity to the osteoid of bone (Kikuchi, Itoh et al. 2001, Wahl 
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and Czernuszka 2006, Moreau, Weir et al. 2009, Matthews, Naot et al. 2014). However, 
these gels show a low mechanical flexibility and it is hard to separate the new collagen 
produced by embedded cells from the scaffold collagen. In addition, the presence of a 
non-cell-derived matrix will most likely have an influence on the differentiation of the 
embedded cells.  
Alternative hydrogels such as fibrin are widely used in tissue engineering and have been 
used in clinical practice and surgery for many years as a haemostatic agent (Eyrich, 
Göpferich et al. 2007). In addition, their biodegradability can be controlled using the 
addition of inhibitions of proteinases, such as aprotinin (Ye, Zund et al. 2000). Whilst 
they have a more limited mechanical strength (Lee and Mooney 2001), their 
biodegradability means that as seen during wound healing, they can be replaced over 
time with endogenous cell-secreted collagenous matrix which can more closely mimic 
the geometry and composition of in vivo bone tissue (Eyrich, Brandl et al. 2007, Eyrich, 
Göpferich et al. 2007). Fibrin gels can be easily assembled by polymerisation of 
fibrinogen in the presence of thrombin and can be produced from the patient’s own 
blood components (Lee, Kwan et al. 2008, Ahmed, Ringuette et al. 2015), making them 
ideal for implantation and minimising the risk for rejection.   
Although these cell-scaffold constructs can simulate the biochemical composition of 
bone tissue, to date, there are no in vitro/3D cell culture systems that are able to 
continuously produce loading forces similar to what is seen in vivo (Weinbaum, Cowin 
et al. 1994, Boukhechba, Balaguer et al. 2009, Vazquez, Evans et al. 2014). For this 
reason, animal models have remained the gold standard for evaluating whole tissue 
response and mechanical function. 
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CHAPTER II 
ENGINEERING A SELF-STRUCTURING BONE SYSTEM 
 
 
 
 
 
 
 
2.1 CONTEXT OF THE PRESENT WORK 
Developing novel ways to produce ossified tissue is essential for several scientific 
reasons. From a biological perspective, new models will help to develop a deeper 
understanding of the fundamental processes underlying both early bone development 
and the pathological ossification events following trauma or injury (Potter, Burns et al. 
2007, Potter, Forsberg et al. 2010). New approaches to develop bone-like materials are 
also required for the augmentation of bone defects and ultimately the replacement and 
surgical transplantation of tissue grafts (Matassi, Nistri et al. 2011, Claes, Recknagel et 
al. 2012, Einhorn and Gerstenfeld 2015).  In this context, the present work focused on 
developing a new, biological model of bone tissue formation, which would allow for the 
investigation of individual osteogenic factors in a less complex environment than in vivo 
conditions, and may ultimately be used for skeletal regeneration. 
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Biological hydrogels provide a 3D microenvironment that is analogous in structure and 
composition to the extracellular matrix (ECM) of innate tissues, and therefore when 
used for cell encapsulation, they enable the embedded cells to exhibit phenotypes more 
representative to those in vivo than cells grown in monolayer culture (Abbott 2003). As 
discussed previously, these materials have been shown to promote cell survival and 
proliferation both in vitro and when implanted in vivo (Wahl and Czernuszka 2006). 
The first scaffold encountered by many types of cells during wound healing, tissue 
trauma and repair is a fibrin clot (Janmey, Winer et al. 2009).  The clot is a fibrin 
network which forms when soluble fibrin is cleaved by thrombin into strands which are 
then cross-linked under the action of factor XIII into a blood clot (Eyrich, Brandl et al. 
2007, Eyrich, Göpferich et al. 2007). Fibrin gels exhibit a high bioactivity and specifically 
their ability to bind cells, growth factors, nutrients and metabolites makes them good 
substrates for stem cell differentiation and tissue engineering research (Lee and 
Mooney 2001, Drury and Mooney 2003, Eyrich, Brandl et al. 2007, Eyrich, Göpferich et 
al. 2007). 
The biomechanical behaviour of these matrices can be clinically relevant and their 
degradability over time means that cells embedded in such a culture system can replace 
the scaffold over time with endogenous matrix, giving rise to more complex tissues than 
pre-formed analogous scaffolds (Eyrich, Brandl et al. 2007). 
Starting from these principles, the work in this thesis focused on engineering a 
biological bone system which is seeded with primary cells and monitored longitudinally 
over significant periods of time, allowing to study the temporal evolution of bone 
mineral and microstructure.  
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2.2 AIMS OF THIS THESIS 
The aim was to develop a system that could be easily manipulated biochemically and 
biomechanically to simulate the ossification microenvironment encountered in both 
normal and pathological environments and that could ultimately be applied to 
investigate both biological and physical research questions. To develop this system, 
populations of osteoprogenitor cells that were extracted from the periosteum of rat 
femoral bones were selected for investigation.  As described in Chapter 1, periosteal 
cells are the main determinants in the reparative phase of bone fracture healing, when 
they interact with the temporary fracture callus, which serves as a scaffold for the 
formation of new bone (Einhorn and Gerstenfeld 2015). Furthermore, they have been 
shown to have the ability to give rise to endochondral bone when implanted in muscle 
(Ueno, Kagawa et al. 2003), and therefore may be central to traumatic heterotopic 
ossification. Moreover, their ability to give rise to endochondral bone has been 
discussed by several groups as being an underlying cause in degenerative conditions 
such as Ankylosing Spondylitis (see Chapter 1).  
Following isolation, periosteal cells were seeded into hydrogels formed from fibrin, 
analogous structurally and biochemically to the microenvironment of the callus formed 
early in fracture healing or the early-wound microenvironment in HO.  
As matrix organization is essential for bone development, the environment of the 
fracture callus was further emulated by introducing two calcium phosphate anchors 
composed of a mixture of brushite and β-TCP at the extremities of the culture dish. 
These anchors exhibit a mineral composition similar to that of the inorganic component 
of bone and mainly served to enhance retention of the forming matrix and to provide a 
source of calcium and phosphate ions to aid in triggering the ossification process. 
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Remarkably, over time, constructs self-structure from a homogenous polymer, in the 
form of fibrin, into complex, heterogeneous structures (for an overview, see Figure 2.1). 
Samples were characterized over a period of 1 year in culture in terms of matrix 
organization, cell behaviour and mineralization using a combination of optical, 
spectroscopic and chemical techniques.  
 
 
 
 
 
 
Figure 2.1 | Schematic representation of the development of a construct over time. Contraction and alignment of the matrix 
occur maximally within the first 7 days. Within the following 2-3 days, the mineralization process becomes apparent, through the 
creation of nucleation points which aid in the formation of mineralized nodules, most prominently around the two anchors. These 
nodules increase in size over the first month in culture and ultimately fuse into a fully mineralized matrix. Following 1 month in 
culture, significant amounts of collagen can be detected around the anchor areas. The mineralized matrix advances from the anchor 
regions towards the centre of the construct until the previous template is completely substituted with the new, bone-like matrix 
containing hydroxyapatite-like mineral. Cells differentiate into osteocyte-like cells after 2 months of full osteogenic supplementation 
and maintain their phenotype over the extended months in culture.  
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2.3 GENERAL METHODS 
 
2.3.1 ASEPTIC TECHNIQUE AND CONTAMINATION PREVENTION 
Cell work was conducted in sterile conditions inside laminar flow cabinets (BSB, Gelaire 
Laminar Flow, Victoria, Australia). Cabinets were sterilised using UV light, followed by 
disinfection using Distel High-Level Medical Surface Disinfectant (Tristel, Snailwell, 
United Kingdom) and in some cases using 70% EtOH. Distel was used to provide 
enhanced protection against bacteria, fungi and viruses as well as having a 
tuberculocidal action and providing protection against blood diseases including 
Hepatitis B. It was also used in some molecular procedures in addition to other reagents 
such as RNAseZAP (Sigma-Aldrich-Merck, Germany) to destroy DNAse and RNAse 
enzymes which could interfere with the results. Dissection tools, pipettes and other 
metallic tools were sterilised using immersion in 70% EtOH. Pipette tips, 1.5 ml tubes 
and ultra-high-recovery centrifugation tubes (Starlab, Milton Keynes, United Kingdom) 
were DNAse and RNAse certified, as well as 15 ml and 50 ml tubes (Corning, New York, 
USA) and culture-treated flasks (Greiner Bio-One, Kremsmünster, Austria). Ethanol of 
molecular grade certification was chosen (Fisher Scientific, New Hampshire, United 
States) and was diluted to the required concentrations using sterile water. Where 
molecular work such as purification was undertaken, molecular grade water was used 
(Fisher Scientific, New Hampshire, United States) and a PCR Mini-UV-cabinet (Geneflow, 
Lichfield, United Kingdom) equipped with four 15 Watt UV lights was used to remove 
potential DNA and RNA contaminants from equipment. A sample sterilisation time of 30 
minutes was used. 
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2.3.2 ISOLATION AND CULTURE OF PRIMARY FEMORAL CELLS 
Femurs from left and right limbs of euthanised female Wistar rats (3 weeks old, 50-70 
grams weight) were excised and surrounding muscular and connective tissue was 
removed. Femurs were stored in phosphate buffered saline solution (pH = 7.4; Gibco®, 
Life Technologies, Thermo Fisher Scientific, UK) until use. Osteoprogenitor cells were 
extracted from the periosteum via enzymatic digestion using a cocktail containing 2.5 
mg/ml collagenase I, 0.7 mg/ml collagenase II and 0.5 units/ml dispase I, in PBS 
(Gibco®, Life Technologies, Thermo Fisher Scientific, UK). Bones were incubated with 
this solution at 37oC for 1 hour in a 5% CO2 atmosphere. Following incubation, tubes 
containing bones and solution were shaken rigorously for 30 seconds to detach the 
remaining cells. Solutions were then pooled and filtered using 70μm filters (Falcon, 
Becton Dickinson, UK). Cells were recovered using centrifugation at 21oC, 1400 rpm for 
6 min. The supernatant was discarded and the resulting pellet was resuspended in 10 
ml D20 growth medium (DMEM containing 20% serum) to encourage attachment. 
Approximately 1 million PO cells extracted from each bone were cultured to a level of 
70% confluence in D20 medium (Figure 2.2) at 37oC, in a 5% CO2, humidity-controlled 
incubator containing copper sulphate water (1 g/L) to prevent fungal contamination 
(Fisher Scientific, USA). The medium was replaced every 2-3 days. 
Where human primary osteoblasts were used, they were derived from tissue obtained 
from the Oxford Musculoskeletal BioBank and were collected with informed donor 
consent in full compliance with national and institutional ethical requirements, the 
United Kingdom Human Tissue Act, and the Declaration of Helsinki. 
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Figure 2.2 | Cell morphologies observed in 2D prior to embedding in fibrin hydrogels.  a, Femoral periosteal cells cultured 
in 2D for ten days displayed typical osteoblastic morphology (a-b), with some developing long projections (c). A few cells 
appeared hypertrophic, with typical senescent morphology (d). 
 
 
2.3.3 CULTURE OF IMMORTALISED CELL LINES 
Cells originating from cell lines MC3T3-E1/2T3 were obtained from the European 
Collection of Authenticated Cell Cultures (ECACC). MC3T3-E1 cells were C57BL2/6 
murine derived calvarial osteoblasts and originated from the Riken Cell Bank in Japan. 
Cells were cultured according to standard procedures in Minimal Essential Medium 
Eagle (MEM) Alpha Modification (10% FBS, 1% P/S, 2.4% L-glutamine) (Sigma-Aldrich, 
Germany).   
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2.3.4 CRYOPRESERVATION OF CELLS FROM CELL LINES 
For long-term storage, cells were frozen at -196oC by immersion in liquid nitrogen 
inside a vacuum insulated, alarm-connected storage vessel (Thermo Fisher Scientific, 
USA). The freezing medium was a solution consisting of 60% culture medium, 30% FBS 
and 10% DMSO (Sigma-Aldrich, Germany) to protect cells from mechanical injury 
induced by ice crystal formation. Cells were frozen at a density of 1 million cells/ml in 
1.5 ml cryovials. The cryopreservation process was performed rapidly, as DMSO is toxic 
at this concentration in metabolically-active cells, but does not affect frozen cells.  
 
2.3.5 THAWING OF CRYOPRESERVED CELLS 
Vials containing cells were quickly removed from liquid nitrogen and tubes were 
immersed into a 37oC water bath for 30 seconds to partially defrost the contents. The 
tubes were gently swirled and transferred to a laminar flow cabinet. The tubes were 
quickly wiped with tissues soaked in 70% EtOH and their contents, whilst still 
containing small amounts of ice, were dispersed into 50 ml of supplemented medium to 
dilute the DMSO and reduce immediate toxicity to cells. Cells were pelleted by 
centrifugation at 1000 RPM for 3 minutes and the supernatant containing residual 
DMSO was discarded. Cells were then re-suspended in supplemented medium and 
cultured in T75 or T175 flasks. The success of thawing was assessed based on the level 
of cellular adherence to culture flasks, the adopted morphology and the rate of 
population doublings. 
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2.3.6 CULTURING OF PASSAGED CELLS  
Primary femoral periosteal cells were cultured immediately following isolation and 
were not frozen for long-term storage. Cells originating from cell lines were only 
passaged for a maximum of 4 times in order to maintain their osteoblastic phenotype.  
 
2.3.7 ISOLATION OF CELLS FROM CULTURE FLASKS  
Adherent cells or cell lines were isolated from T75/T175 culture flasks (Greiner Bio-
One, Kremsmünster, Austria) upon reaching 70% confluency using a TrypLE Select 
enzyme (pH 7.0-7.4, 1X), which did not contain phenol red (Gibco, Thermo Fisher 
Scientific, USA). This enzyme is a non-animal derived, recombinant enzyme which 
cleaves peptide bonds on the C-terminal of lysine and arginine. This product was chosen 
instead of traditional dissociation agents such as Trypsin due to its increased purity and 
hence specificity for cellular bonds, making it less likely to produce cellular damage due 
to additional enzymes present in these products. In addition to the rProtease, the 
product also contained 200 mg/L KCl, 200 mg/L KH2PO4, 8000 mg/L NaCl, 2160 mg/L 
Na2HPO4-7H2O and 457.6 mg/L EDTA. Before addition of the enzyme to the cells, the 
growth medium was removed from the flasks and cells were gently washed with 5 ml of 
sterile PBS for a few seconds to remove cell debris and remaining medium. The PBS was 
then discarded and the enzyme was applied at a ratio of 1 ml per 25 cm2 of growth area 
(i.e. 1 ml for a T25 culture flask, 3 ml for T75 and 7 ml for a T175 flask). The flasks were 
placed in an 37oC incubator for 3 minutes to allow activation of the enzyme and cell 
detachment.  Following the short incubation time, an equal amount of growth medium 
containing 10% FCS was added to the flasks in order to inactivate the enzyme. The 
liquid containing detached cells was then recovered from the flasks and added to a 50 
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cm sterile tube (Corning, New York, USA) which was centrifuged at 1000 RPM for 3 
minutes to pellet the cells. Following centrifugation, the supernatant was discarded and 
cells were re-suspended in 10 ml of fresh growth medium. 
 
2.3.8 DETERMINATION OF CELL NUMBERS 
Isolated cells were counted using the Trypan-Blue dye exclusion test, which selectively 
differentiates viable and dead cells based on the concept that viable cells are not able to 
take up this impermeable dye, whereas dead cells, which have become permeable, are 
able to take up this dye. 10 μl of cell suspension was mixed with an equal part of 0.4% 
Trypan Blue and 10 μl of the mix were inserted into a counting chamber slide (Thermo 
Fisher Scientific, USA), which was introduced into a Countess automated cell counter 
(Thermo Fisher Scientific, USA), which automatically generated the total cell count, 
viable cell count and a distribution of the cell size. Measurements were taken in 
duplicate and an average cell number was calculated. The viability of cells following 
isolation always ranged between 85% - 97% and 85% was set as the lower limit for 
selecting a healthy cell population for embedding into fibrin hydrogels. 
 
2.3.9 PRODUCTION OF THE MINERAL ‘BACKBONE’ 
2.5 g of β-TCP powder (<125 m particle size) were added per 1 ml of Orthophosphoric 
Acid (3.5 M) to generate a paste, composed of a mixture of brushite and β-TCP. The 
liquid mixture was poured into individual, pre-shaped wells of moulds, placed on top of 
a shaking platform, to encourage uniform setting inside the shapes. 1.4 cm stainless 
steel insect pins (Austerlitz minutiens, Fine Science Tools, USA), with a diameter of 0.20 
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mm were inserted into the individual wells on the moulds before the mixtures advanced 
into a solid state.  The mixtures containing the pins were allowed to fully harden for 3-4 
hours and were sterilized overnight using UV light exposure, as well as with 70% EtOH 
for 30 minutes on the day of use. The final anchors had a trapezoidal shape and 
measured approximately 3 mm x4 mm x 4mm in height.  
 
2.3.10 COATING OF CULTURE PLATES  
Culture wells were coated with 1.5 ml of a silicone elastomer base (Sylgard184, Dow 
Corning, USA). This was a colourless polydimethylsiloxane elastomer, which was 
formed by mixing the Sylgard base to a curing agent at a 10:1 ratio. Plates were placed 
on a flat surface and allowed to dry at room temperature for 7 days to allow 
polymerization.  
Two anchors per 35 mm culture well were attached to the silicone base using the pins, 
and were placed at a distance of 1.5 cm from each other. Plates were sterilised using UV 
radiation overnight before the commencement of the experiment and were sprayed 
with 70% EtOH on the date of use with 5 hours before use. 
 
2.3.11 CELL EMBEDDING IN FIRBIN HYDROGELS 
Constructs were developed by seeding fibrin hydrogels with an osteoprogenitor cell 
population, either periosteal cells from mice femurs, or from cell lines such as MC3T3-
E1 or 2T3. The fibrin scaffolds were produced through the interaction of the normal 
plasma components thrombin and fibrinogen and were developed on the mineral 
backbone structure. Bovine-derived thrombin powder (Calbiochem, EDM Chemicals; 
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1KU) was reconstituted using 0.1% w/v BSA and 5 ml F12K Nutrient Mixture (1X) with 
Kaighn’s Modification (Gibco Life Technologies) to make a final concentration of 200 
U/ml. Powdered bovine fibrinogen (Sigma Life Sciences) was reconstituted in F12K 
Nutrient Mixture (1X) with Kaighn’s Modification (Gibco Life Technologies) at a ratio of 
20 mg/ml. Thrombin was added to a solution containing the cell culture medium (either 
DMEM or αMEM) at a ratio of 50 μl/ml solution. The anti-fibrinolytic agents 
aminohexanoic acid (200 mM) and aprotinin (10 mg/ml) were added to the thrombin 
solution at a ratio of 2 μl/ml in order to reduce the degradation rate of the fibrin gel, in 
order for it to match the rate of new matrix formation so that the mechanical integrity of 
the tissue can be maintained over longer periods of time. Hydrogels were generated by 
mixing 500 μl thrombin solution with 200 μl fibrinogen. Thrombin cleaves small 
peptides from the fibrinogen chain, producing soluble fibrin monomers, which then 
cross-link into an insoluble, polymerized fibrin clot. Gels were allowed to polymerize for 
30-40 minutes. Cells were seeded into the fibrin constructs immediately following gel 
polymerization; at a density of 100K/2ml of cell culture medium. 
 
2.3.12 FULL OSTEOGENIC SUPPLEMENTATION OF CONSTRUCTS 
Constructs developed with periosteum cells were supplemented following 1 month of 
culture with full osteogenic DMEM culture medium containing β- glycerophosphate (10 
mM), ascorbic acid (0.1 mM) and dexamethasone (10 nM) (Sigma Aldrich, Germany), to 
encourage new matrix deposition along the entire length of the constructs. 
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2.3.13 PRO-COLLAGEN SUPPLEMENTATION OF OTHER CONSTRUCTS 
Following 7 days of development, the MC3T3-E1 constructs were supplemented with 
ascorbic acid (250 μM final concentration) and proline (50 μM final concentration) 
every 2 days, to stimulate collagen deposition (Sigma Life Sciences, Germany). 
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CHAPTER III 
EARLY EVENTS AND INITIATION OF OSSIFICATION 
 
 
 
3.1 INTRODUCTION 
Following cellular embedding into the scaffolds, early developmental events were 
monitored to determine whether the population of osteoprogenitor cells encapsulated 
was able to adhere to the new 3D environment and to observe how successful the cells 
were in proliferating and re-modelling the surrounding hematoma-like matrix. 
Constructs were visually observed in order to determine the extent of contraction, the 
initiation of mineralisation and the localisation of mineral in constructs. 
 
3.2 AIMS AND OBJECTIVES 
The aim of this work was to characterize the early events as well as the development of 
mineralisation microscopically and macroscopically using a combination of optical and 
histological techniques. 
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3.3 CHARACTERISATION METHODS 
 
3.3.1 WHOLE MOUNT STAINING OF MINERAL DEPOSITS  
An Alizarin Red dye was used to chemically detect the presence of mineralization in 
constructs. Alizarin Red S powder (Sigma-Aldrich, Germany) was dissolved in distilled 
H2O to a concentration of 40 mM. The pH was adjusted to 4.2 with 10% (v/v) 
ammonium hydroxide (Fisher Scientific, USA). Constructs were fixed with 10% PFA for 
30 minutes at room temperature. Following fixation, the constructs were rinsed in 
phosphate buffered saline solution (Sigma-Aldrich, Germany) to remove the excess PFA, 
and were inserted into 2 ml of Alizarin Red solution for 30 minutes at room 
temperature. Constructs were rinsed 3 times with PBS to remove unbound dye. 
 
3.3.2 OPTICAL VISUALISATION OF MINERAL DEPOSITS 
Constructs were imaged using a CETI Inverso TC100 brightfield microscope (Medline 
Scientific, Oxon, United Kingdom) and Alizarin Red-stained constructs were visualised 
using a Zeiss Axio Lab A1 microscope (Carl Zeiss, Jena, Germany). 
 
3.3.3 PHOTOGRAPHS OF CONSTRUCTS 
Constructs were photographed at various time points to illustrate the degree of 
contraction during the first week in culture. Photographs were acquired using a Canon 
EOS 1100D camera (Canon, Tokyo, Japan).  To illustrate the visually noticeable 
compositional change in constructs over the first three months of culture, photographs 
were taken using the Bruker M4 Tornado μXRF built-in camera, equipped with strong 
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lighting source (Bruker Instruments, Germany). Pictures were taken before chemical 
mapping of whole constructs, which will be discussed in Chapter V, Characteristics of the 
Newly-Formed Matrix. 
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3.4 RESULTS AND DISCUSSION 
Early developmental events commence with remodelling of the callus-like matrix 
following cell attachment to the scaffolds. The presence of the two calcium phosphate 
anchors causes the cells to contract the matrix around the two holding points (Figure 
3.1a). Cell-seeded constructs which are not provided with the anchorage points 
assemble into spherical structures (Figure 3.2a), as demonstrated in previous work 
(Wudebwe, Bannerman et al. 2015). Over time, this retention results in the formation of 
tensile forces in the soft tissue between the two anchors, which causes alignment at the 
cellular and molecular level along the direction of the force (Figure 3.1b and Figure 
3.3b). Unanchored constructs do not show this complex organisation (Figure 3.3a). 
Early mineralization started adjacent to the bone-like anchors between days 7-10, and 
progressed over the subsequent days as mineral nodules formed throughout the 
structure (Figure 3.1b-c).  The initial fibrin scaffolds became visibly transformed during 
the first 3 weeks from the anchors towards the centre, until the structures became 
completely opaque at 3 months (Figure 3.1d).   
The use of cells extracted from the periosteum of rats was advantageous for this system 
as these animals contain a much higher proportion of cortical bone (72%) compared to 
humans (12.5%) that is evenly distributed across many regions, compared to humans 
bones, which can show mm-thick differences between different anatomical portions 
(Bagi, Wilkie et al. 1997). This feature made the isolation procedure more constant and 
reproducible. In terms of cell activity, because biomineralization and metabolic 
processes take place much quicker in rodent cells compared to human ones (bone 
turnover in rats is several times higher)(Takakura, Takao-Kawabata et al. 2016), they 
are able to quickly adapt cortical and periosteal thickness via modelling-mediated 
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periosteal apposition in order to increase inertia and meet mechanical demands (Bagi, 
Wilkie et al. 1997). As such, the tension-induced biomineralization in this system should 
be observed more rapidly using rat cells compared to human cells. Indeed, the 
compatibility of primary, human-derived cells has been tested in this system and these 
observations are mentioned in Chapter 10 – Further work. Results from these quick 
experiments suggest that human osteoblastic cells can attach to and remodel the matrix 
in a similar way to rodent cells, however, the rate of contraction is less consistent across 
construct populations and develops over much longer time scales. Unlike rat cell 
constructs, human constructs require approximately 3 weeks for full contraction. 
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Figure 3.1 | Early construct development. a, Fibrin scaffold is reorganized around the retention points over the first week in 
culture. Control constructs, developed without cells showed a small degree of contraction over 7 days, but remained as flat gels and 
did not assemble into 3D structures. b, Tensile forces between the two anchor points cause cell alignment before day 6 (left). 
Mineralization nodules are observed throughout the structure after 10 days (middle). c, Mineral deposits are not noticeable 
following 7 days but individual mineralization points can be observed 4 days later in the close proximity of the calcium phosphate 
source. Scale bars b = 50 µm (Day 6, 10), 200 µm (Day 11). d, Changes in the fibrin template are visually noticeable at 14 days, with a 
distinct matrix forming from the anchor regions towards the centre, until the constructs appear to be fully covered with the new 
matrix at 3 months. 
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                                              (Wudebwe, Bannerman et al. 2015) 
 
Figure 3.2 | The effect of CaP anchors on matrix contraction and alignment. Previous work has demonstrated that in the 
absence of anchors (illustrated in the diagram series in the top row), cells contract the fibrin scaffolds over three weeks into 
spherical structures (a), whereas the provision of the 2 retention points (bottom row) allows the formation of a cylindrical structure 
in-between the two calcium phosphate structures (b). Scale bars = 10 mm.  Images a and b are taken from (Wudebwe, Bannerman et 
al. 2015). 
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        (Iordachescu, Amin et al.) 
 
Figure 3.3 | Anchors are required for cellular alignment in constructs. Previous work has demonstrated using 
immunofluorescence staining that the formation of tensile forces during contraction causes alignment at a cellular level, with the 
cytoskeleton and nuclei arranged along the direction of force. Confocal microscopy images of (a) disordered cells in unanchored 
constructs at day 0 and (b) elongated, highly aligned cells in anchored constructs at day 18.  
 
Images a and b are taken from Iordachescu A., Amin D.H., Rankin S.M., Williams R.L., Yapp C., Bannerman A., Pacureanu A., Addison 
O., Hulley P.A., Grover L.M. An in-vitro model for the development of mature bone containing an osteocyte network. Advanced 
Biosystems (2017). 
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CHAPTER IV 
LONG-TERM STRUCTURAL AND CHEMICAL EVALUATION 
 
  
 
4.1 INTRODUCTION 
Early results indicated marked changes in the matrix of constructs during the first 
culture month. To determine whether this visually distinct matrix was composed solely 
of inorganic components or whether organic matrix was being produced at the same 
time, the density of the matrix was probed by applying non-destructive X-ray imaging to 
create 3D density-based reconstructions of whole constructs, at a scale of high 
resolution, and without interfering with the construct chemical composition, thus 
keeping constructs intact. Additional non-destructive imaging and spectroscopic 
techniques were employed to characterise the formation of bone in 3D, in intact 
constructs. These include micro-X-Ray Fluorescence, Two-Photon Microscopy, but also 
physico-chemical technologies which have only recently been employed to study 
disease processes, such as Raman spectroscopy.  
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4.1.1 MICRO-COMPUTED TOMOGRAPHY 
The underlying principle of tomographic analysis (CT) is that the X-rays applied to the 
sample are attenuated at different rates depending on the density of the tissue they are 
passing through. As the object is rotated during scanning, thousands of images are 
acquired from numerous angular views, creating stacks of virtual cross-sections which 
are then integrated to give the final volume. Thus, internal structure can be analysed 
and fine scale details are significantly more visible compared to conventional 
microscopy (Campbell and Sophocleous 2014, Peyrin, Dong et al. 2014), without the 
need to interfere with the sample during processing. Moreover, morphometric 
parameters can be quantitatively analysed following reconstruction, something that will 
be discussed in more detail in Chapter IX – Administration of ossification-inhibiting 
compounds. 
 
4.1.2 RAMAN SPECTROSCOPY 
Raman spectroscopy is a technique which can detect specific chemical groups 
associated with mineral formation and the deposition of matrix components by 
detecting the vibrational bands associated with bonds between molecules (Morris and 
Mandair 2011). It has also been recently employed in understanding the molecular 
mechanisms of heterotopic ossification in wound injuries caused by blast overpressure 
and bone formation in general (Crane, Popescu et al. 2006, Crane, Polfer et al. 2013).  
The technique is based on using monochromatic light (in the case of this work, a near-
infrared laser) to exploit the effect of inelastic scattering (Butler, Ashton et al. 2016), 
which concerns the excitation of photons to virtual energy states. The laser light 
interacts with the vibration associated with chemical bonds between molecules in the 
 
 
 
 
 114 
sample, which causes the energy of the laser photons to fluctuate higher or lower 
(Figure 4.1). This shift in energy can reveal biochemical information based on the 
vibrational models of the polarisable molecules (Butler, Ashton et al. 2016).   
Because this technique has a high molecular specificity and because different biological 
materials have a characteristic Raman spectrum, this technique is exceptional for both 
qualitative and quantitative analysis of biological materials which are different at the 
molecular scale. Biological samples tend to occupy the 400 – 2000 cm-1 region of the 
Raman spectrum, with proteins appearing between 1500-1700 cm-1, carbohydrates 
between 470-1200 cm-1, and phosphate groups associated with mineralisation between 
950-970 cm-1 (Morris and Mandair 2011, Butler, Ashton et al. 2016). 
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Figure 4.1 | Inelastic scattering in Raman spectroscopy. This technique uses monochromatic light (laser) to excite photons to 
virtual energy states. When photos are scattered from a molecule most of them are elastically scattered (Rayleigh scattering), having 
the same energy (frequency and wavelength) as the incident photons. A very small proportion of these photons (1 in 10 million) are 
scattered inelastically (Raman scattering), which involves the loss (Stokes) or gain (anti-Stokes) of energy due to the interaction of 
light with vibrations associated with bonds within the sample.  
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4.1.3 SECOND HARMONIC IMAGING AND TWO-PHOTON EXCITATION FLUORESCENCE 
 
Multi-photon microscopy was employed to image collagen in 3D in live constructs by 
making use of the non-linear optical effect known as second-harmonic generation (SHG) 
generated exclusively by collagen when exposed to a laser of an infrared/near-infrared 
wavelength (Chen, Nadiarynkh et al. 2012). This optical phenomenon in microscopy 
was first described in 1978 (Gannaway and Sheppard 1978). Generation of a second 
harmonic takes place when the incident light used has an electrical field of sufficient 
power to cause molecular deformations (Cox and Kable 2006). If the molecule is not 
symmetrical (i.e. non-centro-symmetrical), the resulting anisotropy creates an 
oscillating field at twice the frequency and half the wavelength, the second harmonic 
(Cox and Kable 2006). Individual non-centro-symmetric molecules of collagen, arranged 
in a triple helix, are able to generate very strong SHG signals (Figure 4.2).   
Where structural information was necessary, such as the spatial dynamics between 
osteoblasts and their secreted matrix protein, second harmonic imaging was used in 
combination with an additional high-resolution optical technique, two-photon excited 
fluorescence (TPEF) (Denk, Strickler et al. 1990, Gauderon, Lukins et al. 2001), which 
allowed the simultaneous visualization of collagen and viable cells, stained with a cell-
permeant fluorescent dye (Calcein AM), at a cellular resolution but over the tissue 
length scale. 
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Figure 4.2 | The optical effect of Second Harmonic Generation. Collagen has a molecular structure (triple helix) which is non-
centro-symmetrical. The incident monochromatic light emitted by a laser interacts with collagen and creates an oscillating field at 
twice the frequency and half the wavelength. 
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4.1.4 MICRO X-RAY FLUORESCENCE MAPPING 
Novel techniques such as micro-X-Ray Fluorescence (μ-XRF) spectroscopy have been 
traditionally used in archaeology for resolving the chemical composition of valuable 
artefacts (Shackley 2014), and recently for quantitating elements in Leonardo da Vinci’s 
most famous paintings, using specifically designed algorithms (de Viguerie, Sole et al. 
2009, de Viguerie, Walter et al. 2010) (Figure 4.3b-d). This is due to the high accuracy of 
the technique, the ability to work on irregularly-shaped samples and the non-
destructive properties. Although this technique can only provide information in the 
form on individual elements, it is extremely valuable for monitoring the temporal 
evolution of these elements, thus providing information on compositional changes.  This 
technology was employed in this work to chemically map the inorganic composition of 
developing constructs over significant periods of time in a non-destructive manner 
based on the emission lines of calcium (Ca) and Phosphorus (P), the main constituents 
of calcium phosphates and bone mineral. The increased or decreased presence of these 
elements can give valuable structural information regarding the local formation of 
ossified matrix. The principle by which X-Ray fluorescence works is based on the 
response of atom excitation by high energetic radiation (Figure 4.3a), which generates a 
vacancy in the affected shell as a photoelectron is ejected. This vacancy is filled by 
electrons from outer shells, a process that is accompanied by the emission of a 
characteristic X-Ray photon, otherwise known as X-Ray Fluorescence. This fluorescence 
is different for each element and the yield depends on the atomic number, that is, a high 
atomic number generates high fluorescence and low atomic number elements generate 
low levels of fluorescence. When the transition of an electron takes place from the outer 
L layer to the K layer, the emission line is known as the Kα emission line, whereas when 
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electrons from the outer M shell jump to occupy the vacant position the emission line is 
known as Kβ. 
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Figure 4.3 | Applications of non-destructive XRF. a, XRF follows a series of processes including a photoelectron ejection from the 
atomic shell exposed to high-energy primary X-Ray radiation and the subsequent ‘jump’ of an outer electron from the near shells in 
order to fill this vacancy. The process is associated with the emission of X-Ray Fluorescence, with different characteristics for each 
chemical element. When the jump takes place from the L to the K layer, it is known as the Kα emission line. When an electron from 
the M layer jumps to fill the place, the emission line is known as Kβ.  b-e, Due to its non-destructive properties and highly accurate 
detection levels, this technique has been recently applied to some of the most valuable historical artefacts and paintings, including 
Mona Lisa (b), St. John the Baptist (c), Bacchus (d) and the Gayer-Anderson cat (e).  Original images. Author would like to thank the 
Louvre Museum, Paris and the British Museum, London. 
 
 
 
 
 
 121 
4.2 AIMS AND OBJECTIVES 
The aim of this work was to observe the structural evolution of the cell-seeded fibrin 
matrix over extended periods of time (1 year) and to monitor the concomitant evolution 
of the newly forming matrix longitudinally. Micro-computed tomography (μCT) was one 
of the many techniques used in this work for assessing maturation the cell-produced 
matrix. Density-based inspections and comparison with the inorganic component 
(anchors) were used to estimate the temporal maturation of the ossified component. 
The subsequent goals were to identify the composition, organisation and pattern of 
deposition of the new matrix in early and mature stages. Preliminary work was 
conducted in all cases to optimize the system for use with different analytical and 
imaging techniques, on aspects including sample preparation, determination of suitable 
sample holders and positioning of sample. 
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4.3 CHARACTERISATION METHODS 
 
4.3.1 MICRO-TOMOGRAPHIC ANALYSIS  
A micro-Computed Tomography (μCT) system (SkyScan 1172, Bruker Instruments, 
Germany), was used to evaluate mineralization and matrix development in constructs 
over time. Constructs were removed from the culture medium and were placed 
vertically inside plastic tubes, on a rotating stage located at 260.650 mm distance from 
the X-ray source and 347.109 mm from the detector. High-resolution scans were 
performed at ambient pressure using the cone-beam imaging system, composed of a 
Hamamatsu X-Ray source with a voltage of 80 kV and a tube current of 100 μA. The X-
Ray detector consisted of an 11 Mp X-Ray camera of a 9.01 μm pixel size, generating 
images of 6.76 μm pixel size. 2D cross-section slices of the constructs were acquired at a 
rotation step of 0.2 degrees, with 2 frames averaging per step and an exposure time of 
1050 ms. Acquired images were 3D reconstructed using the Bruker micro-CT NRecon 
Software (v. 1.6.10.2). For removal of scanning artefacts, several reconstruction 
parameters were adjusted during reconstruction. The beam hardening parameter was 
set to a value of 30 to correct for the surface-to-depth density gradient caused by 
increased X-Ray attenuation at the surface of the constructs. A ring artefact correction 
was set to a level of 9. The smoothing parameter was adjusted to a value of 4. These 
optimized, construct-specific settings were used for all time points investigated.  
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4.3.2 RAMAN SPECTROSCOPY 
Confocal Raman spectroscopy was used to detect and spatially resolve specific chemical 
groups associated with mineralized collagen deposition through the constructs. Maps 
and spectra were acquired using a confocal Raman microscope (Alpha 300R, WITec, 
Ulm, Germany), equipped with an Acton SP2300 Imaging Monochromator/ 
Spectrograph (Princeton Instruments, MA, USA), fitted with a 300g/mm with 750nm 
blazing grating, and a 785nm 250mW diode laser (XTRA II, Toptica photonics, Munich, 
Germany). Spectra were acquired from various points on the constructs, including the 
anchor; the interface between the anchor and the soft tissue and the central portion, via 
a 20X (NA = 0.45) objective lens and using an integration time of 3s and 20 
accumulations. Data was accumulated and exported using the WITec Control software 
version 1.6 (WITec, Ulm, Germany). 
Raman maps of whole constructs (Large scale image scans) were acquired by rastering 
the beam over the samples via the 20X (NA = 0.45) objective lens with a 20µm step size 
and accumulating 3 spectra with in integration time of 0.5 seconds at each point. The 
laser power was measured at 60mW (standard deviation 0.06mW) at the back aperture 
of the objective lens. The data was accumulated using the WITec control version 1.6 
software (WITec, Ulm, Germany). To prevent sample movement during the long scan 
times, the slides the samples were mounted on were clamped to the stage with Blu-
Tack. In all cases, map data acquisition involved between 3 and 4 days of continuous, 
uninterrupted scanning. Spectral data cubes were pre-processed to remove cosmic rays 
using the instrument associated software (Witec Project v2.10., Witec, Ulm, Germany).  
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4.3.3 SECOND HARMONIC IMAGING AND TWO-PHOTON EXCITATION FLUORESCENCE  
A multi-photon microscopy system was used to observe collagenous matrix formation 
in constructs using the optical effect of second harmonic generation (SHG). To 
concomitantly visualize collagen and cells, constructs were stained with the fluorescent 
dye Calcein AM (Sigma-Aldrich, Germany) at a ratio of 2 μl/ml of Opti-MEM culture 
medium (Gibco, Thermo Fisher Scientific, USA) to assess viability and distribution of 
cells.  The microscopy system consisted of a Zeiss LSM710 NLO (Zeiss Gmbh, Germany) 
coupled to a Ti:Sapphire mode-locked Coherent Chameleon Vision II laser. Collagen and 
fluorescent cells were imaged using second harmonic generation (SHG) and two photon 
excitation fluorescence (TPEF) between 385-475 nm and 480-655 nm 
respectively. Photons were collected through a 10x Plan Apo 0.45 N.A. and the two-
photon laser was tuned at 860 nm. The presence of collagen was confirmed by spectral 
imaging and collecting the second harmonic signal at 430 nm via a 10x Plan Apo 0.45 
N.A. or 40x Plan-Apo 0.95 N.A. objective. Where z-stacks were acquired, a slice interval 
of 6 μm was used. Images were visualised in ZEN 2009. Cell viability measurements 
were taken at different time points using Calcein AM, as described above and imaging 
was performed using either the Zeiss LSM710 NLO or a Leica DM2500/TCS SPE 
Confocal (Leica Microsystems, Wetzlar, Germany). Where z-stacks were acquired, a step 
size of 0.50 μm was used and excitation was performed using a 488 nm laser.  
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4.3.4 ELEMENTAL CHARACTERIZATION USING MICRO X-RAY FLUORESCENCE  
A micro X-ray fluorescence (μ-XRF) system (M4 Tornado, Bruker Nano Gmbh, Berlin, 
Germany) was used to generate spatially-resolved elemental maps of constructs and to 
investigate mineral and organic matrix distribution using the localization of Ca, P and S 
in constructs. 
The machine contains a Rhodium μ-focus X-Ray tube and a polycapillary lens, used to 
focus the X-Rays to a spot size of 25 μm. Recordings were taken without sample 
processing, at room temperature and ambient pressure. The X-Ray tube voltage used 
was 50 kV and tube current was 400 μA. μXRF spectra and maps from constructs of 
different ages were acquired using a 50 μm spot distance, 25 μm spot size and 50 
ms/pixel exposure time.  
Elemental maps were formed in real time by integrating the photon counts around the 
emission lines of: Calcium (Kα1 3.692 keV), Phosphorus (Kα1 2.010 keV), Sulphur (Kα1 
2.309 keV), generating an image where pixel intensity was proportional to the number 
of X-Ray counts/second per electronvolt (eV) from each measured point on the 
construct. Thus, pixel intensity increased with X-Ray counts, with maximum pixel 
intensity normalized to the highest count rate per eV for each element of interest, across 
the entire construct.  
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4.3.5 HISTOLOGICAL DETECTION OF COLLAGEN  
Sirius Red dye was used to detect collagen synthesis in constructs. Sirius Red dye 
(Direct Red 80, Sigma- Aldrich, Germany) was dissolved in saturated aqueous picric acid 
at a concentration of 100 mg/100 ml. Constructs were rinsed with PBS and fixed with 2 
ml standard Bouin’s fluid for 1 hour at room temperature. The fixation fluid was 
aspirated and constructs were washed with dH2O for 15 minutes. 2 ml of dye was added 
per construct and the recipients were placed on a plate shaker for 1 hour (100 RPM). 
The excess liquid was removed and the unbound dye was removed by rinsing with 2 ml 
0.01 N hydrochloric acid. Collagen deposits were visualized under the microscope.  
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4.4 RESULTS AND DISCUSSION 
The evolution of mineral and matrix in constructs over time is presented in Figure 4.4, 
which contains microtomographic 3D reconstructions of early (12-15 days) and mature 
constructs (3 months-1 year) developed with periosteal cells. These high-resolution 
microtomographies, acquired at sequential time points, also showed, similarly to whole-
mount histology, that mineralized matrix started forming in early stages (12-15 days) at 
the calcium-phosphate extremities in the absence of further osteogenic 
supplementation (Figure 4.4a-c). This matrix advanced with further osteogenic 
supplementation throughout the entire length of the constructs, until the structures 
became fully ossified after approximately 3 months (d-e). The initial fibrin structure 
became gradually replaced with greater-density matrix (h-j), which after 3 months 
contained deposits of high density mineral independent of the main bone-like structure 
(k-l).  Thus, a combination of clinically-relevant types of ossification were noticed in this 
system: the first type - starting from the bone-like ends- resembling fracture repair; as 
well as an isolated form, distant from the main bone-like structure, resembling mineral 
deposition in soft tissues as seen in ectopic ossification (Potter, Burns et al. 2007, Potter, 
Forsberg et al. 2010, Einhorn and Gerstenfeld 2015). During the subsequent culture 
period up to one year, this new matrix becomes very dense and compact (f-g/m-n), 
containing a high-proportion of mineral, particularly on the outside surface (g).  
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As indicated by tomographic analysis, constructs became mineralized through a process 
that was more complex than a simple calcification, i.e. the precipitation of calcium 
phosphate compounds on the fibrin matrix. Microtomographies indicated significant 
amounts of new, greater-density matrix co-localized with mineral deposits, which 
formed gradually throughout the culture period, indicating that a process of ossification 
was taking place. The nature and characteristics of these matrix components were 
analysed through a combination of molecular, spectroscopic and optical methods, which 
revealed an abundance of structural proteins associated with the extracellular matrix of 
connective tissues. 
Figure 4.5a illustrates a comparison between the novel matrix observed in early stages 
(15 days) using µCT, and a high-resolution compositional Raman map developed based 
on the signal corresponding to one of the organic components identified in abundance, 
CH2 (1447 cm-1), indicative of collagen. The latter analysis revealed that a higher 
amount of this compound was distributed in a similar pattern observed with CT, at this 
equivalent time point. In bone, collagen is produced by osteoblastic cells during the 
assembly of the extracellular matrix (ECM) and accounts for approximately 90% of the 
organic component (Boskey 2013). As such, its simultaneous deposition with the early 
mineral can be used as an indication of early ossification. Spectral analysis of constructs 
which had just completed undergoing the contraction phase (7 days), revealed that the 
CH2 band was accompanied by other bands such as amides I and III (1646 cm-1 and 
1316 cm-1 respectively), proline and hydroxyproline (861 cm-1 and 872 cm-1, 
respectively), major components of collagen, and later, at day 12, by phosphate 
compounds in the central and interface regions, indicative of mineral formation and co-
localised with the organic components (Figure 4.5b). All the mineral detected using 
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Raman spectroscopy at these early time points was different from the anchor material 
(Figure 4.6), the majority being octacalcium phosphate (OCP, 954 cm-1). OCP, 
Ca8H2(PO4)6.5H2O is a calcium phosphate with a Ca:P molar ratio of 1.33 and has been 
suggested a few decades ago to be to be an intermediate crystalline phase in 
hydroxyapatite formation in bones, enamel and dentin (Johnsson and Nancollas 1992). 
Fundamental studies by Eanes and colleagues in the 1960s-1970s (Eanes, Gillessen et al. 
1965, Eanes and Meyer 1977) did suggest that in aqueous suspensions at physiological 
pH, the first crystals which form from amorphous calcium phosphate are strikingly 
different from apatitic crystals, in terms of morphology structure and solubility and 
molar ratio (1.4). These crystals then undergo a process of maturation to HA by 
becoming thicker, but smaller laterally and less soluble. The authors suggested OCP as 
an intermediate phase which subsequently hydrolyses to HA. However, the presence of 
OCP as an intermediate  phase in the formation of bone and dentin mineral has been a 
subject of great debate over the subsequent decades and it has more recently been 
confirmed and described as taking place during in vivo mineralized tissue formation 
(Ban, Jinde et al. 1992), and in pathological dental and renal calcifications (Kani, Kani et 
al. 1983). It has also been identified using similar Raman spectroscopy analysis in 
cultured calvarial bone tissue explants (Crane, Popescu et al. 2006).  
The presence of a novel phosphate phase in our system support a cell-mediated 
mineralisation, but also indicates an advantage of our system in terms of the ability to 
simulate the temporal evolution of bone mineral.  
At the end of an initial month in culture, a regime of full osteogenic supplementation 
was commenced, containing additional ascorbate, β-glycerophosphate and 
dexamethasone. The purpose of this additional supplementation was to encourage 
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ossification to progress more rapidly towards the centre, at a point when the matrix 
was robust enough to maintain integrity during the rapid dissolution of the remaining 
fibrin caused by the new matrix replacement. Raman spectroscopic analysis performed 
following 2 months of supplementation revealed the presence of the complete set of 
peaks that have been reported to be present in mature bone, and in all regions 
investigated, including the centre (Morris and Mandair 2011, Crane, Polfer et al. 2013) 
(Figure 4.5c).  Interestingly, the mineral detected at this time point was the complex 
bone hydroxyapatite (957-962 cm-1), suggesting a maturation process from the 
intermediate phases, and was in all cases associated with collagen.  
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Figure 4.6 | Raman Spectra of the anchors of early constructs. Raman spectra acquired from distinct points on the anchor 
surface at 3 time points within the first two weeks of development revealed spectral characteristic for the brushite-TCP component, 
and different in all cases from the new mineral phases forming within the soft tissues. 
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In terms of localisation and organisation of collagen in constructs, as early as day 7, 
collagen was detected using whole-mount picrosirius red staining, abundantly around 
the edges in the vicinity of the two anchors (Figure 4.7a) and adjacent to the anchors, 
where it appeared to emerge from cell-like structures (Figure 4.7b).  As mineral 
deposits composed of calcium phosphate advance towards the centre during the first 
month of culture (Figure 4.7c), the organic matrix progresses as well.  
Three-dimensional second harmonic imaging of collagen and excitation fluorescence 
analysis of cells in constructs which were cultured for approximately one month, 
showed significant deposits of collagen arranged in pocket-like structures in the 
interface regions, surrounded by cells (Figure 4.7d illustrates an example). Further 
analysis using second harmonics (Figure 4.7e) revealed that the central region of 
constructs did not contain detectable deposits of collagen at this time point, indicating 
that the ossification had not progressed as far up to that time point, but also that the 
collagen species secreted by cells centrally had not reached the sufficient maturity (i.e. 
the non-centro-symmetrical, triple-helical structure) required to reflect half the 
wavelength of the incoming laser and thus to be detected using this technique (Denk, 
Strickler et al. 1990, Chen, Nadiarynkh et al. 2012).  
Throughout the additional osteogenic regime, over the following months, ossification 
progressed at the mm scale until the two sides met centrally, showing the same pattern 
of organisation of collagen pockets as observed in murine femoral bones (Figure 4.7e). 
Together, these results suggest a progressive deposition and maturation of mineralised 
collagen as seen in bone formation and fracture repair (Phillips 2005).   
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The visualisation of collagen exclusively in the emission channel corresponding to the 
432 nm wavelength (half of that of the incoming laser) for all samples investigated is 
presented in Figure 4.8 for validation.  
Interestingly, over the following culture months up to one year the inorganic 
component proportion (calcium phosphate) increases to a level similar to that of 
mature murine femurs (Figure 4.9). This process will be discussed further in the 
following chapter, Cellular development in constructs. 
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Figure 4.7 | Development of the collagenous matrix in constructs. a, Images of 7 day constructs stained with Sirius Red for collagen. Left image 
illustrates high amounts of collagen in the marginal region adjacent to the brushite anchor; right image demonstrates collagen emerging from cell-like 
structures next to the anchor. Scale bars = 200 μm. b, Micro-XRF mapping of live constructs over 21 days, based on Ca and P, the inorganic components 
of bone and S, as an indicator of the organic matrix. Maps show the progression and co-localisation of Ca and P from the anchor towards the centre 
during this period of development up to one month. Scale bar = 4mm.  c, Two-photon microscopy 3D reconstruction of cells (TPEF) and collagen (SHG), 
simultaneously visualised in live constructs. Collagen is present in ‘pocket’-like deposits. Scale bars = 100 µm. d, SHG visualisation of collagen in 
distinct regions at different time points. e, Collagen is abundant around the anchor areas in early stages, but not detected in the central region at 1 
month. Over the subsequent 2 months, the collagenous matrix extends into the tissue at the mm level, displaying a level of organisation similar to 
murine femora.  
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Figure 4.9 | Evolution of the inorganic component over a year in culture, as detected through micro-XRF. Calcium and 
Phosphorus, main components of the inorganic component of bone, increase with extended culture times until they reach a level 
similar to that of murine femurs. 
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CHAPTER V 
CELLULAR DEVELOPMENT IN CONSTRUCTS 
 
 
 
 
 
5.1 INTRODUCTION 
During the culture period, the combination of biomechanical and chemical factors (i.e. 
presence of tensile forces, continuous source of calcium phosphates and osteogenic 
supplementation) ultimately had an influence on the specialization of the stem cells 
embedded in the constructs towards an osteoblastic lineage and subsequently 
recapitulated successive phases of ossification, including cell attachment to scaffold, clot 
remodelling and matrix production (Franz-Odendaal, Hall et al. 2006, Dallas and 
Bonewald 2010).  
 
5.2 AIMS AND OBJECTIVES 
The aim of this work was to monitor the evolution of the stem cells embedded in the 
constructs as the matrix changed locally and chemically. Of particular interest was to 
determine whether embedded cells can terminally differentiate to mature bone cells, 
osteocytes. The goal was to use a combination of molecular and imaging techniques to 
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analyse and visualise the maturation of the structures. Lastly, preliminary work was 
carried out to determine the best type of sample processing for mechanically 
characterising these 3D, matrix embedded mammalian osteocytes and their 
environment using atomic force microscopy (AFM) mapping. 
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5.3 CHARACTERISATION METHODS 
 
5.3.1 REAL-TIME PCR (qPCR) 
 5 months (n=4) and 12 months (n=2) constructs were removed from culture media and 
the calcium phosphate anchors were cut out of the tissue and discarded. Tissues were 
snap frozen by submersion in liquid nitrogen for 1 minute, then rapidly pulverized 
using a multi-sample biopulverizer (BioSpec Products Inc., OK, USA). mRNA extraction 
was performed using a Dynabeads® mRNA DirectTM detection kit. The powdered 
tissue extract was added to 1 ml of a lysis/binding buffer containing 100 mM Tris-HCl, 
pH 7.5; 500 mM LiCl; 10 mM EDTA, pH 8; 1% LiDS; and 5 mM dithiothreitol (DTT) and 
was gently vortexed for 2-3 minutes until complete lysis was obtained.  The viscosity of 
the solution was reduced by a DNA-shear step by passing the lysate 3 times through a 
21-gauge syringe needle. The fragments of tissue that were not lysed were pelleted by 
10 seconds centrifugation and the supernatant was separated.  
mRNA isolation was performed by mixing the lysate with 1 mg superparamagnetic 
beads (Dynabeads®, approx. 2.8 μm diameter) which were covalently coupled to Oligo 
(dT)25 residues, having a capacity of binding a maximum of 2 μg mRNA. Beads were 
previously removed from the PBS storage suspension (pH 7.4) using a Dynabeads MPC-
S magnetic particle concentrator (Dynal AS Oslo, Norway), washed with the 
lysis/binding buffer and then re-suspended in the crude lysate. Each lysate was 
incubated with the beads at room temperature for approximately 5 minutes, by 
continuously mixing on a rotating platform to allow the polyA tail at the 3’ end of the 
mRNA to hybridize to the Oligo (dT)25 residues on the beads. The supernatant was then 
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removed by concentrating the mRNA bound beads at the magnet site and the beads 
were then washed one time with 500 μl of a buffer solution containing 10 mM Tris-HCl, 
pH 7.5; 0.15 M LiCl; 1 mM EDTA; 0.1% LiDS; and twice with 500 μl of a buffer solution 
containing 10 mM Tris-HCl, pH 7.5; 0.15 M LiCl; and 1 mM EDTA. RNA-bound beads 
were isolated using the magnet, washed in an enzyme-free RT buffer and then re-
suspended in a solution containing a reverse transcriptase (RT) polymerase in order to 
proceed with cDNA synthesis. cDNA synthesis was performed directly on the bead 
bound mRNA  using a SuperScript Reverse Transcriptase kit (Invitrogen, Thermo Fisher 
Scientific, CA, USA), using 1 μl 10 mM dNTP mix (dATP, dGTP, dCTP, dTTP), 12 μl dH2O, 
4 μl 5X first strand buffer (250 mM Tris-HCl, 375 mM KCl, 15 mM MgCl2), 1 μl 0.1 M 
DTT, 1 μl RNAse out (40 U/ μl) and 1 μl of the SuperScript RT enzyme (200 U/ μl). 
cDNA was synthesized by incubating the 20 μl reaction volume using a Veriti thermal 
cycler (Applied Biosystems, CA, USA), at 50°C for 5 minutes, 55°C for 20 minutes and 
75° for 15 minutes. Amplification of cDNA was performed using a ViiA 7 real-time PCR 
instrument (Applied Biosystems, CA, USA). The PCR reaction consisted of 2 μl cDNA 
template, 6 μl dH2O, 10 μl fast SYBR green master mix (containing a mixture of the SYBR 
Green I dye, AmpliTaq fast DNA polymerase, Uracil –DNA glycosylase, Rox dye and 
dNTPs) (Applied Biosystems, CA, USA) and 2 μl rat primer (GAPDH (QT00199633) 
/SOST (QT00418558) /PDP (QT00174706) (Qiagen, Manchester, UK) and beta-actin 
(QT00193473) previously reconstituted in Tris –EDTA (TE) buffer, pH 8.1 (Alfa Aesar, 
MA, USA). 
As positive control, cells from an osteosarcoma cell line positive for SOST and PDPN, 
UMR-106, were used and mRNA was extracted and processed in an identical manner.  
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These cells were obtained from the American type culture collection (ATCC) and were 
cloned derivatives of a transplantable rat osteogenic sarcoma. 
Data was recorded and analysed using the QuantStudio real-time PCR software, version 
1.2 2015 (Applied Biosystems, CA, USA). In addition to no template controls, products 
were validated using melt point analysis to show a single high temperature melt point. 
 
5.3.2 HISTOLOGICAL PROCESSING 
For histology and immunohistochemistry, constructs were fixed in 10% neutral 
buffered formalin for 3 days, and were then embedded in paraffin wax blocks for 
sectioning. 4 μm thick paraffin tissue slices were produced using a Leica microtome 
(Leica Microsystems, Wetzlar, Germany).  
Glass slides containing tissue sections were deparaffinised and rehydrated through 
subsequent washes with Neo-Clear (xylene substitute, Merck Millipore, Massachusetts, 
USA), twice for 5 minutes, 100% EtOH, 96% EtOH and 70% EtOH twice for 30 seconds 
each time, followed by a 1 minute wash with dH2O. Following the application of dyes, 
slides were prepared for long-term storage by washing with dH2O followed by 
dehydration in ascending concentrations of EtOH, as follows: 70%, 96% and 100% 
EtOH twice for 1 minute, followed by a final wash with Neo-Clear, twice for 5 minutes. 
Slides were mounted using a water-free agent, Neo-Mount (Merck Millipore, 
Massachusetts, USA) for long-term storage. Tissue sections were imaged using a Leica 
DM500 microscope (Leica Microsystems, Wetzlar, Germany).  
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5.3.3 H&E STAINING  
A Haematoxylin and Eosin (H&E) stain was used in order to stain cell nuclei, cytoplasm 
and the matrix of constructs. Haematoxylin staining solution was applied for 3 minutes 
and slides were washed under running tap water for 3 minutes. Eosin Y solution 0.5% 
was applied for 3 minutes. Samples were rinsed under running tap water for 30 
seconds. 
 
5.3.4 IMMUNO-HISTOLOGICAL ANALYSIS 
Slides containing tissue sections were deparaffinised and rehydrated through 
subsequent washes with Neo-Clear (xylene substitute, Merck Millipore, Massachusetts, 
USA ) and 100% EtOH  twice for 3 minutes; followed by washes in 95% EtOH, 70% 
EtOH and 50% EtOH for 3 minutes each time, followed by a wash with dH2O. Antigen 
retrieval was performed using the water-bath immersion method, where the slides 
containing tissue sections were immersed in citrate buffer (10 mM sodium citrate in 
dH2O, pH 6, Abcam, Cambridge, United Kingdom) for 8 hours at 37°C. Slides were 
washed twice for 5 min in TBS which contained 0.025% Triton X-100 (Thermo Fisher 
Scientific, Massachusetts, USA). Tissue sections were blocked in medium containing 1% 
BSA and 10% normal serum in TBS from either donkey or goat, depending on the 
species of the secondary antibodies, for 2 hours at room temperature. Primary rabbit 
antibodies against rat sclerostin (Abcam, Cambridge, United Kingdom), podoplanin 
(Abcam, Cambridge, United Kingdom) and collagen type I (Thermo Fisher Scientific, 
Massachusetts, USA) were diluted to a concentration of 10 μg/mL in TBS with 1% BSA. 
Antibodies were applied to the slides and incubation was performed overnight at 4°C. 
Samples were rinsed twice with TBS containing 0.025% Triton X-100, with gentle 
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agitation. Secondary antibodies (donkey anti-rabbit or goat anti-rabbit) conjugated to 
Alexa Fluor 488 (Figure 5.1) fluorophores, were diluted to 10 μg/mL (donkey) or 5 
μg/mL (goat) in 1% BSA in TBS and were incubated with the slides for 1 hour at room 
temperature. Following incubation, tissue sections were washed three times with TBS 
for 5 minutes. In order to check for non-specific antibody binding, the steps listed above 
were performed on additional slides, without the addition of the primary antibodies. 
Slides were washed with TBS containing 0.1% Triton X-100 for 5 minutes. Phalloidin 
(Thermo Fisher Scientific, Massachusetts, USA) conjugated to Alexa Flor 594 or 555 
(Figure 5.1) was used for cytoskeletal labelling. The lyophilized phallotoxin powder was 
diluted to a concentration of 200 U/mL using methanol (6.6 μM) and 3U were applied in 
TBS to each tissue-containing slide. Samples were washed with PBS twice. DAPI (Figure 
5.1) was used for nuclear/DNA staining dissolved in mounting agent. Tissue sections 
were mounted with Pro-Long Diamond anti-fade permanent mountant (Thermo Fisher 
Scientific, Massachusetts, USA) for fluorescence preservation. Fluorescence images were 
acquired using an Olympus Fluoview FV1000 confocal laser scanning microscope 
(Olympus, Tokyo, Japan) equipped with a multi-line argon laser FV5-LAMAR/LAMAR-2 
and a Helium-Neon Green Laser FV5-LAHEG-2/FV5-LAHEG. Images acquired from 
excitation at 405, 488 and 543 nm wavelengths were collected in individual channels 
and combined using the Fluoview FV10-ASW software, version 4.2 (Olympus, Tokyo, 
Japan). 
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Figure 5.1 | Excitation-Emission Spectra of fluorophores chosen for Immuno-Histochemistry. The Alexa Fluor 488 
fluorophore was conjugated to antibodies raised against the molecular markers of interest, Alexa Fluor 555 was conjugated to 
Phalloidin for detection of cytoskeletal actin and DAPI was applied to detect the presence of DNA/nuclei. Spectra were produced 
using the Fluorescence SpectraViewer online resource (Thermo Fisher Scientific, MA, USA). 
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5.3.5 SCANNING ELECTRON MICROSCOPY 
12 months-old constructs were fixed with 2.5% glutaraldehyde in phosphate buffered 
saline and dehydrated over several steps including immersion in ethanol of increasing 
concentrations and critical point drying using CO2. Samples were coated with platinum 
and Scanning Electron Microscope (SEM) images were acquired under vacuum using a 
Philips xl30 FEG ESEM at a resolution of 3 nm at 15 kV. Various cellular structures were 
coloured using Adobe Photoshop CC 2015 (Adobe Systems Incorporated, CA, USA) to 
allow a better visualization. 
 
5.3.6 SYNCHROTRON RADIATION COMPUTED-TOMOGRAPHY  
Nano-computed tomography (nanoCT/srCT) represents imaging at resolutions below 1 
micron using synchrotron radiation. Synchrotron radiation uses a high-photon flux 
monochromatic X-Ray beam that is extracted from a synchrotron source, as opposed to 
microCT, which uses a polychromatic X-Ray source. This prevents beam-hardening 
artefacts (described in Chapter 4), which allows high-resolution, accurate measurements 
(Martín-Badosa, Amblard et al. 2003). srCT analysis was conducted on the nano-
imaging beam line ID16 at the European Synchrotron Radiation Facility (ESRF) in 
Grenoble, France. Constructs were fixed with 4% formaldehyde and dried for 30 
minutes at 50oC. 5 mm samples of constructs were excised and placed on the rotating 
stage (Figure 5.2). Images were acquired at a resolution of 50 nm or 100 nm and a 
number of slices of 65-200 was acquired and used for 3D reconstruction.  
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Figure 5.2 | Equipment design for sample scanning using synchrotron-radiation computed tomography. a, Stage containing 
sample is fixed in place. b, 5 mm samples were cut from dried constructs and were placed in the centre of the stage used for high-
resolution scanning. 
 
 
5.3.7 THERMAL ISOLATION OF MINERAL 
Constructs were removed from culture and their calcium phosphate anchors were 
excised. Remaining tissues were dried at room temperature overnight and weighed 
using an Ohaus Pioneer Plus analytical balance (Ohaus, NJ, USA). Tissues were then 
introduced into a 900°C hot oven for 13 hours to remove organic matter (Carbolite 
CWF1300, Carbolite Gero, Hope Valley, United Kingdom). Following this period, the 
inorganic matter isolated was weighed and the percentage mineral content was 
calculated. 
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5.3.8 X-RAY DIFFRACTION  
X-ray diffraction (XRD) was used to determine the crystalline composition of the 
samples. The crystals produced from the samples following 13 hours of heating in a 
furnace were ground into fine powders with a marble mortar and pestle and carefully 
formed into a 10mm wide thin circular layer on sticky tape. X-Ray diffraction patterns of 
the mounted powders were then collected using with a Bruker D5000 X-ray 
diffractometer (Bruker ASX, Karlsruhe, Germany) using the Cu Ka1 1.5406Å line, with a 
2θ range of 24.6º to 48º, a 0.02º step-size and a step time of 0.05 s/ º leading to a total 
scan time of approximately 1 hour. Detected peaks were compared to JCPDS reference 
patterns to identify the crystalline phases in each sample. PDF 00-009-0432 and 00-
012-0404 were used as reference patterns for hydroxyapatite and Whitlockite, 
respectively. 
 
5.3.9 MICRO X-RAY FLUORESCENCE  
High-resolution elemental mapping of the lacunar structures and matrix of 1-year 
constructs was performed on flat, 4 μm thick slices (see Histoprocessing) using a spot 
size of 25 μm, distance of 5 μm, with 10 ms/pixel exposure time and 100 frame counts. 
Measurements were recorded under vacuum, at approximately 800 mbar. 
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5.3.10 RAMAN MAPPING OF WHOLE CONSTRUCTS 
Large-scale image scans were acquired from fresh constructs using the methodology 
described in section 5.3.1. Spectral data cubes were pre-processed to remove cosmic 
rays using the instrument associated software (Witec Project v2.10., Witec, Ulm, 
Germany). For some experiments (see Formation of a Periosteal Structure in 1-year-old 
constructs) files were exported in .SPC format and imported into MATLAB (MATLAB 
2016b. Mathworks, Natick, Massachusetts, USA), baseline corrected using an adaptive 
iteratively reweighted penalized least squares method and vector normalised. Least 
squares regression was used for fitting of individual Gaussians to each peak. 
Octacalcium phosphate was represented by the P−O stretching mode (v1) of the PO4 
group between 953-956cm-1. Hydroxyapatite was represented by the symmetric 
stretching mode (v1) of the PO4 group (P−O bond) between 958-961cm-1. Collagen was 
represented across all maps by the amide I peak spanning 1620-1650 cm-1. To best 
visualise the relative amounts, distribution of, and association between, mineral and 
collagen throughout the samples RGB image maps were produced by integrating over 
the sum of peaks of interest. Red represented OCP, Green represented hydroxyapatite 
and Blue represented collagen. MATLAB was employed in all cases in order to visually 
represent the co-localisation of the signals for the inorganic-organic components and to 
be able extract further information regarding the dynamics of ossification. As such, the 
overlap of different components generated the following colours: yellow when HA 
(green) and OCP (red) were co-localised, grey when HA (green) and collagen I (blue) 
were co-localised, and violet/purple when OCP (red) and collagen I (blue) were co-
localised.  
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5.3.11 ATOMIC FORCE MICROSCOPY 
  
5.3.11.1 FRESH SAMPLE PREPARATION FOR AFM 
Fort the initial tests, constructs were removed from culture medium following a year in 
culture and rinsed with PBS for a few seconds. A 1 cm2 section was cut from the central 
portion of constructs and positioned flat on a 35 mm x 10 mm polystyrene dish 
(Corning, New York, USA), which was immersed in 1 ml PBS (Sigma-Aldrich, Germany), 
a quantity sufficient to maintain the hydration of the tissue section, whilst preventing its 
movement during testing.  
 
5.3.11.2 FIXED SAMPLE PREPARATION FOR AFM 
An alternative type of sample was used to optimise the force measurements, using glass 
mounted tissue sections of 1 year constructs.  These sections were 4 μm thick paraffin 
and were produced by formalin fixation, followed by paraffin embedding and sectioning 
using a Leica microtome (Leica Microsystems, Wetzlar, Germany), using the procedures 
listed previously for histological processing, in Chapter 5.  
The glass slides containing tissue sections were deparaffinised and rehydrated through 
subsequent washes with Neo-Clear (xylene substitute, Merck Millipore, Massachusetts, 
USA), twice for 5 minutes, 100% EtOH, 96% EtOH and 70% EtOH twice for 30 seconds 
each time, followed by a 1 minute wash with dH2O. Samples were kept hydrated with 
PBS prior to and during measurements.  
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5.3.11.3 MECHANICAL TESTING  
Samples were mechanically mapped using a NanoWizard II atomic force microscope 
(JPK Instruments AG, Berlin, Germany). The NanoWizard II setup consisted of a Carl 
Zeiss Axiovert 200 microscope, with a joystick controlled motorised stage and 
ForceWheel device, which allowed navigation across the sample surface; a NanoWizard 
II head, a manual and automated, and alloy base plate stage providing a travel range of 
20 x 20 mm2 within the field of a 100x objective. The instrument was located inside a 
closed, acoustic isolated chamber paced on a vibration-isolated table to reduce noise 
and artefacts.  
High-resolution maps were acquired using pyramidal cantilever tips by intermittent 
contact mode across an X-Y range of 50 x 50 μm, and 100 x 100 μm (512x512 pixels), 
and across a z range of 15 μm. The acquisition time was approximately one hour for 
each area scanned. Data was acquired using JPK NanoWizard Control software and 
measurements for height, slope and adhesion were analyzed and exported using JPK 
Data Processing software version 4.1.8 (JPK Instruments AG, Berlin, Germany). 
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5.4 RESULTS AND DISCUSSION 
 
5.4.1 FORMATION OF OSTEOCYTES AND A LACUNO-CANALICULAR SYSTEM 
Optical analysis of the cellular morphological features during the months of culture 
revealed a pronounced restructuring of the cytoskeleton (Figure 5.3), showing the 
formation of extensive projections characteristic of osteocytes and of long micro-canals 
as early as 3 months (a). Following 1 year in culture, most of the cells observed 
displayed an osteocytic morphology (b).  
At the molecular level, cells present after a period of 5 months expressed osteocytic 
marker sclerostin, a negative regulator of bone formation and an inhibitor of 
osteoblastic activity (Poole, van Bezooijen et al. 2005, Bonewald 2011, Kalajzic, 
Matthews et al. 2013), on their outer membranes and in their surroundings, which 
resembled cell networks (Figure 5.4a and 5.5). Further networks rich in sclerostin but 
also podoplanin, a marker for the embedding osteoid osteocyte (Bonewald 2011), and 
which is involved in reorganization of the cytoskeleton (Zhang, Barragan-Adjemian et al. 
2006), could also be detected following the very extended culture time of 1 year (Figure 
5.4a illustrates an example). Sclerostin and podoplanin mRNAs were also detected at 
these late (5 months) and very late time points (1 year) (Figure 5.4b), suggesting an 
active role of the cells in building and remodelling the bony matrix.  
Interestingly, the mineral to matrix ratio of these constructs at the latter time point 
reached a value similar to that of bone, with mineral occupying approximately 70% of 
the total content (Boskey 2013) (Figure 5.4c). Moreover, the mineral was confirmed to 
be the mature bone hydroxyapatite using X-Ray Diffraction analysis (Bonar, Roufosse et 
al. 1983) (Figure 5.6). 
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Figure 5.3 | Cellular morphological changes over a year in culture and final differentiation to osteocytes. a, Following a 
month in culture, morphology of cells in constructs is mainly elongated and resembling osteoblastic cells (left). With additional 
osteogenic supplementation and over the following 2 months, cells develop typical osteocytic characteristics, including numerous 
interconnected osteocytic networks (middle) and canaliculi-like structures containing long cell projections (right). b, The most 
mature cells (1 year) show a marked re-structuration of the cytoskeleton, displaying osteocytic phenotypes strikingly similar to 
those encountered in vivo (left).  The long projections are very well preserved (right top and bottom). 
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Figure 5.4 | Detection and localisation of bone markers in mature constructs. a, Immunohistochemistry of constructs, showing 
expression of osteocytic marker sclerostin on the surface of cells and in neighbouring network-like structures at 5 months (middle). 
The matrix of 1 year-old constructs contains long networks, where podoplanin could be detected (right). Scale bars = 100 µm. b, 
mRNA for sclerostin and podoplanin was detected at these time points as well. Results are presented compared to a rat 
osteosarcoma cell line as positive control. UMR-106 produces sclerostin and podoplanin continuously. Please note cycle threshold 
(Ct) is inversely proportional to the amount of target nucleic acid in the sample. npdpn= 4 (umr,5 m), 2 (1 yr). nsost= 4 (umr), 2 (5m,1 
yr). ngapdh= 4 (umr,5 m), 2 (1 yr). c, The inorganic component of constructs following a year in culture equals approximately 70% of 
the total content. n=3.  
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Figure 5.5 | Secondary antibodies are highly specific and do not bind at random locations on constructs during 
immunohistochemistry. Goat anti-rabbit IgG conjugated to Alexa Fluor 488 (green) were applied to all samples in the same 
conditions, without the addition of a primary antibody in order to detect non-specific binding. These results that these antibodies 
were highly specific, showing minimal or non-existent binding to the construct slices, thus reducing the possibility of false positive 
results.   
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Figure 5.6 | Typical X-Ray Diffraction pattern obtained from mature constructs. The pattern confirms the presence of 
hydroxyapatite, the mature bone mineral in 1 year samples. Traces of whitlockite, a second type of mineral abundant in bone (Jang, 
Jin et al. 2014, Jang, Lee et al. 2015), can also be detected.  
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Sclerostin, visualised in a section of a 5 months-old construct using immunohistochemistry.  
Blue - Nuclei (DAPI)  Red - Actin (Phalloidin conjugated to Alexa Fluor 555), Green - Sclerostin (Goat anti-Rabbit IgG conjugated to Alexa Fluor 488) 
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High-resolution optical analysis of the cells in the most mature constructs (1 year) 
demonstrated further osteocytic morphological features. Cells at the surface of 
constructs, imaged using scanning electron microscopy (Figure 5.7a), appeared 
embedded in the heavily mineralized matrix. These cells contained a high number of 
large projections emerging from the cell bodies and reaching adjacent cells, as seen in 
bone (Gorustovich 2010, Schneider, Meier et al. 2010). Synchrotron radiation computed 
tomography (srCT), which enabled resolution down to the nanoscale (Langer, 
Pacureanu et al. 2012, Peyrin, Dong et al. 2014), was used to visualise cells located 
below the surface, inside the constructs. Figure 5.7b illustrates an example. The 
tomographic reconstruction further confirmed the presence of a complex canalicular 
network that linked the embedded cells, the first time that such elaborate structures 
have been attained using an in vitro culture. These channels were visualised using 
micro-XRF to provide a chemical map of the tissue structures (Figure 5.7c).  Lacunae, 
which were shown to house cells expressing osteocytic markers, were surrounded by a 
matrix rich in calcium and phosphate salts.  The presence of a canalicular network was 
further supported by this analysis, which showed a sulphur rich network (indicative of 
the presence of protein) which permeated through and between the lacunar structures 
(Figure 5.7c). Similar osteocytic structures, containing cellular DNA, were observed at 
earlier time points as well using histological analysis (Figure 5.8). These lacunar 
structures were aligned with the mechanical axis of construct and in some cases were 
connected by microchannels (Figure 5.8c).   
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Figure 5.7 | Development of bone cells in constructs. a, SEM images of cells in constructs after 12 months of culture, showing 
cells embedded in the significantly mineralized matrix. The main cellular structure in a has been false-coloured to allow a better 
visualization. There are many podocytes embedded in the heavily mineralized matrix. Cells communicate through extensive 
projections. b, Synchrotron radiation computed tomography illustrating a typical osteocyte lacuna (L) with emerging canaliculi (C) 
that branch into the tissue. c, XRF maps based on S, Ca, P showing network-like structures throughout the matrix and connecting 
adjacent lacunar-like structures (arrows). Scale bars = 200 μm. 
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     Osteocyte lacunae and canaliculi inside a 1 year-old construct, as seen through synchrotron radiation computed tomography (srCT) 
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Figure 5.8 | Development of osteocytic features, H&E stain of tissue sections. Canalicular-like structures emerging from lacunar 
spaces were observed as early as 3 months (a, arrows), with some branching into the tissue (b, arrows) and connecting adjacent 
similar structures, which contained cell DNA and remnants of the cytoplasm (a, b). Networks of DNA containing lacunae (c, arrows), 
could be observed arranged along the length of constructs. Scale bars a, b = 10 μm; c = 100 μm. 
 
 
Taken together, these results suggest that the microenvironment inside constructs, 
which developed into mature, mineralized collagen, reached a level of ossification 
similar to in vivo bone following long-term culture, which allowed the differentiation 
and survival of osteocytic cells over an extended, clinically-useful period of time.  
Osteocytes are extremely difficult to differentiate in-vitro (Kalajzic, Matthews et al. 
2013), as these mature cells form under complex conditions in their environment. They 
are also very difficult to investigate in vivo due to their localization, embedded in 
lacuno-canalicular networks in hard bone, and their final stage differentiation into 
mitotically inactive cells (Kalajzic, Matthews et al. 2013). Following isolation, culturing 
these cells require complex supplementation regimes to prevent a quick de-
differentiation into osteoblastic phenotypes. Although standard immortalized osteocyte 
cell lines (e.g. MLO-Y4) are available, (Kato, Windle et al. 1997) they are not entirely 
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representative due to reduced marker expression, particularly sclerostin. As a 
consequence, to this date there are few models available for ex-vivo or in-vitro study of 
osteocytes and certainly none that allow for the long-term growth of these cells.  
This work demonstrates that it is possible to fine-tune a primary osteoprogenitor cell 
population towards an osteocytic phenotype in a physiologically-relevant system that 
develops into bone tissue at most levels, including cellularly (osteoblast and osteocyte 
development), compositionally and structurally (organised collagenous matrix 
production and mineralization). Although primary osteoblast to osteocyte cell 
transition has recently been reported in 3D by a few research groups (Kalajzic, 
Matthews et al. 2013); this model differs in the close recapitulation of complex in-vivo 
conditions (Boukhechba, Balaguer et al. 2009), and in the self-structuring process as 
opposed to a pre-formed organic-inorganic matrix template (e.g. collagen scaffold with 
embedded HA particles) (Sun, Gu et al. 2015). As such, constructs survive over much 
greater periods of time (i.e. 12 months compared to a few weeks); as well as developing 
over a real tissue length-scale. 
 
5.4.2 FORMATION OF A ‘PERIOSTEAL’ STRUCTURE IN 1-YEAR-OLD CONSTRUCTS 
Several techniques indicated the formation of a gradient of ossification, not only from 
the anchors towards the center but also from the midpoint of the constructs towards 
the edges.  These were observed as outer structures which were denser than the 
remaining construct (Figure 5.9). This process could have been triggered by individual 
or a combination of factors including the design of the system, mechanical pattern of 
self-organisation, or local chemical and biological cues. Irrespective of the nature of the 
underlying mechanisms, the process itself was both fascinating and valuable to this 
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model, as it brought this system closer to simulating bone by recreating an outer 
‘periosteal’ structure. Figure 5.9 presents the analysis of  this aspect. Firstly, the dense 
outer matrix layer observed with micro-CT (a), when mapped using Raman 
spectroscopy, it showed an abundance of HA-associated collagen composition, whereas 
the central portion of constructs contained a mix of mature HA and intermediate phase 
OCP (b). Interestingly, the abundant collagen content detected at earlier time points 
using this technique as well as with SHG, was loaded during extended culture periods 
with further mineral deposits, confirming the high mineral content (70%) detected 
using other techniques.  It cannot be determined soley based on this data whether the 
formation of this outer structure and the assembly of this highly-mineralised matrix 
was due to the absence of a marrow-like cavity. Further work involving vascularisation 
of constructs would be able to shed light on this matter.  Sections of these mature 
tissues were subjected to immunohistological and histological analysis, which revealed 
some further interesting aspects. The outer, dense layer contained proportonally-high 
levels of sclerostin, the negative regulator of bone formation, compared to the central 
portion, where it was encountered in network-like structures (c, left). These outer 
structures also contained considerable amounts of cellular DNA, suggesting a 
localisation of the osteocytic cells in this part of the constructs. The presence of cellular 
DNA was also identified in this region using haematoxylin staining (c, right). It is hard to 
speculate whether the localisation of cells particularly on the outside layers was a 
preferential choice due to the heating gradient provided by the well-plate system, but 
several fine tests could be run in further work to investigate this matter by modifying 
the culture system, as well as the chemical composition and design of the multi-well 
plates in order to uniformize the microclimate they provide to the cells. 
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Figure 5.9 | Formation of a ‘periosteal’ structure in constructs. a, Micro-CT tomographies indicated a density difference between 
the outer layer of constructs and the central portion in the oldest constructs. b, Raman maps of the central area revealed that the 
outer structure contained collagen type I associated with hydroxyapatite, whereas the central region contained a combination of HA 
and OCP. c, Immunohistochemistry on tissue sections indicated that this region was rich in sclerostin (green) and cellular DNA 
(blue). The latter was also observed using H&E staining, where DNA was localised to the outer region (blue). 
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5.4.3 MECHANICAL CHARACTERISATION OF OSTEOCYTES 
The ability to differentiate osteoprogenitor cells towards an osteocytic path in this 
system provides an opportunity to study these cells in a more native environment than 
previous in vitro models.  As discussed in Chapter 1, the hierarchical embedding of 
osteocytes into the bony matrix is essential for their role as mature, mechano-sensing 
cells. Therefore, preliminary work was performed to determine a suitable method for 
characterising these cells from a mechanical perspective in order to understand their 
immediate micro-environment. Atomic force microscopy (AFM) was employed to 
mechanically map the properties of constructs at high-resolution. Atomic force 
microscopy is a technique that has been increasingly used in cell biology in the past 
years for analysing cell features at the nanometre resolution (Lehenkari, Charras et al. 
2000, Graham, Hodson et al. 2010) and has been applied for the study of individual 
osteocytes (Nguyen and Gu 2014).  
Whole constructs (1-year-old) were initially subjected to mapping by AFM (Figure 
5.10). Maps of 100 μm2 allowed the identification of cell features, including cellular 
projections and bodies (top row). Identical features were also observed at a resolution 
of similar scale using synchrotron radiation computed tomography, where these cell 
pods appeared to connect to lacunar structures (Figure 5.11). The cell projections 
showed a high adhesion, indicating the presence of biological material, whilst the matrix 
surrounding them showed little to no adhesion, suggesting an inorganic, less adhesive 
component.  Smaller areas were then selected (80 and 30 μm2) to observe further 
details, however, the procedure generated noisy maps, potentially due to sample 
movement during investigation (Figure 5.10 Areas 2 and 3).  
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Figure 5.10 | Mechanical characterisation of 3D constructs. Several cellular features can be observed, particularly projections 
characteristic to osteocytes (Area 1). Pods appear more adhesive compared to the surrounding matrix, suggesting the presence of 
biological material entrapped within a less adhesive, inorganic component. Areas 2 and 3 appear noisier due to sample movement. 
These maps appear to show a mixture of structures with different mechanical properties, including round, adhesive structures with 
a low slope, indicating biological material, and structures which are harder (higher slope) and have less adhesion, indicating 
inorganic material. 
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Figure 5.11 | Nano-characterisation of osteocytic features. The cellular projections observed using AFM were also detected 
using synchrotron radiation tomography, where they appeared as canaliculi (C), connecting lacunar structures (L). 
 
 
As such, a new type of sample was prepared to remove the issue of movement during 
measurement, which involved using deparaffinised, re-hydrated 4 μm thick tissue 
sections fixed onto glass slides. The combination of tissue sectioning and atomic force 
microscopy has been previously reported as successful for resolving intracellular and 
extracellular structures in connective tissues (Graham, Hodson et al. 2010).   
This method was successful in preventing the sample noise issue and trial 50 μm2 maps 
were able to identify osteocytic bodies and projections, with mixed mechanical 
properties, potentially composed of both organic and inorganic materials (Figure 5.12). 
Interestingly, the matrix surrounding the osteocytic structures (Figure 5.12 right) 
showed some degree of consistency, with organic structures alternating inorganic ones.  
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Although AFM has been increasingly used in biology recently to obtain information at 
the nanometre resolution scale, many biological features are too unstable or out of the 
probe’s reach (Lehenkari, Charras et al. 2000). In live cells, this is further complicated 
by the fact that many biological processes take place within seconds as opposed to 
minutes – hours, which are required for AFM scanning.  Further optimisation work in 
this area is needed to confirm and expand on these results. 
 
 
 
 
 
 
Figure 5.12 | Mechanical characterisation of individual osteocytes in tissue sections. Tissue sectioning allows the detection of 
clearer osteocytic structures, including cell body and projections. These cells and surrounding matrix showed mixed mechanical 
properties. The adhesion channel (right) shows a pattern of alternative soft and hard structures.  
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CHAPTER VI 
MATRIX MINERALISATION BY MATRIX VESICLES 
 
 
 
6.1 INTRODUCTION 
The process of ossification takes places through a cell-mediated route, where 
cartilaginous and collagenous matrix built by chondrocytic and osteoblastic cells 
becomes subsequently mineralised in an organised manner, giving rise to the mature 
bone tissue (Mackie, Ahmed et al. 2008).  
It is generally accepted that the process of calcium and phosphate deposition in 
cartilage, bone and dentin is mediated through exosome/vesicle-like nano-structures, 
generally referred to as matrix vesicles (MVs) (Anderson 1969, Anderson 2003, 
Anderson, Sipe et al. 2004). These nanovesicles are thought to bud-off from the plasma 
membrane of hypertrophic chondrocytes and osteoblasts (Cui, Houston et al. 2016) and 
contain the optimal conditions for the assembly of Ca and P into Hydroxyapatite, which 
ultimately becomes precipitated on the surface of collagen fibrils (Anderson 2003, 
Golub 2009), forming nucleation points (Felix, Herrmann et al. 1978).  
The presence of matrix vesicles in the environment of cells embedded in constructs is 
an indication of the active role played by cells in the ossification process. This has been 
an area of intense research in the past years and numerous methods have become 
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available for selecting these nanostructures for further characterisation, each 
presenting various advantages and disadvantages (Li, Kaslan et al. 2017).  
Traditional protocols for selecting these small vesicles involve ultracentrifugation (UC) 
(Hutcheson, Goettsch et al. 2014), which allows the separation of matrix vesicles on the 
basis that larger particles sediment faster, while the smaller particles remaining in the 
supernatant and which can be recovered using further centrifugation steps. In the case 
of matrix vesicles, it is thought that the mineral phase contained by the vesicles 
increases their density such that they pellet at a faster rate (Hutcheson, Goettsch et al. 
2014). Whilst this method can produce a high yield of nanovesicles, the selection of 
nanostructures solely on this basis presents significant disadvantages such the inability 
to remove similar exosomes of equal weight (Safdar, Saleem et al. 2016); deformations 
and damage associated with the centrifugation process, such as exosomal aggregation 
(Chiou and Ansel 2016), which can potentially impact proteomic and RNA content 
analysis (Lamparski, Metha-Damani et al. 2002, Lobb, Becker et al. 2015) as well as 
inconsistencies related to using the same protocol with different rotors (Livshits, 
Khomyakova et al. 2015). Moreover, subsequent characterisation techniques used to 
confirm the nature of exosomes isolated through differential ultracentrifugation, such 
as optical visualisation using TEM, which has been traditionally used to observe these 
structures at high resolution, is not always able to confirm the nature of vesicles due to 
artefacts associated with the sample preparation process for TEM, which causes 
extreme dehydration and collapse to extracellular vesicles (Lobb, Becker et al. 2015, Li, 
Kaslan et al. 2017); and the presence of matrix vesicles lacking a mineral phase (Landis, 
Paine et al. 1977, Landis and Glimcher 1982, Cui, Houston et al. 2016).  
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Therefore, methods which can select nanovesicles based on previously characterised 
markers are more reassuring and appropriate to confirm their presence in the 
mineralising matrix. Markers involved in ossification, abundantly present on the surface 
of these matrix vesicles, such as tissue non-specific alkaline phosphatase 
(TNAP)(Hessle, Johnson et al. 2002, Anderson, Sipe et al. 2004, Ciancaglini, Simao et al. 
2006, Millán and Whyte 2016) can be targeted and used for immuno-isolation using 
standard immunoprecipitation protocols (Wittrup, Zhang et al. 2010, Hussain and 
Davanger 2015). Although a much smaller population can be selected using this 
procedure, it can provide a confirmation of the presence and involvement of these 
vesicles in the biomineralization process.  
Immuno-isolation of matrix vesicles is a straightforward process in-vitro, given the high 
number of osteoblastic cells that can be cultured in 2D. Extracting these vesicles from 
more complex structures, such as 3D-engineered bone, can be more challenging due to 
the smaller number of cells inserted and hence secretome produced. The growth 
medium of engineered bone tissue such as the one described in this thesis is a useful 
source of vesicles which can be collected for analysis.  
 
6.2 AIMS AND OBJECTIVES 
The goal of this work was to further support the role of embedded cells in constructs in 
the mineralisation process by attempting to isolate a small sub-population of matrix 
vesicles from the secretome of cells. The work was based on immunoselection, 
combined with a panel of characterisation techniques that were used to determine the 
role of these nanostructures in biological processes taking place in constructs. This 
chapter presents the results from this work. 
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6.3 CHARACTERISATION METHODS 
 
6.3.1 IMMUNO-ISOLATION OF VESICLES INVOLVED IN MATRIX MINERALISATION 
 
Matrix vesicles were isolated from the culture medium of constructs by 
immunoprecipitation using 2.8 μm superparamagnetic Dynabeads (Invitrogen, Thermo 
Fisher Scientific, CA, USA), covalently coupled to Protein G on their surface (approx. 17 
kDa). Rabbit monoclonal antibodies against Rat Alkaline Phosphatase, Tissue Non-
Specific (TNAP) were used to isolate the vesicles (Abcam, Cambridge, United Kingdom). 
Antibodies were attached to the magnetic beads through their Fc region during a 15 
minutes incubation with rotation at room temperature, at a ratio of 5 μg of Ab/ 200 μl 
PBS containing 0.01% Tween-20 and 0.09% sodium azide, in which 1.5 mg magnetic 
beads were resuspended (Invitrogen, Thermo Fisher Scientific, CA, USA). The complex 
formed was washed by resuspending in 200 μl buffer and 1000 μl of culture medium 
containing the matrix vesicles was added to the formed Dynabeads-Ab complex. 
Samples and complex were incubated for 15 minutes at room temperature, with 
rotation. Following vesicle binding to the antibody, the beads-Ab-vesicle complex 
formed was washed four times using PBS washing Buffer (Invitrogen, Thermo Fisher 
Scientific, CA, USA). The Ab-Vesicle complex was eluted from the beads though the 
addition of 20 μl elution buffer (Invitrogen, Thermo Fisher Scientific, CA, USA). For gel 
electrophoresis, vesicles were resuspended in a loading mixture containing 2.5 μl 
NuPAGE LDS Sample buffer (4X), 1 μl NuPAGE Reducing Agent (10X) (all from Thermo 
Fisher Scientific, CA, USA) and 6.5 μl dH2O and were incubated for 10 minutes at 70°C. 
Samples were loaded onto NuPAGE Novex 4-12% Bis-Tris Protein gels (1 mm thick) and 
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were run at 160 V for 60 minutes using MOPS buffer. 500 μl NuPage Antioxidant 
(Thermo Fisher Scientific, CA, USA) was added to the buffer to maintain the reduced 
state of proteins during protein gel electrophoresis.  A Novex Sharp Pre-stained protein 
standard was used for reference (Thermo Fisher Scientific, CA, USA). For controls, PBS 
was used instead of culture medium and samples were subjected to the same isolation 
procedure and steps.  
 
6.3.2 NANOPARTICLE ANALYSIS USING DYNAMIC LIGHT SCATTERING  
Dynamic light scattering (DLS) using a Zetasizer Nano ZS Instrument (Malvern 
Instruments Ltd, Malvern, United Kingdom) was used to characterize the culture 
medium of young and old constructs at the nano-scale in order to detect the presence of 
extracellular vesicles. 2.5 ml of supplemented medium for cell culture and culture 
medium from young and mature constructs were diluted 1:10 in PBS, inserted into 12 
mm polystyrene cuvettes (Malvern Instruments Ltd, Malvern, United Kingdom) and size 
measurements were taken at a 173 degrees scattering angle, using a RI parameter of 
1.33, at 22°C. A 4mW, 633 laser was passed through the samples. 3 readings were taken 
per sample and averaged to obtain the size distribution of nanoparticles based on 
scattered light intensity.  
 
6.3.3 NANOPARTICLE TRACKYING ANALYSIS  
Nanoparticle tracking analysis (NTA) was performed using a NanoSight LM10 
instrument (Malvern Instruments Ltd, Malvern, United Kingdom), in order to measure 
matrix vesicle size and concentration within the culture medium of constructs. 
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Calibration of the machine was performed using 200 nm polystyrene latex 
microspheres. Culture medium samples from young (14 days) and old constructs (1 
year) were collected and stored at -80°C.  Matrix vesicles were isolated using 
immunoprecipitation and used immediately for NTA.  
Approximately 300 μl of nanovesicles suspended in buffer were injected into the 
NanoSight sample chamber. Control medium samples were diluted 1:10 in PBS prior to 
injection. In-between recordings, loading chamber was washed with 0.2 μm-filtered PBS 
and dH2O for three times. 
Particle detection threshold was set to 8 and camera gain was set to a value of 1. For 
each sample, two NTA videos of 60 seconds duration, containing recordings of the 
nanovesicles moving under Brownian motion, were collected using the NTA 2.2 
software.  Nanovesicles were tracked individually by the software based on scattered 
light when exposed to a 50 μm wide laser. The long-distance scattered light from the 
vesicles was detected by a 20X magnification microscope, connected to the recording 
camera. The matrix vesicles hydrodynamic diameters were calculated using the Stokes-
Einstein equation and concentration was calculated based on volume. Data generated 
by the software concerning size and concentration was averaged to produce the final 
distribution for each sample.  
 
6.3.4 ATP CONTENT  
Mineralisation is an ATP-dependent process and staining for ATP was performed 
directly on the beads to detect its presence using quinacrine dihydrochloride (Orriss, 
Knight et al. 2009, Akopova, Tatur et al. 2012).  Quinacrine dihydrochloride ≥90%, 
produced by Bayer (Sigma – Aldrich, Germany), was reconstituted using deionised H2O 
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(dH2O ) and was used at a concentration of 10 μM, based on previous research (Loncar, 
Zotz et al. 2007). Following isolation, 750 μl of the bead-antibody-vesicle complexes and 
controls (beads-antibody complexes, dH2O was used instead of culture medium) were 
incubated with the dye for 30 minutes at room temperature. Following incubation, the 
beads were washed 4 times with dH2O and samples were imaged using an Olympus 
Fluoview FV1000 confocal laser scanning microscope (Olympus, Tokyo, Japan) 
equipped with a multi-line argon laser FV5-LAMAR/LAMAR-2 and a Helium-Neon 
Green Laser FV5-LAHEG-2/FV5-LAHEG. Images acquired from excitation at a 
wavelength of 405 nm were collected using the Fluoview FV10-ASW software, version 
4.2 (Olympus, Tokyo, Japan) with an exposure time of 20 μs/pixel,  
 
6.3.5 OSTEOCOMPETENCY 
An experiment was conducted to determine the ability of these vesicles to interact with 
a bone-like extracellular matrix composed of collagen I.  Matrix vesicles bound to the 
monoclonal antibody against TNAP were eluted from the beads using the procedures 
described above using 20 μl elution buffer (Thermo Fisher Scientific, USA) and were 
added to 300 μl TBS buffer. 100 μl of the re-suspended vesicles were applied in 
triplicate to 1.9 cm2 wells in 24 well plates coated with collagen I (Gibco, Life 
Technologies, Thermo Fisher Scientific, USA) to determine whether the vesicles would 
be able to bind to collagen type I.  Antibody-vesicle complexes were incubated in the 
plates for 30 minutes at room temperature, followed by a further incubation step at 
37oC for 30 minutes to partially simulate the physiological context. To be able to detect 
the amount of binding, a secondary antibody against the rabbit monoclonal primary 
antibody was used. Following incubation, wells were washed three times with TBS to 
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remove the unbound vesicles. Secondary donkey anti-rabbit antibodies conjugated to 
Alexa Fluor 488 fluorophores, were diluted to 10 μg/mL in TBS containing 1% BSA and 
100 μl were applied in triplicate to the bottom of the wells and left to incubate for 1 
hour at room temperature. Following incubation, tissue sections were washed three 
times with TBS for 1 minute. In order to check for non-specific antibody binding, the 
steps listed above were performed on additional wells, in triplicate without the addition 
of the primary antibodies. Samples were imaged using the confocal system described 
above, using a 10x objective lens. Images acquired from excitation at a wavelength of 
488 nm in triplicate for the samples, controls and antibody controls. Data was collected 
using the Fluoview FV10-ASW software, version 4.2 (Olympus, Tokyo, Japan). 
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6.4 RESULTS AND DISCUSSION 
MV outer membranes have been demonstrated to be rich in tissue non-specific alkaline 
phosphatase (TNAP), a form of ALP involved in skeletal mineralization and ectopic 
calcifications (Hessle, Johnson et al. 2002, Ciancaglini, Simao et al. 2006, Golub 2009, 
Golub 2011, Cui, Houston et al. 2016). Deactivating defects in the TNAP gene have been 
shown to cause hypophosphatasia (Mornet 2000, Hessle, Johnson et al. 2002, Millán and 
Whyte 2016), leading to rickets, osteomalacia, spontaneous fractures (described in 
Chapter 1). At a molecular lever, these mutations cause elevated levels of  extracellular 
inorganic pyrophosphate (PPi), a natural substrate of TNAP which is a potent inhibitor 
of mineral formation (Millán and Whyte 2016). TNAP is present in abundance on the 
membrane of matrix vesicles (Golub 2011) and as such was targeted for 
immunoisolation. 
Figure 6.1 presents a schematic of the immuno-isolation system used to purify a 
population of nanostructures with similar characteristics to matrix vesicles. The method 
involved building an isolation complex by coupling TNAP monoclonal IgG antibodies 
(Ab) to recombinant protein G (17 kDa) which was covalently bound to the surface of 
2.8 μm superparamagnetic beads (MBs). During a 15 minutes incubation at room 
temperature in PBS-Tween 20, the antibodies became bound via their Fc regions to the 
beads, leaving the Fab regions on the antibodies available to bind TNAP on the outer 
surface of vesicles.  
As the constructs underwent ossification (Figure 6.2a), secretome analysis was 
performed on culture medium collected from early (14 days), mature constructs (1 
year) and controls to compare the normal distribution of nanoparticles. The medium 
was subjected to dynamic light scattering analysis (DLS) to obtain an account of the size 
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distribution of nanoparticles in the growth medium, and compared to cell-free 
supplemented culture medium (Figure 6.2b-c). Interestingly, both the early and mature 
culture medium contained nanoparticles in the size range of 50 nm to 300 nm 
compared to controls (serum supplemented but cell-free medium), which corresponds 
to the range in which previously described matrix mineralization vesicles were detected 
(Anderson 1969, Bonucci 2007, Golub 2009). These nanoparticles were particularly 
abundant in older constructs (1 year). This may be evidence for a sustained population 
of mineralising osteoblasts during the lengthy culture period, as osteocytes have 
differentiated away from a primary secretory phenotype and have a more limited ability 
to mineralise compare to osteoblasts. 
To determine whether this set of cell-secreted exosomes contained a sub-population of 
matrix vesicles involved in skeletal mineralization, the immuno-isolation procedure was 
used to separate this subset of vesicles from the rest of the exosomes. The isolation 
procedure involved incubating 1000 μl of culture medium with the Ab-MB complex 
(Figure 6.2d) for 15 minutes at room temperature, in PBS-Tween-20. During this 
incubation, the Ab-MB complexes attached to the surface of vesicles via Fab-TNAP 
binding (e). The remaining debris and unbound vesicles were removed by magnetic 
separation (f). The Ab-MV complex was subsequently eluted from the beads and used 
with different analytical techniques. 
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Nanoparticle tracking analysis (NTA) performed on isolated matrix vesicles and non-
purified construct medium samples (Figure 6.3a-b), indicated that it was possible to 
isolate a small population of TNAP-containing nanostructures with sizes in a much 
narrower range than the ones present in the growth medium. The highest 
concentrations were those of particles which ranged in size from 100-200 nm (Figure 
6.3b). This corresponds to the range in which previously described matrix 
mineralization vesicles were detected by previous authors (Anderson 1969, Golub 
2009, Golub 2011, Cui, Houston et al. 2016).  
When denatured under SDS-gel electrophoresis, MV-IgG complexes eluted from the 
beads separated into several fractions (Figure 6.3c). The TNAP band can be observed as 
a dimer between 80-110 kDa (Ishida, Komaru et al. 2011, Satou, Al-Shawafi et al. 2012), 
further supporting these results. IgG bands appeared at around 170 kDa, as confirmed 
by controls, and fractions of other, unidentified proteins belonging to matrix vesicles 
appeared between 110-160 kDa. 
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Figure 6.3 | Characterisation of immuno-selected vesicles. a, Nanoparticles, visualised in real-time exclusively using NTA. Controls (sterile PBS) do 
not contain any nano-particles. The growth medium of constructs contains an abundance of nano-particles, whereas the buffer containing the isolated 
vesicles contains a very small population of particles. Positive controls (200 nm polystyrene beads) are provided for comparison. b, The small 
population of purified vesicles contains particles of sizes in a much more narrow range than total exosomes in construct medium. Vesicles ranging 
between 100-200 nm are particularly abundant. c, When denatured using SDS-PAGE, the Ab-MV complexes separate into several fractions, which 
include the TNAP protein dimer (80-110 kDa), the IgG antibody (170 kDa) and several unidentified protein fractions belonging to matrix vesicles (110-
160 kDa).  
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TNAP is the major phosphatase of MVs which regulates the generation of extracellular 
Pi from ATP (Hessle, Johnson et al. 2002, Cui, Houston et al. 2016).  These vesicles can 
maximally initiate the deposition of calcium in the presence of ATP (Hsu and Anderson 
1978). Therefore, the potential existence of ATP with the vesicles could be indicative of 
an active role of these structures in the mineralisation process of constructs. Its 
presence in matrix vesicles was tested using quinacrine dihydrochloride staining and 
was imaged indirectly using confocal microscopy of beads (Figure 6.4a).  The beads 
which contained the selected matrix vesicles showed a higher amount of fluorescence 
compared to controls (beads bound to the antibody-only) (Figure 6.4b).  
The role of these vesicles was probed further by assessing their osteogenic potential, or 
their ability to bind a bone-like extracellular matrix. This was tested by incubating the 
eluted vesicle-antibody complexes from the beads to collagen I-coated surfaces. Matrix 
vesicles have been shown to bind to collagen type I, II and X (Wu, Genge et al. 1991) and 
collagen I has been shown to induce the vesicle-mediated mineralisation of articular 
cartilage embedded in agarose-collagen hydrogels (Jubeck, Gohr et al. 2008). 
 The amount of binding of matrix vesicles to collagen was detected by applying a 
fluorescently-labelled secondary antibody against the primary antibodies.  Results are 
presented in Figure 6.5b and show a striking difference between the MVs-incubated 
collagen surfaces and controls. The purified vesicles showed a high degree of binding to 
the collagen matrix, which can be distinguished due to its typical morphology. Eluted 
antibodies targeted with secondary antibodies and secondary antibodies alone showed 
a very small degree of non-specific binding. 
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Figure 6.4 | Isolated MVs contain ATP. a, Mineralisation is an ATP-mediated process. ATP is transformed by membrane-bound 
TNAP on the surface of vesicles into Pi. ATP on vesicles was labelled using quinacrine dihydrochloride and visualised indirectly 
using confocal microscopy, where it was detected as blue fluorescence from the beads. b, Purified MVs and controls were stained 
directly on the magnetic beads using quinacrine dihydrochloride. Controls contained the bound antibody but were treated with 
dH2O as opposed to culture medium. All images were acquired under the same conditions and settings. Some degree of background 
staining can be observed in control beads. The vesicle-bound beads show a higher amount of fluorescence, indicating the presence 
of ATP associated with the MVs. 
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Figure 6.5 | Isolated matrix vesicles show a high degree of osteocompetency. The TNAP-bound vesicles have the ability to bind 
collagen type I (top row), whereas TNAP antibodies alone (post-elution, centre) show a small degree of non-specific binding. The 
binding of vesicles and controls to collagen I was detected using secondary antibodies conjugated to Alexa Fluor 488. These 
secondary antibodies showed a small amount of non-specific binding to the collagen I matrix in the absence of sample/control 
(bottom). Images were acquired using the same settings and conditions. Scale bar = 100 μm. 
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CHAPTER VII 
ADMINISTRATION OF OSSIFFICATION-INHIBITING COMPOUNDS 
 
 
 
7.1 INTRODUCTION 
As discussed in previous chapters, the ability to simulate mature bone at multiple levels, 
including chemical composition, architecture and mature bone cell differentiation, 
provides the opportunity to apply this system to different research areas where in vivo 
research is in early stages or too complex. Such areas include toxicology and 
pharmacology and therefore, application of various chemical compounds to this system 
could provide meaningful results. The interaction between these chemicals and the 
mature bone tissues was of interest because if successful, this system could provide a 
screening or testing platform for novel compounds. 
Chapter 1, section 1.11.4 describes the current agents used to manage and prevent 
heterotopic bone formation, as well as their advantages and limitations. 
A pilot study over 3 weeks in culture was conducted in order to test novel compounds 
that can inhibit the ossification process, obtaining promising results. Two promising 
compounds were selected, CD1530, a nuclear retinoic acid receptor gamma agonist 
(RAR-γ) that has been increasingly used recently in treating both the acquired and 
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congenital forms of heterotopic ossification (Kaplan and Shore 2011, Shimono, Tung et 
al. 2011), and LDN193189, which is a selective inhibitor of the BMP type I activin 
receptor-like kinase ALK2, ALK3 (Figure 7.1), and a weak inhibitor of ALK 4 and ALK7 
and which has been successfully used to reduce heterotopic ossification in transgenic 
murine models of Fibrodysplasia ossificans progressiva (Yu, Deng et al. 2008). RAR-γ 
agonists like CD1530 are thought to inhibit the formation of ossification in early stages, 
at the pre-chondrogenic and chondrogenic stages. They also act by blocking BMP-2 
signaling, reducing the skeletogenic potential of osteoprogenitor cells and reduce 
phosphorylation of signaling effectors SMAD 1, SMAD 5 and SMAD 8, thus preventing 
the subsequent mineralization steps. Similarly, LDN193189 also reduces activation of 
the BMP signaling effectors, in particular SMAD1, SMAD5 and SMAD8 (Yu, Deng et al. 
2008). 
 
 
 
Figure 7.1 | Application of two ossification-inhibiting compounds to constructs. Two novel drugs were selected based on recent advancements. 
The first compound, CD1530 is a retinoic-acid-γ receptor agonist that has been recently tested with multiple types of heterotopic ossification; while 
LDN 193189 is an inhibitor of the BMP mineralisation pathway, acting as a selective inhibitor of the BMP type I activin receptor like kinase ALK2 and 
ALK3.  
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7.2 AIMS AND OBJECTIVES 
The goal of this work was to determine whether heterotopic ossification drugs can 
prevent the advancement of ossification in constructs. This was performed to 
demonstrate the system’s potential as a drug screening platform and to offer further 
evidence on the central role of cells in the ossification process.  
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7.3  CHARACTERISATION METHODS 
 
7.3.1 CONSTRUCT DEVELOPMENT 
Constructs were developed using the procedures described in Chapter 2, using newly-
extracted femoral periosteal cells which were derived from euthanised 3 weeks-old 
Wistar rats and cultured until confluency. Cells were applied to constructs using the 
procedures described in Chapter 2 and allowed to contract for 7 days before 
supplementation. 
 
7.3.2 CD1530 AND LDN193189 SUPPLEMENTATION 
RAR-γ agonist CD15030 and ALK2/3 inhibitor LDN193189 were administered in the 
culture medium of constructs at a concentration of 1 μM and 25 nM, respectively. 
Starting with day 7 of culture, constructs received one dose every two days (6 doses 
total) of either CD1530 or LDN193189. Controls received an equivalent amount of 
DMSO, which was used in drug dissolution. 3 constructs were collected for analysis at 
each time point from each group (Control, CD1530 and LDN193189). The experiment 
was terminated at day 22. 
 
7.3.3 VOLUMETRIC ANALYSIS USING MICRO-COMPUTED TOMOGRAPHY  
As these constructs were younger (7-21 days) compared to our most mature constructs 
(3 months-1 year) and hence less ossified and dense, acquisition settings were adjusted 
for this study to an X-Ray voltage of 50 kV and a tube current of 100 μA; an image pixel 
 
 
 
 
 191 
size of 13 μm, with an exposure time of 510 ms, a rotation step of 0.4 degrees and a 
frame averaging value of 2. Flat field correction was performed for image clarity and no 
ring artefact correction was applied.  
Transfer functions were created in the CTVox software that allowed segmentation of the 
high-density matrix components, as well as for creating colour-coded versions of the 
components in the constructs. The same transfer function was used for all constructs in 
the same group of investigation.  
Volumetric quantification of the mineral component was performed using 
morphometric analysis in the CTAn software (v. 1.13). 200 slices from equivalent 
regions in the central portions of control and drug treated constructs were isolated and 
a threshold of 220-255 was applied to segment the high-density mineral component. 3D 
analysis of the segmented volume was performed and data was averaged to obtain the 
final volume in mm3. 
 
7.3.4 STATISTICAL ANALYSIS 
Measurements were acquired in triplicate and/or from a sample number of 3 
constructs, unless otherwise indicated in the text. Raw data was not pre-processed 
(normalised/transformed) unless indicated otherwise. All data is presented as mean ± 
SD. Statistical analysis was performed using a one-tailed distribution t-test, with a 
heteroscedastic variance assumed. A p value lower than 0.05 was chosen for 
determining significance (MS Excel, Washington, USA). Percentage difference was 
calculated using the formula X = (A-B)/A*100. 
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7.4 RESULTS AND DISCUSSION 
Volumetric analysis performed using morphometric CT analysis revealed that treatment 
with compound CD1530 prevented the advancement of ossification towards the center 
by 99% compared to controls in the 21 days study (Figures 7.2-7.3). Similarly, the 
second compound tested, LDN193189, was effective in reducing the mineralized matrix 
volume centrally by 70% compared to controls, confirming the results seen when RARs 
were administered (Figures 7.2-7.3).  
The fact that CD1530 caused a bigger reduction in the progression of ossification is very 
interesting, as this drug is thought to prevent bone formation at the chondrogenic stage 
(Baird and Kang 2009, Shimono, Tung et al. 2011).  
The marked reduction in matrix volume following administration of these compounds 
was further confirmation that mineralization takes place through a cell-mediated route, 
as encountered during normal long bone formation, fracture repair, and heterotopic 
ossification (Kaplan and Shore 2011). It also demonstrates the system’s potential as a 
drug screening tool, meaning that it could act as an intermediate between in vitro and in 
vivo research and that it could potentially reduce the number of animals used for 
skeletal research. 
In vitro testing is currently used as a first-stage method for assessing the toxicity and 
compatibility of drugs and implants with different physiological systems, and can avoid 
the unnecessary use of animals in the testing of cytotoxic or incompatible materials. 
Whilst this method is the most suitable for standardization and quantification, giving 
more reproducible results in some cases compared to in vivo testing,, there are 
numerous problems with in vitro testing of pharmacological and other compounds 
(Pearce, Richards et al. 2007). 
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Figure 7.3 | Ossification – inhibiting compounds decrease matrix and mineral formation in constructs. Comparison of the 
mineral volume located in the central portion of constructs following 21 days of culture, quantified by morphometric CT analysis. 
Constructs treated with CD1530 showed an average of 99% less mineral in this region compared to controls, which was statistically 
significant, whereas the group treated with LDN193189 showed 70% less mineral, although not significant. Data is presented as 
means ± SD. *p < 0.05, n=3. 
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First of all, the cell-response extracted from the results of in vitro testing, often referred 
to as ‘biocompatibility’ is most of the time incorrect, as this type of cell culture is 
focused on the behavior of individual cells, which are not organized into complex 
tissues, and as such, these tests cannot demonstrate whole-tissue response to drugs, 
biomaterials and implants. In these situations, ‘cytotoxic’ and ‘genotoxic’ effects are 
more suitable terms (Hanks, Wataha et al. 1996, Pearce, Richards et al. 2007, Li, Zhou et 
al. 2015). 
Secondly, the response of isolated cells to drugs and toxic compounds can be much 
greater than in vivo, meaning that the effect of these compounds can be overestimated. 
This, together with the short lifespan of cells means that the investigations are limited 
to the acute, short-term effects of these compounds (Hanks, Wataha et al. 1996). 
Thirdly, there can be a great variability between cells of different passages and between 
cells of the same type of cell line, meaning that some cells within an experiment can be 
less responsive to some compounds, as noted with metal ions from dental materials 
(Wataha, Hanks et al. 1994).   
Lastly, it is difficult to control the behavior of cells in vitro and to simulate the 
organization and cellular interactions found in vivo. For this reason, animal models have 
remained essential for evaluating biocompatibility, whole-tissue and systemic response 
and mechanical function under chemical and mechanical stress. 
The model developed in this thesis provides the advantage of an in vitro system in terms 
of reproducibility and flexibility as well as adaptability, but with a biological complexity 
more similar to in vivo testing. These features are, to the best of my knowledge, unique 
to date. The system offers a number of additional advantages, such as the ease of 
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implementation in general cell laboratories and therefore could potentially reduce the 
unnecessary use of animals for preliminary pharmacological and toxicological research.  
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CHAPTER VIII 
FURTHER APPLICATIONS OF THE SYSTEM AND 
VASCULARISATION OF CONTRUCTS 
 
 
 
8.1 INTRODUCTION 
One of the principal advantages of this system compared to previous models is its 
flexibility and compatibility with cells of different origins, both primary and 
immortalised lines, derived from different species. Unlike pre-made connective tissue 
scaffolds which provide temporary structural support to cells when implanted into the 
affected tissues, this system provides a temporary scaffold which allows cells to 
produce their endogenous matrices. The versatility of this system makes it possible to 
develop constructs resembling other tissues of the musculo-skeletal system, including 
tendons, ligaments and cartilage.  Moreover, it would be possible to generate 
personalised tissues using the patient’s own cells and with human-derived components 
(Meijer, de Bruijn et al. 2007), created using either commercially available fibrinogen 
and thrombin or extracted from the patient’s plasma. The results presented in this 
chapter represent exploratory work performed to demonstrate these aspects in order 
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to further support the biological relevance of this model, its potential impact in 
regenerative medicine and its applicability for the study of different connective tissues.   
 
8.2 AIMS AND OBJECTIVES 
Experimental work was undertaken to determine the viability and compatibility of cells 
from different musculo-skeletal origins with the fibrin constructs. Their development 
was observed and recorded, including advantages and disadvantages for each system. 
The second goal was to develop a ‘vascularised bone’ model by attempting to form 
endothelial tubes in constructs and to optimise a culture system for a mixed 
osteoblastic-vessel construct model. 
The final aim of this thesis was to perform a preliminary scoping exercise to create 
other analogous skeletal structures, such as the vertebral column.  
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8.3 CHARACTERISATION METHODS 
 
8.3.1 TENDON CONSTRUCTS 
Tendon-like constructs were developed using a cell line of avian-derived tendon 
fibroblasts (CTFs) using the standard methodology described in Chapter 2. Cells had 
been previously isolated from the flexor tendons of 13 days-old chick embryos using 
collagenase type-II digestion and recovery using 100 mm cell strainers (BD Biosciences, 
United Kingdom). They were frozen and thawed using the procedures listed in Chapter 
2 and were then cultured in standard DMEM containing 10% FBS and 1% P/S (Thermo 
Fisher Scientific, USA).  
 
8.3.2 CARTILAGE CONSTRUCTS 
Cartilage constructs were developed using the standard procedures described in 
Chapter 2.  
 
8.3.2.1 CHONDROCYTIC CELLS 
Human primary chondrocytes were derived from tissue obtained from the Oxford 
Musculoskeletal BioBank and was collected with informed donor consent in full 
compliance with national and institutional ethical requirements, the United Kingdom 
Human Tissue Act, and the Declaration of Helsinki. 
 2-5 cm cartilage tissue sections were excised following surgery, minced with a blade 
prior to overnight digestion in collagenase, followed by plating in sterile, 90 mm 
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diameter polystyrene petri dishes containing 25 ml DMEM - F12 growth medium, 
supplemented with 10% FBS and 1% P/S (all from Lonza, Basel, Switzerland).  
 
8.3.2.2 HUMAN FIBRIN SCAFFOLDS 
Unlike previous constructs, the fibrin scaffolds developed for use with human-derived 
chondrocytes were built using human-derived fibrinogen and thrombin (Sigma-Aldrich, 
Germany).  
Following isolation from Petri dishes, cells were seeded into these scaffolds and 
contraction was monitored over three weeks of culture. At the end of the three weeks, a 
regime of chondrogenic supplementation was administered to half of the constructs, 
whereas the remaining half continued to receive the normal DMEM-F12 
supplementation.  
 
8.3.2.3 PRO-CHONDROGENIC SUPPLEMENTATION 
The supplementation regime consisted of a combination of pro-chondrocytic factors, 
which were part of a hMSC Chondrogenic SingleQuots Poietics kit (Lonza, Basel, 
Switzerland). The final supplementation medium consisted of 10% FBS, 0.1% 
gentamicin sulphate - amphotericin-B, 2.16% L-glutamine, 1.08% proline, 1.08% 
ascorbate, 1.08% sodium pyruvate, 1.08% insulin-transferrin-selenium 
supplementation and 0.54% dexamethasone. In addition to these components, TGF-β3 
(Lonza, Basel, Switzerland), was added with each feed. TGF-β3 was prepared by 
resuspending the lyophilized powder in sterile 4mM HCl supplemented with 1 mg/ml 
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BSA to a concentration of 20 μg/ml. TGF-β3 was added at a ratio of 0.5 μl per ml of 
chondrogenic feeding medium. 
Supplementation was administered for one month, which was the point when visual 
differences were observed between the groups.  
 
8.3.2.4 WHOLE MOUNT HISTOLOGICAL STAINING FOR CARTILAGE 
Whole-mount histological staining for cartilage using Alcian Blue was performed to 
detect the presence of sulphated proteoglycan-rich matrix in the supplemented and the 
non-supplemented groups. 
Constructs were removed from culture, rinsed with 2 ml PBS twice for 5 seconds and 
fixed with 2 ml standard Bouin’s fluid for 5 hours at room temperature. The fixation 
fluid was then aspirated and constructs were washed with dH2O for 15 minutes. 
Constructs were then stained with Alcian Blue (1%, pH 2.5 in acetic acid) for 1 hour at 
room temperature. Constructs were gently washed with 70% EtOH to remove excess 
dye and photographs were taken of constructs in each group. 
 
8.3.3 ANGIOGENESIS IN CONSTRUCTS 
Endothelial tubes were formed in constructs using a population of commercial Human 
Umbilical Vein-derived Endothelial Cells (Cell Applications Inc, San Diego, CA, USA). 
Cells were cultured using the procedures described in Chapter 2, in Endothelial Basal 
Medium (EBM-2, Lonza, Basel, Switzerland) containing 10% FBS and 1% P/S. 
Constructs were developed using the standard procedures described in Chapter 2.  
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Constructs were allowed to contract for 7 days. A regime of angiogenic supplementation 
was commenced following contraction in order to initiate blood vessel formation. 
Supplementation components were part of a Clonetics EGM-2 SingleQuots kit (Lonza, 
Basel, Switzerland). The final supplementation medium consisted of 2% FBS, 0.1% 
Gentamicin Sulfate Amphotericin-B, 0.1% ascorbate, 0.4% pro-angiogenic factor 
Recombinant Human Fibroblast Growth Factor – B (rhFGF-B), 0.1% pro-angiogenic 
factors Vascular Endothelial Growth Factor (VEFG), Human Recombinant Epidermal 
Growth Factor (hrEGF) in buffered BSA saline solution, heparin and recombinant long r 
insulin- like growth factor-1 (R3-IGF-1) and 0.04% hydrocortisone.   
Images of forming tubes in whole constructs were acquired using a CETI Inverso TC100 
brightfield microscope (Medline Scientific, Oxon, United Kingdom). 
 
8.3.4 MIXED ENDOTHELIAL-BONE SYSTEMS 
Co-cultures of HUVECS and 2T3 cells were developed using the methodology described 
previously by encapsulating equal numbers (50.000 cells from each population) in 
constructs. The culture medium used consisted of equal parts of MEM α and angiogenic 
EBM-2.  Images of viable endothelial tubes were acquired using Two-Photon Excitation 
Fluorescence using the procedures described in Chapter 5. 
 
8.3.5 VERTEBRAL DISK CONSTRUCTS  
To prove this concept, spinal ‘discs’ were developed by dispersing mouse mesenchymal 
stem cells in fibrin gels using the procedures described previously. 3D models of 
human-size vertebra (approximately 65 mm3) were acquired online and down-scaled to 
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approximately 15 mm3 to fit the size requirements for culture into standard 35 mm2 
dishes.  For this initial study, the vertebras were 3D printed using standard plastic 
material from the shape of the ninth thoracic vertebra. Custom moulds were taken of 
this vertebra and were filled with a liquid brushite-TCP mixture, as described in Chapter 
2. 
Anchors were placed in the centre of sterilised, Sylgard-coated 6-well dishes and fibrin 
gels were formed in the dishes using the standard procedures. Stem cells were 
dispersed into the scaffold and allowed to contract the matrix for a duration of 2 weeks 
(stem cells contract the matrix slower). During the contraction time, the vertebral 
‘anchors’ served as single retention points around which the cells organised a ‘disk-like’ 
structure. Following a month and 5 days of culture, the individual vertebra containing 
their attached soft tissues were assembled together to form a spinal-like structure. The 
gels were allowed to fuse with the neighbouring vertebra for a period of approximately 
one month, during which the matrix also became progressively replaced with 
mineralised collagen, thus mimicking the ossified spine, or ‘bamboo’ spine encountered 
in degenerative conditions such as Ankylosing Spondylitis.  
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8.4 RESULTS AND DISCUSSION 
 
8.4.1 TENDON CONSTRUCTS 
Constructs developed with fibroblastic cells contract very quickly compared to 
osteoblastic cell constructs and assemble into tendon-like 3D structures as early as 7 
days. Figure 8.1a provides an example of a 6 months old, mature construct. Different 
versions of these constructs have been developed in this research group over the past 
years, containing modifications such as stainless-steel pin-anchors, titanium anchors 
and spring reinforcements and chemically adjusted brushite anchors. These constructs 
were very well characterized biomechanically and biochemically and several papers 
describe extensive research conducted in this group in this area (Paxton, Donnelly et al. 
2010, Paxton, Wudebwe et al. 2012, Lebled, Grover et al. 2014, Wang, Williams et al. 
2016).   
 
8.4.2 CARTILAGE CONSTRUCTS 
Figure 8.1b-c illustrates examples of constructs developed with chondrocytic cells, 
which have been stained with Alcian Blue to detect the presence of cartilage. Firstly, this 
work demonstrates a successful model composed of human-only components. Secondly, 
the work demonstrates the successful maintenance of the chondrocytic phenotype in 
constructs after 2 months of culture and following a regime of pro-chondrogenic 
supplementation. Figure 8.1c illustrates a representative example of a construct which 
has undergone TGF-β3 and ITS supplementation (left) compared to a control (right). 
The amount of cartilage produced in the system is higher in the supplemented 
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construct. In addition, supplemented constructs appeared to be much stiffer, supporting 
their own weight and survived the histological processing very well compared to the 
untreated group, which underwent shrinking. As seen in bone constructs, higher 
amounts of matrix form around the edges, forming a similar ‘periosteal collar’ (Mackie, 
Ahmed et al. 2008).   
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Figure 8.1 | Development of other connective tissues. a, 6-months old construct developed using chick tendon fibroblasts, 
showing a tendon-like 3D structure. b, Example of a construct developed with human chondrocytes and human-derived matrix 
components, and which has been fixed with Bouin’s fluid (yellow, not visible) and stained with Alcian Blue for cartilage detection. c, 
examples of constructs which have undergone pro-chondrogenic treatment (left) vs. control (right). Constructs supplemented with 
ITS and TGF-β3  develop more matrix (blue) compared to control (green-blue), are more still and more resilient to histochemical 
processing compared to controls, which undergo shrinking. 
 
 
 
 
 207 
8.4.3 ANGIOGENESIS IN CONSTRUCTS 
Endothelial tubes were successfully demonstrated to grow in constructs aligned with 
the mechanical axis. Figure 8.2 (left) contains an image of a 3 month-old construct, 
reconstructed from multiple images acquired using a brightfield microscope. Constructs 
were supplemented with rhFGF-B, VEFG, hrEGF and R3-IGF-1 for 2 months following 
contraction to maintain the cellular phenotype and encourage the formation of micro-
vessels. The endothelial tube networks were well developed on the surface of 
constructs (Figure 8.2 middle right) and were part of larger vessel-like structures with 
diameters ranging from 50 -200 μm (bottom right).  
The ability to initiate aligned vascularization in constructs brings the model closer to 
producing a mature bone system with further similarities to in vivo bone (Marenzana 
and Arnett 2013) and could provide a valuable tool for assessing the role of 
angiogenesis in traumatic heterotopic ossification (Cocks, Mohan et al. 2017).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 208 
 
 
 
 
Figure 8.2 | Endothelial tubes resembling microvasculature align with the mechanical axis in constructs. Large image (left) 
has been reconstructed from multiple brightfield images and shows endothelial tubes branching along the axis of constructs. When 
observed in a 2D plane (middle right), these cells established complex networks which connect to larger tubes, with diameters 
ranging between 50-200 μm, as seen through a cross section using TPEF (bottom right). Scale bar = 200 μm. 
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8.4.4 MIXED ENDOTHELIAL-BONE CONSTRUCTS 
A mixed cell system was developed containing co-cultures of osteoblastic cells and 
endothelial cells to determine whether a vascularised bone model could be produced. 
Figure 8.3 presents examples a comparison of cellular morphologies in groups of 
constructs developed with either 2T3 osteoblastic cells, HUVECS or a combination of the 
two. 2T3 cells in constructs showed an osteoblastic morphology while HUVEC cells, as 
described above, were able to assemble into micro-vessels as described previously in 
vitro (Naik, Mousa et al. 2003, Chen, Htay et al. 2009).  Constructs developed with both 
types of cells showed tubular structures co-localised with osteoblastic looking cells. 
 
 
 
 
 
Figure 8.3 | Osteoblastic and vascular cell morphology in individual and mixed-cell constructs. 2T3 cells (left) attached to the 
matrix and showed a typical osteoblastic morphology, while HUVECS (centre) were able to assemble into tubular structures of 50-
200 μm in dimeter. Constructs containing co-cultures of these cell populations showed both types of cell morphology, with 
endothelial tubes forming adjacent to osteoblastic cells. 
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8.4.5 VERTEBRAL DISKS CONSTRUCTS 
Figure 8.4 shows an example of the assembly process of spinal constructs. Phosphate 
vertebra are individually placed at the bottom of Sylgard-coated 35 mm2 wells (Figure 
4a). Fibrin gels containing a population of MSCs are formed around the vertebra and 
allowed to contract fully for 14 days – 1 month. They are assembled together into the 
spinal structure and discs are allowed to fuse with the neighbouring vertebra over an 
additional month, until the structure can support its own weight (Figure 8.4b). Over 
time, the matrix changes in a similar way as observed with regular bone constructs.  
This work demonstrated that it is possible to simulate a vertebral-column-like structure 
and further optimisation work should be carried out to enhance the fusion process and 
the design.  
The spinal model could be further developed by encapsulating a population of 
intervertebral disk cells (Johnson and Roberts 2003, Erwin and Hood 2014), which are 
commercially available from a few scientific suppliers, or developing an isolation 
protocol for extraction from murine spinal discs. Composite hydrogels which can 
further simulate the biochemical nature (fibrocartilaginous composition) and structure 
(annulus fibrosus and nucleus pulposus) of vertebral disks (Mizuno, Roy et al. 2004) 
could be used instead of fibrin, such as mixed type I-II collagen gels/fibrin (Yang, Seol et 
al. 2007).  
Similar analysis can be undertaken to characterise the ossification process in ‘spinal’ 
soft tissue, including micro-CT, and histology-immunohistochemistry of individual discs. 
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Figure 8.4 | A tissue-engineered model of pathological bone formation in spinal soft tissue where calcium phosphate 
“vertebrae” are connected with fibrin gels encapsulating a population of stem cells. a, Fibrin gels encapsulating stem cells are 
formed around phosphate vertebra. Over time, these gels attach strongly to the anchoring material and contract, giving rise to a 
disk-like structure after approximately 14 days. b, The individual ‘vertebra’ with soft tissue attached to them are assembled 
together into the spinal structure and gels are allowed to connect to the adjacent vetrebra over the subsequent 3-4 weeks until the 
structure can support its own weight.  Over time, the fibrin is replaced with mineralised collagen and the resulting structures mimic 
the complex cellular organisation of real bone. These culture systems can be used to study pathological bone formation or to trial 
new therapies. 
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 A tissue-engineered model of pathological bone formation in spinal soft tissue where calcium phosphate “vertebrae” are connected with fibrin gels    
 encapsulating a population of stem cells. 
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CHAPTER IX 
FINAL CONCLUSIONS 
 
 
 
 
 
This work demonstrates how simple homogeneous materials (fibrin) may be structured 
and modified by populations of cells to create complex tissues by making relatively 
simple geometrical and chemical modifications to the culture system.  The composition 
of the tissues was probed using a suite of chemical analysis techniques that allowed the 
identification of the distribution and local organisation of matrix components.  
After even short periods of culture, the tissues were shown to be heterogeneous in 
composition and structure, with collagen and mineral distributed in spatially distinct 
regions.  Importantly, the Raman spectral data suggested that the mineral deposited 
within the tissue was associated with collagen as opposed to precipitated on the surface 
of the tissue. The mechanism of tissue formation recapitulated several stages of 
development of a fracture callus and the distribution of collagen and mineral within the 
tissue was similar to that found in mouse femoral bones. 
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This model allowed for the production of a complex bone-like tissue in vitro, which 
exhibits features typical of native bone, including a canalicular network populated with 
mature osteocytes. From longitudinal analysis, it was demonstrated that the tissues 
form through the differentiation of periosteally-derived stem cells into a heterogeneous 
population of cells that ultimately lay down a mineralised collagenous matrix with 
composition similar to native bone. This work is of considerable significance since it 
was possible to produce mature bone-like tissue and to maintain cultures of osteocytes 
within it for periods of up to 1 year. This is remarkable since the osteocytic phenotype is 
extremely hard to maintain in culture for longer than one month. This work 
demonstrates that by providing cells with the right microenvironment, they can build a 
complex matrix more representative to the endogenous tissues and as such they can be 
cultured for significant amounts of time. This work further demonstrated the 
physiological relevance of this model by blocking the bone formation process using a 
RAR inhibitor that is known to inhibit bone formation in vivo by preventing 
chondrogenesis as opposed to directly inhibiting mineralisation. 
This model will help to fill the gaps between basic research and human applications and 
will provide insights into bone formation and pathological conditions which may have 
an influence beyond this field of research. This system can serve as template for further 
explorations, which could pave the way to organogenesis in vitro, reducing the number 
of animals used in research and screening of drugs prior to in-vivo or human studies. 
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CHAPTER X 
FURTHER WORK 
 
 
10.1 CHOICE OF HYDROGELS 
Additional experiments could be performed for comparison by substituting the fibrin 
matrix with a pre-made collagen scaffold in order to observe the dynamics of collagen 
remodelling. The first motivation is that collagen matrices have different mechanical 
properties (Rhee and Grinnell 2007, Grinnell and Petroll 2010, Provenzano, Eliceiri et al. 
2010, Song, Olsen et al. 2010) compared to fibrin and that will have an influence on the 
differentiation and activity of embedded cells. It would be expected that the degree of 
contraction and modelling seen in this system would be low or absent when using 
collagen matrices, as they are not as flexible as fibrin (Ngo, Ramalingam et al. 2006). 
There are additional reasonings for conducting this type of work, including the distinct 
biochemical characteristics of collagen, which will be discussed in later chapters.    
Although less clinically relevant, the use of collagen with cells originating from 
immortalised cell lines could be attempted. This is because the biodegradability of fibrin 
can also be disadvantageous (Yang, Seol et al. 2007) when using engineered osteoblastic 
cell lines such as MC3T3 or 2T3s, which unlike primary cells, were observed to dissolve 
the fibrin matrix, which then fails to maintain integrity following 14 days of culture. This 
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is because immortalised cell lines like MC3T3-E1 continuously produce matrix 
metalloproteinases capable of degrading the extracellular matrix, such as MMP-2 and 
MMP-13, the later which is up-regulated in the presence of ascorbic acid along with 
MT1-MMP (Mizutani, Sugiyama et al. 2001). Ascorbic acid is already present in high 
quantities in the growth medium required for proliferation of these cells (MEM medium 
containing the alpha modification, approx. 50 mg/L or 0.28 mM) and further ascorbic 
acid supplementation is added from day 7 in order to induce differentiation (0.25 mM). 
From that point, the fibrin matrix can only maintain integrity for a maximum of 7 
further days. Composite models containing both types of scaffold could be attempted, as 
described by Yang and colleagues (2007) and could be used for fundamental studies 
where the requirement for primary cells is not obligatory. 
 
10.2 EARLY EVENTS 
In addition, it would be interesting to compare the early events and contraction to a 
group of constructs treated with pharmacological compounds which inhibit the 
contractile ability of the cells, such as statins. For this purpose, drugs which can arrest 
the actin dynamics in living cells could provide further information on the early 
organisation and matrix re-modelling. Compounds such as Latrunculin (Kopecka, 
Yamaguchi et al. 2015), which cause G-actin sequestration and prevent F-actin assembly 
in biological cells, and drugs which can interfere with the rearrangement of the actin 
network (Blebbistatin) and cytoskeletal structure (Atorvastatin, Simvastatin) and 
alternatives could be used (Watanabe, Yumoto et al. 2010, Peng, Wilson et al. 2011, 
Dick, Jonak et al. 2013). Moreover, statins such as Atorvastatin, Simvastatin and 
Fluvastatin have been shown to inhibit the production of MMPs in certain types of 
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fibroblasts embedded in 3D collagen cultures, including MMP-1, MMP-3 and MMP-9 
(Kamio, Liu et al. 2010), highlighting the important role of these enzymes in the initial 
matrix building process.  
 
10.3 MONITORING MINERALISATION 
The dynamics of mineral deposition could also be temporally and spatially monitored 
using chromogenic/fluorescently-labelled bisphosphonates (Bae, Sun et al. 2014). 
Bisphosphonates have been used for many years as the first line therapy for numerous 
bone myelomas, metastases, Paget’s disease, fractures and osteoporosis (McDonald, 
Schindeler et al. 2007, Drake, Clarke et al. 2008). They have the ability to bind to bone 
and to remain attached for many years, acting through several mechanisms, including 
by inhibiting osteoclastic activity (Maraka and Kennel 2015). The wide availability and 
the numerous types of bisphosphonates available would allow the design of a multi-
chromogenic labelling method for spatial localisation of the newly forming bone, which 
could complement the tomographic data and could provide another method to quantify 
the newly forming mineral. The same or different type of drug, labelled distinctly, could 
be applied to forming constructs with every feed, which would be of particular 
importance especially in the early ossification stages, when different mineral phases are 
laid down rapidly. 
 
10.4 COLLAGEN ORGANISATION      
It would be interesting to analyse constructs using transmission electron microscopy 
(TEM) at various points during the maturation process, as it would give information on 
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the organisation and mineralisation of collagen at the nano-scale (Everts, Niehof et al. 
2012).  
High-resolution Raman maps could be performed for constructs of different ages based 
on peaks corresponding to different matrix proteins and minerals (amides, phosphate 
groups, hydroxyproline). These maps can be superimposed and could offer detailed 
information on regional chemistry and the dynamics of matrix production and 
ossiffication. These maps can be further supported by histology for collagen using 
picrosirius red or van Gieson (Segnani, Ippolito et al. 2015)  and immunohistochemistry 
for collagen I.  
The presence of other matrix proteins in the newly forming matrix, such as sulfated 
glycoaminoglycans (GAGs) like chondroitin sulfate, chondroitin 6-sulfate and 
keratosulfate (Catini and Gheri 1990, Ling, Murali et al. 2006), also involved in 
ossiffication and bone function, could be evaluated using chemical colorimetric assays. 
This is particularly important as some types of GAGs have been found in high amounts 
around osteocytes (Catini and Gheri 1990), the development of which is discussed in the 
next chapter.  
 
10.5  MECHANICS OF CONTRACTION 
The ideal formation of a ‘periosteal’ structure in constructs could have also occurred 
due to a preferential migration of cells towards the edges of the culture well walls (and 
hence fibrin gels) and therefore, a higher number of cells could have given rise to 
additional bone tissue in this region. This could have been initiated by an ‘edge effect’ 
(Lundholt, Scudder et al. 2003), caused by a lack of uniform temperature transfer in the 
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culture wells (as a result of differences in plastic thickness) in the initial period of 
incubation.  
Viability and morphology analysis on different areas of constructs during the initial 7 
days of culture would be able to provide insight into this matter.  
To prevent this effect, several commercially available culture plates have been recently 
designed by many scientific suppliers (e.g. Thermo Fisher, USA; StarLab, UK), which 
provide a modified design in order to minimise this effect and provide a uniform layer 
of cells during culture and hydrogel embedding. One example (StarLab) is the chimney 
well design with 360° open channels around each well, which can be filled with cell 
growth medium during incubation to prevent the aggregation of cells at the edges. 
This type of culture system might also show differences in contraction or matrix 
production, which would be worth investigating for comparison.  
 
10.6 MECHANICAL PROPERTIES OF CONSTRUCTS  
It would be interesting to extend the AFM mechanical characterisation work towards 
constructing mechanical maps of whole constructs, but at a cellular resolution. High-
resolution maps on sections of early, intermediate and mature constructs could be 
generated using Nano-Indentation mapping (Chen, Lin et al. 2008, Chen, Schirer et al. 
2011). Mechanical properties including hardness and reduced modulus could be then 
compared to cellular distribution in order to obtain further information on the matrix 
properties around the osteo-canalicular networks. Additional information from this 
method could support the results seen in micro-tomographies, for example, the regional 
variation in mechanical properties due to the fracture union-like progress of ossification 
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and the density gradient from the central portion of constructs to the outer ‘periosteal’ 
like structure. 
 
10.7 MOLECULAR MARKERS 
Further molecular work should be carried out to detect the presence of other molecular 
markers involved in the transition of osteoblasts to osteocytes, including PHEX, DMP1, 
and FGF-23 (Dallas and Bonewald 2010) as well as the starting point of this transition 
(e.g. low ALPL). 
 
10.8 ENDOCRINE ROLE 
Immunocytological and histochemical work should be carried out to test whether the 
osteocytic cells express features indicating responsiveness to endocrine signalling 
(Dallas, Prideaux et al. 2013), such as expression of FGF-23 (which acts on the kidneys) 
or CX-43 gap junctions (Ishihara, Kamioka et al. 2008, Plotkin 2014) which  if positive, 
could make them a potential target for a range of drug investigations.  
 
10.9 VESICLE-MEDIATED MINERALISATION 
Additional work should be completed in order to further characterise the matrix 
vesicles detected in the medium of constructs. Chemical characterisation of protein 
content should be performed using mass spectrometry, to detect the presence of 
annexins (5,2,6,11) and peptidases (aminotripeptidase, alanyl beta-naphthylamidase) 
commonly described as being part of matrix vesicles (Hirschman, Deutsch et al. 1983, 
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Xiao, Camalier et al. 2007, Xiao, Conrads et al. 2008). Fluorescence imaging using super 
high-resolution microscopy (SIM, STED, PALM, STORM) (Huang, Bates et al. 2009, 
Wegel, Göhler et al. 2016) and TEM (Anderson 2003, Anderson, Sipe et al. 2004) would 
allow visualisation of these nanostructures.  
Demonstration of their role in cartilage mineralisation could be attempted using 
collagen type II – X surfaces (Wu, Genge et al. 1991).  
Numerous molecular techniques (qPCR, microarrays, ELISA, Western Blots) that would 
allow detection and isolation of MMPs, integrins, transport proteins and miRNA species 
could be used to characterise the role of these structures further (Jiang, Cui et al. 2013, 
Chaturvedi, Chen et al. 2015, Lin, Rodriguez et al. 2016).  
Further analysis of the cellular phenotype at different time points would be useful to 
reveal the peak of activity and type of cells which secrete the largest amount of vesicles 
(i.e. osteoblasts vs osteocytes). 
 
10.10 DRUG SCREENING AND ENDOCHONDRAL OSSIFICATION 
Further work should be carried out to determine whether the efficacy of CD1530 was 
due to an inhibition of cartilage formation in constructs. This would be able to confirm 
whether ossification in this system takes places through a cartilage intermediate as well 
as through an intramembranous route. This could be accompanied by histological 
staining with Alcian Blue and Sox-9 and Collagen II Immunohistochemistry. The 
formation of a cartilage template in some regions is very likely, as the population of 
stem cells isolated from the periosteum of long bones has a strong chondrogenic 
potential (see Chapter 1).  
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Investigations using CD1530 should be further expanded to detect the upper and lower 
limits of efficacy as well as efficiency over longer periods.  
The dose-response curves produced for all pharmacological agents investigated will be 
able to indicate the drug potential and biocompatibility. 
 
10.11 CHONDROCYTE CONSTRUCTS 
Chondrocyte constructs could be further exploited to simulate additional steps of the 
endochondral ossification pathway. With adequate optimization, constructs could be 
either partially decellularized to remove the chondrocytic cells, and the template could 
be used as a scaffold for newly-introduced osteoblasts (Thakkar, Fernandes et al. 2015). 
Alternatively, the population of osteoprogenitor cells could be co-cultured with the 
chondrocytes from an experimentally-determined time point. Moreover, as 
demonstrated here, vascularization of these structures can be attempted, creating an 
alternative route for in vitro bone formation and could recreate some additional stages 
of endochondral ossification, fracture repair and heterotopic ossification. Figure 5 
presents a list of all the cell types that have been tested with this system, together with 
their advantages and disadvantages.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 223 
Species Tissue Cell Type Contraction Mineral 
Avian Tendon Fibroblasts +++ - 
Human Cartilage Chondrocytes ++ - 
Human Blood Vessels Umbilical Vein Endothelial Cells + - 
Human Bone Osteoblasts + + 
Human Skin Dermal Fibroblasts ++ - 
Mouse Bone Osteoblasts (MC3T3) +++ +++ 
Mouse Bone Osteoblasts (2T3) +++ +++ 
Mouse Bone Marrow Stromal Cells + + 
Rat Bone Marrow Stromal Cells + ++ 
Rat Bone Periosteal cells ++ +++ 
Mixed Bone + Vessels 
Osteoblasts + 
 Umbilical Vein Endothelial Cells 
++ ++ 
     
 
Figure 10.1 | An account of cell types compatible with the present model. Several types of cells, including primary, expanded 
from tissue and cell lines were encapsulated in constructs. Their characteristics in terms of ability to fully contract the initial fibrin 
scaffold and their ability to mineralise the tissue were amongst the criteria used for evaluation in developing the final system. 
Periosteal cells of rat origin were selected due to their enhanced ability to contract the matrix and mineralise it. Cell lines tend to 
over-contract and detach the constructs from the anchors. 
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